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General introduction
Osteoarthritis
Osteoarthritis (OA) is the most prevalent form of chronic arthritic diseases, involving all 
tissues present in the joint, such as the cartilage, ligaments, menisci, muscle, the peri- 
articular bone and the synovium. It is considered one of the most disabling diseases in the 
Western world and the majority of people over 65 years of age have radiographic and/or 
clinical signs of OA [1]. The main characteristics (depicted in Figure 1) are degeneration of 
the articular cartilage, inflammation and fibrosis in the synovium, sclerosis of the subchondral 
bone plate and osteophyte formation at the joint margins. Clinically, OA is characterized 
by joint pain, stiffness, impaired mobility, signs of inflammation and eventually a loss of 
joint function [2]. Although various risk factors have been identified, the primary etiology 
of the disease remains to be elucidated. Aging is generally considered one of the main risk 
factors, together with other systemic factors, such as genetic predisposition, race, gender 
and nutritional behavior. In addition, also local risk factors such as abnormal loading (due to 
joint deformation, obesity or abnormal physical activity leading to trauma) are involved 
in the pathogenesis of OA [3-9]. Due to the increase in the incidence of obesity and the 
increasing life expectancy, the incidence of OA will rise in the future [10].
Although these risk factors have been well-established, due to its multifactorial origin and 
a lack of knowledge about underlying pathological mechanisms, no satisfying disease- 
modifying therapies have so far been developed. This limits current therapies to increasing 
the mobility and controlling the pain that patients experience [11].
Figure 1  Schematic overview of pathophysiological changes in osteoarthritis.
On the left, a healthy joint is depicted with the main tissue structures present in a synovial joint. On the 
right, a joint with osteoarthritis is depicted, which shows synovial inflammation, synovial fibrosis, 
osteophyte formation, cartilage degeneration, cartilage loss and sclerosis of the subchondral bone. 
These pathologies are the main hallmarks of osteoarthritis.
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Osteoarthritis as a whole joint disease
In the past, OA was considered a wear and tear disease where degeneration of the articular 
cartilage was the result of either increased pressure on one joint or fragile cartilage matrix, 
two conditions that are affected by the previously described risk factors. The main 
functions of articular cartilage are absorbing stress and providing a smooth surface that 
results in nearly frictionless movement. This is made possible by the structure of healthy 
articular cartilage, which consists of chondrocytes that are embedded in a unique 
extracellular matrix that mainly consists of collagen and proteoglycans. The major collagen 
present in the cartilage is collagen type II, whereas aggrecan is the most abundant 
proteoglycan [12]. During OA, this matrix is broken down, due to an imbalance between 
anabolic and catabolic processes. A shift towards dominance of catabolic processes is 
both the cause and result of increased production of pro-inflammatory cytokines and/or 
catabolic enzymes that can break down the cartilage matrix. The most important families 
of catabolic enzymes that are involved in OA pathology are the matrix metalloproteinases 
(MMPs) and members of the “a disintegrin and metalloproteinase with thrombospondin 
motifs” (ADAMTS) family. Specifically, MMP1 [13, 14] and MMP13 [13-15], both collagenases, 
MMP2 [16], MMP3 [14, 17] and MMP9, which degrade non-collagen matrix components, 
and the aggrecanases ADAMTS4 and ADAMTS5 [18-20] have been implicated in OA 
pathology. Yet, the paradigm that both cause and effect of OA are solely to be sought 
after in the articular cartilage has shifted towards the idea that the disease involves all 
tissues that are present in the articular joint: the articular cartilage, bone, ligaments, 
muscles, menisci and synovium. Together, this shifted the view of clinicians and researchers 
on OA towards a “whole joint” disease. Important pathophysiological hallmarks, such as 
changes in the subchondral bone, osteophyte formation, inflammation and fibrosis in the 
synovium are likely to be involved in the disruption of normal joint homeostasis [21-23]. 
However, degeneration of the articular cartilage is still considered the foremost characteristic 
of the disease. 
The synovium as important player in osteoarthritis pathology
It is increasingly recognized that the synovium plays an important role in the pathogenesis 
of OA [22, 23]. The synovium is the tissue that lines the joint cavity and consists of the 
intima layer, which is only a couple of cell layers thick and contains type A macrophage-like 
cells and type B fibroblast-like cells. Under this layer, we find the loose subintima layer that 
mainly consists of connective tissue and blood vessels. The synovium produces synovial 
fluid, which contains lubricating substances. Furthermore, because the cartilage is avascular, 
it is dependent on the synovium for its nutrients. During OA the synovial tissue can 
become thickened as the result of influx and possibly local proliferation of cells. Although 
synovitis is less severe and shows higher variability in OA patients compared to rheumatoid 
arthritis (RA) patients, this process is nowadays generally believed to be actively involved 
in the disease development. Around 50% of OA patients show activation or inflammation 
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of the synovium as was found using arthroscopy [24] and it has been found that inflammation 
correlates with cartilage damage [25-27]. Furthermore, depletion of macrophages, which 
are important in innate inflammatory reactions, results in reduced cartilage damage and 
osteophyte formation [28, 29]. The synovial tissue produces a plethora of factors that 
aggravate the inflammatory reaction in the joint, such as toll-like receptor ligands, various 
cytokines and chemokines and gives complement activation (reviewed in [30]). 
Despite this increasing knowledge about factors and mechanisms that might underlie the 
pathogenesis of OA, no satisfying therapies have been established so far. This urges for 
further research to uncover possible therapeutic targets. In this light, it is of importance to 
mention that previous studies in our lab have revealed strongly increased expression of 
the alarmins S100A8/A9 and various members of the Wnt signaling pathway in the synovium 
during experimental animal models of osteoarthritis, especially in the collagenase- 
induced OA model that has considerable synovial inflammation [31, 32]. Later, we 
elucidated the roles of these factors during OA in follow-up studies.
S100A8 and S100A9
S100A8 and S100A9 are two members of the S100 family, which are considered damage 
associated molecular patterns (DAMPs) and are mainly produced by granulocytes, 
monocytes and activated macrophages and have been shown to activate the innate 
immune system mainly via Toll-like receptor (TLR)4 [33]. Both members potently induce 
the production of a wide range of pro-inflammatory molecules in various cell types present 
in the joint, such as macrophages, osteoclasts and chondrocytes. Among other, upregulation 
of interleukin (IL)-1β, IL-6, IL-8 and tumor necrosis factors-α (TNFα), but also various MMPs 
under the influence of S100A8/A9 has been reported [34-37]. S100A8/A9 are present in 
high levels in the synovial fluid of patients with (RA) but are also found in OA, and these 
levels have been shown to correlate with disease activity and joint damage [38, 39].
In the context of OA, we have previously shown that stimulation of chondrocytes with 
S100A8/A9 induces the production of catabolic mediators, such as MMP1, MMP3, MMP9 
and MMP13 as well as various cytokines, including IL-6 and IL-8 in a TLR-4-dependent 
manner [37]. Moreover, S100A8/A9 were shown to aggravate osteophyte formation in 
experimental osteoarthritis and to predict progression of osteophyte growth in a cohort 
study of patients with early symptomatic OA [40]. Finally, we have demonstrated that 
inhibition of S100A9 with the quinoline-3-carboxamide paquinimod reduced synovial 
thickening, cartilage degeneration and osteophyte formation in an experimental animal 
model of OA [41].
Wnt signaling
First identified in 1982 [42], Wnt proteins are today known to have crucial functions in most 
animal species [43]. Wnt signaling is involved in multiple biological processes, including 
embryonic development, organogenesis and tissue homeostasis. Not surprisingly, dysfunction 
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of this signaling pathway is associated with a number of diseases [44]. The family of Wnt 
ligands consists of at least 19 members. They are characterized as glycoproteins that need 
to undergo post-translational modification, such as glycosylation and acylation, in order to 
carry out their signaling activity [45-48]. Porcupine in the endoplasmic reticulum catalyses 
the binding of a palmitoyl lipid molecule to the Wnt protein, which is necessary for its 
function [49]. Additionally, Wntless has been attributed a central role in the intracellular 
shuttling and secretion of Wnt proteins [50].
Wnt proteins can signal via the canonical and various noncanonical pathways. The 
canonical pathway is characterized by the translocation of β-catenin into the nucleus, 
whereas β-catenin-independent cascades are collectively classified as noncanonical. 
Since several Wnt proteins have the capacity to signal via both pathways [51, 52], signaling 
is increasingly being considered dependent on the cellular context in addition to the 
features of individual Wnt proteins. An overview of the various Wnt signaling pathways is 
provided in Figure 2. 
The main cell surface receptors for all Wnt signaling pathways are the Frizzled (FZD) 
receptors [53, 54]. These receptors are G-protein-coupled seven-transmembrane domain 
proteins with an extracellular Wnt binding domain. Although it is generally believed that 
various Wnt ligand proteins can bind to one FZD family member and that one Wnt ligand 
can bind to various FZD receptors, the specific combinations remain to be elucidated. This 
can be largely attributed to the problems in synthetic production or purification of specific 
Wnt proteins, due to their hydrophobic character and the extensive post-translational 
modifications that are necessary for their biological activity.
Canonical Wnt signaling
In order to activate the canonical signaling pathway, binding of a Wnt ligand to both its 
FZD receptor and the co-receptors low-density lipoprotein receptor-related protein 
(LRP)5/6 is required (the off-state of canonical Wnt signaling is shown in Figure 2A, 
whereas active canonical Wnt signaling is displayed in Figure 2B). This triggers the release of 
β-catenin from its inhibitory protein complex [consisting of glycogen synthase kinase-3 
(GSK3-β), casein kinase 1-α (CK1α), adenomatous polyposis coli (APC) and Axin2], which in 
the off-state phosphorylates and ubiquitinates β-catenin, leading to proteasomal 
breakdown. In the on-state, Axin is relocated to the cytoplasmic tail of LRP5/6 where it 
forms a complex with Dishevelled (Dvl) and GSK3-β. This allows the accumulation of free 
β-catenin in the cytoplasm and the translocation into the nucleus where it binds the TCF/
LEF transcription factors. In the absence of β-catenin, TCF/LEF act as repressors of target 
transcription in a complex with Groucho. However, when translocated into the nucleus, 
β-catenin displaces Groucho and thereby converts the TCF/LEF complex to transcriptional 
activators causing the transcription of target genes that were repressed by TCF/LEF alone. 
A protein complex is formed, in which it has been shown that β-catenin binds to the 
histone modifiers Brg-1 and CBP and to Cdc73 [44, 55], whereas other players in this 
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complex are BCL9 and Pygopos. One of the proteins that is induced by active canonical 
Wnt signaling is Wnt1-induced Secreted Protein-1 (WISP1), a matricellular protein that 
belongs to the CCN family [56].
Figure 2  A schematic overview of the Wnt signaling cascades.
The canonical Wnt signaling cascade is dependent on the intracellular signaling molecule β-catenin. 
In the off-state (A), β-catenin is sequestered in a destruction complex, consisting of APC, Axin, 
CK1 and GSK-3β, which causes the phosphorylation, ubiquitination and proteasomal degradation 
of β-catenin. This happens when no Wnt ligands are present, when Wnt ligands are secluded by 
binding to soluble Wnt inhibitors, such as WIF-1 or sFRP family members, or when the inhibitors of 
canonical Wnt signaling SOST or the DKK family members bind to the LRP5/6 co-receptors, which is 
necessary for activation of the canonical Wnt signaling pathway. Upon binding of a Wnt ligand to its 
Fzd receptor, in the presence of the LRP5/6 co-receptors, DSH associates with the intracellular part 
of the Fzd receptor and subsequently recruits the destruction complex to the cell membrane, which 
allows the accumulation of free β-catenin in the cytoplasm and the translocation of this protein into 
the nucleus (B). There, β-catenin disrupts the binding of the co-repressor Groucho to members of the 
TCF family of transcription factor, and binds itself to these TCF transcription factors in the presence of 
CBP, Cdc37, Brg-1, BCL9 and Pygo, which causes the transcription of a multitude of target genes. In 
the less well-studied noncanonical Wnt signaling cascade (C), when binding of Wnt ligands to their 
Fzd receptors is not inhibited by soluble Wnt inhibitors, multiple intracellular pathways are activated. 
These include MAP-kinase pathways, such as JNK and PKC, whereas a central role is attributed to the 
release of calcium, which activates calcineurin and CaMKII pathways.
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Noncanonical Wnt signaling
In addition to the β-catenin-dependent canonical Wnt signaling pathway, various β-catenin- 
independent noncanonical signaling pathways exist (which are shown in Figure 2C), 
promoting intracellular signaling after binding of a Wnt ligand to its FZD receptor. 
Although it is generally believed that noncanonical Wnt signaling cascades have crucial 
roles in the regulation of cell differentiation, shape, orientation and the migratory 
capacities of cells, the signaling pathways are less well-studied than the canonical pathway 
and therefore lack well-defined insights in the intracellular signaling machinery. 
Noncanonical Wnt signaling includes the Ca2+ and planar cell polarity pathways [57], 
which engage in the regulation of cell mobility, differentiation and communication 
[58-60]. When Wnt ligands activate noncanonical Wnt signaling pathways, by binding to 
FZD receptors without interacting with the LRP 5/6 co-receptors, the FZD receptors cause 
activation of more common intracellular signaling pathway members such as the mitogen 
activated kinases (MAPKs), p38, c-Jun N-terminal kinase (JNK) and protein kinase C (PKC). 
Additionally, noncanonical Wnt activation can result in the intracellular release of calcium, 
activating calcium/calmodulin-dependent protein kinase II (CaMKII). While at present the 
majority of studies focus on the role of canonical Wnt signaling in OA, noncanonical 
signaling might add to the complexity of the processes involved because it can affect 
multiple cell types present in the joint and is known to counter-regulate canonical Wnt 
signaling [61, 62]. 
Antagonists of Wnt signaling cascades
In view of the fact that Wnt signaling cascades are involved in such a cornucopia of 
biological processes, it is not surprising that all cascades are tightly regulated by a set of 
inhibitors in addition to Wnt signaling agonists (Figure 2A shows Wnt antagonists that 
keep the Wnt signaling pathway in an off-state). Members of the Dickkopf (DKK) family 
and sclerostin are being considered Wnt inhibitors. They can bind to LRP5/6, interfering 
with the ability to interact with Wnt-FZD, thereby specifically inhibiting the canonical Wnt 
signaling pathway. Although considered Wnt/β-catenin inhibitors, the DKK family 
members all have different functions. DKK2 can act either as inhibitor or activator of the 
pathway, whereas DKK3 was not found to inhibit Wnt signaling. Furthermore, the family of 
secreted Frizzled-related proteins (sFRP) 1-4 and Wnt inhibitory factor (WIF)-1 act as 
soluble scavengers of Wnt ligands, thereby preventing the activation of both canonical 
and noncanonical Wnt signaling cascades. The sFRP family members resemble the CRD 
domain of the FZD receptors, which binds to Wnt ligands, thereby sequestering Wnt 
ligands away from their FZD receptors. Although the exact mechanism how WIF-1 inhibits 
Wnt signaling remains poorly understood, it is suggested that, in a comparable way as 
sFRPs function, WIF-1 prevents binding of Wnt proteins to FZD receptors.
15
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The implications of Wnt proteins in osteoarthritis
Wnt signaling during development of joint tissues
Balanced canonical Wnt signaling is critical for the correct development and function of 
the tissues that are present in the joint [63, 64], which implies that dysfunctional Wnt 
signaling might disturb developmental processes and increase susceptibility to OA.
Canonical Wnt signaling has been shown to affect chondrogenic differentiation of cells at 
various developmental stages and to play a crucial role in skeletal development [65]. 
Furthermore, active β-catenin signaling is important for the formation of the secondary 
ossification center and epiphysal cartilage development [66]. While canonical Wnt 
signaling was found to inhibit chondrogenesis during early developmental stages [67-69], 
it promotes hypertrophic differentiation of mature chondrocytes [70-72]. In contrast, 
activation of noncanonical signaling stimulates early chondrogenesis while inhibiting 
terminal differentiation [73]. Finally, it has been suggested that canonical Wnt signaling 
stimulates osteoblast maturation [67, 72].
Genetic evidence – Wnt signaling in OA
Various groups have stressed the requirement of Wnts for correct joint homeostasis and 
that imbalanced Wnt signaling is linked to the development of OA. Despite some 
discrepancies [74], several studies have provided strong genetic evidence for the 
association between single nucleotide polymorphisms (SNPs) in the gene encoding the 
Wnt inhibitor sFRP-3/FRZB and OA. It has been suggested that disease-associated variants 
show decreased binding affinity for Wnt ligands, thereby exhibiting a reduced capacity to 
antagonize β-catenin signaling [75]. Another genetic study confirmed the role of Wnt 
signaling in OA because a polymorphism in the Frizzled co-receptor LRP5 was associated 
with an increased risk of spinal OA [76]. Mutations in LRP5 prevent the Wnt signaling 
antagonists sclerostin and DKK1 from binding [77-79], thus inducing pathology due to 
increased Wnt signaling. Accordingly, several studies have shown that LRP5 variants 
influence human bone density [80-82], and a homozygous mutation in LRP5 was 
associated with osteoporosis-pseudoglioma syndrome [81].
Differential expression of Wnt members
While polymorphism studies established a significant link between mutations in proteins 
of the Wnt signaling cascade and OA, these assumptions were furthermore reinforced by 
gene expression analyses. The association found between a mutation in the Frizzled 
co-receptor LRP5 and OA [76] could be supported by a study linking deficiency of LRP5 to 
joint pathology in mice [83]. Absence of FRZB resulted in increased expression of MMP3 
and augmented cartilage damage in vivo in experimental OA [84]. Cartilage loss was 
associated with increased β-catenin levels, suggesting that FRZB plays a regulatory role in 
β-catenin accumulation [85]. A link between increased β-catenin activity and OA 
pathology could furthermore be established, because β-catenin accumulation was found 
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in the superficial cartilage layer in several OA models [32] and in areas of degeneration 
[86-89]. The pathological effect of this differential gene expression was explained as due 
to activation of β-catenin because it stimulated OA hallmarks, such as hypertrophy, matrix 
mineralization, expression of MMPs and vascular endothelial growth factor in mature 
cartilage cells. In a study by Zhu et al., inducible overexpression of β-catenin in mature 
chondrocytes resulted in increased expression of the maturation markers collagen type X 
and osteocalcin, increased levels of MMPs and strongly increased cartilage degeneration 
[88]. A similar experimental setup showed that β-catenin induced articular cartilage 
thickening, and increased cell density and proliferation [90]. Meanwhile, while their 
presence in cartilage is confirmed, no (or only subtle) differential expression could be 
detected for Wnt proteins in cartilage of OA models [32, 91]. Dell’Accio et al. [91] found an 
upregulation of Wnt16 in human OA cartilage; however, no differential expression could 
be confirmed for other Wnt proteins. Interestingly, whereas our lab could not find 
differentially regulated Wnt ligands in the cartilage [32], we observed strongly increased 
expression of several Wnt ligands, including Wnt2b and Wnt16, in the synovium in 
experimental OA. These findings are of particular relevance in light of OA as a disease of 
the entire joint. Notably, the Wnt-induced protein WISP1 was increased in both the 
synovium and the cartilage, suggesting migratory capacities of Wnts produced in the 
synovium are enabling canonical Wnt signaling in the cartilage [32]. In addition, the Wnt 
signaling cascade has been linked to the induction of cytokine expression. Overexpression 
of Wnts in fibroblasts results in increased expression of IL-6, IL-15, and TNF-α but also MMPs 
[92-94]. Another study showed that Wnt3a potentiates IL-1β, stimulating the loss of 
proteoglycans from the matrix [95]. The production of pro-inflammatory cytokines and 
matrix-degrading enzymes in the synovium has been attributed an important role in the 
process of OA, as elegantly reviewed by both Berenbaum et al. and Scanzello et al. [30, 96].
Less well-studied is the role of Wnt signaling in other features of OA pathology including 
ectopic bone formation and fibrosis. Nevertheless, canonical Wnt signaling has been 
described as a central pathway in bone formation [97-101]. In this context, DKK1-mediated 
inhibition of the canonical Wnt pathway was associated with decreased bone mass [102]. 
Moreover, Wnt activity orchestrates osteoblast maturation [67, 72], whereas Wnt signaling 
decreases osteoclast activity [99]. Hence, the balance is shifted towards anabolism, 
suggesting an active role of canonical Wnt signaling in osteophyte formation and 
subchondral plate sclerosis during OA [88, 97, 103]. Furthermore, many OA patients suffer 
from severe fibrosis in the synovium, which is a major contributor of joint stiffness [104]. In 
the past, Wnt signaling has been linked to many types of fibrosis, including pulmonary 
[105-108], liver [109-111] and renal fibrosis [112-114].
Altogether, these data suggest that increased canonical Wnt signaling is not merely 
present in OA, but in fact plays an active role in the development of OA pathology. Despite 
the destructive role of excessive canonical Wnt signaling in cartilage, extreme care should 
be taken in inhibiting this process. Balanced Wnt signaling has been shown to inhibit 
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chondrocyte apoptosis and has therefore been recognized as having a protective role 
[115-117]. In support of this, conditional knock-down of β-catenin induced chondrocyte 
apoptosis and cartilage destruction in mice [118]. Chondrocyte apoptosis could be 
detected upon inflammation-induced elevation of DKK1 expression; the associated 
OA-phenotype underlines the necessity of Wnt signaling for cell survival [119]. Furthermore, 
inhibition of the Wnt signaling antagonist DKK1, showed its protective potential for 
cartilage and bone in a rat OA model [120]. In contrast, various other studies using 
overexpression of the Wnt signaling inhibitor DKK1 clearly demonstrate a protective role 
of DKK1 in OA [97, 103].
In summary, increased β-catenin activity has been shown to induce cartilage destruction 
by affecting the chondrocyte phenotype and stimulating the expression of pro-inflam-
matory cytokines and proteases. However, blocking of excessive signaling might trigger 
equally detrimental effects as has been suggested in chondrocyte viability studies. Thus, 
a correct balance of active Wnt signaling is ultimately required to ensure healthy joint 
tissue, making targeting of upstream Wnt signaling complicated. Possible leads for 
therapeutic intervention might be found in the profound crosstalk that Wnt signaling has 
with other pathways, such as the TGF-β signaling pathway.
Crosstalk between the Wnt and TGF-β signaling pathway
Whereas the importance of balanced Wnt signaling for maintenance of the tissues in the 
joint has been described in the previous section, similar importance in maintaining joint 
homeostasis has been attributed to the TGF-β signaling pathway. Interestingly, while 
canonical Wnt signaling enhances the rate of chondrocyte maturation, TGF-β signaling via 
ALK5, resulting in Smad2/3 phosphorylation potently blocks chondrocyte hypertrophy. 
Additionally, TGF-β has been shown to bind to the ALK1 receptor, which results in 
Smad1/5/8 phosphorylation, a pathway that is known to mediate BMP signaling and 
which is associated with chondrocyte hypertrophy and hallmarks of cartilage destruction 
[121-124].
Several studies have highlighted a profound interplay between Wnt signaling and TGF-β 
signaling and have shown that this interaction orchestrates the processes in which both 
signaling pathways are involved [125, 126]. However, the molecular mechanisms and 
impact of the communication between the Wnt and TGF-β pathways are largely unknown. 
In this section we present up-to-date knowledge about the complex interplay between 
the pathways at the extracellular, cytoplasmic and nuclear level, and this is schematically 
summarized in Figure 3.
Extracellular Wnt/TGF-β crosstalk
TGF-β and Wnt ligands have already been shown to regulate each other’s expression 
during early development. Wnt8c induces the expression of the TGF-β family member 
Nodal [127], whereas a study in Xenopus found Wnt8 expression to be regulated by TGF-β 
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family members [128] (Figure 3, extracellular compartment where modulators of 
extracellular signaling are shown in yellow). On the other hand, BMP-2 enhanced 
chondrogenesis by downregulating Wnt7 and β-catenin expression [129]. An additional 
study revealed the requirement of β-catenin for BMP-4 expression in human cancer cells 
[130]. Several extracellular proteins, including sclerostin, CTGF and sFRPs modulate and are 
modulated by receptors or ligands of both the Wnt and TGF-β pathways [131-135]. Among 
others, sclerostin was shown to antagonize canonical Wnt signaling by binding to the 
receptor LRP5/6. Notably, inhibition via sclerostin was in turn shown to be modulated by 
BMPs [131, 132]. Like sclerostin, CTGF modulates Wnt signaling [134] and exhibits binding 
capacity for both BMP-4 and TGF-β. Interestingly, whereas binding of CTGF to BMP 
receptors reduces the activity of BMP-4, TGF-β activity is enhanced upon binding to CTGF 
[133]. In contrast, CTGF expression has been shown to be tightly regulated by Wnt3A and 
BMP-9 which have been suggested to be crucial in normal osteoblast differentiation [136].
Communication in the cytoplasm
In addition to the active crosstalk between the extracellular compartments of Wnt and 
TGF-β signaling, complexity of interaction between both pathways is further enhanced 
on the intracellular level (an overview of the interactions described in this section can be 
found in Figure 3, cytoplasmic compartment). In the cytoplasm of adult human 
mesenchymal stem cells (MSC), TGF-β induces nuclear translocation of β-catenin in a 
Smad3-dependent manner, thereby increasing activation of canonical Wnt signaling. 
β-catenin thus stimulates the proliferation of MSCs and inhibits their osteogenic differen-
tiation via TGF-β [137]. Synergistic signaling was found to stimulate chondrocyte differen-
tiation and to inhibit adipocyte gene expression [138]. The effect of the Wnt pathway on 
chondrogenesis was further investigated by Im et al. [139], who demonstrated 
enhancement of early chondrogenesis upon application of Wnt inhibitors. The effect of 
the Wnt inhibitor sFRP-1 on chondrogenic expression levels was however obscured by 
TGF-β during long term culture, suggesting that TGF-β overrides the effect of β-catenin 
during later chondrogenesis. In murine MSCs, BMP-7 was introduced to regulate 
chondrogenic and osteogenic differentiation. Simultaneously, BMP-7 inhibits Wnt11 and 
BMP-4 expression, whereas Wnt5b expression was found to be upregulated during 
chondrogenic differentiation [140]. Therefore, even during the early developmental 
stages, a tight regulation of the crosstalk between Wnt and TGF seems essential for 
accomplishing the normal course of bone and joint development. In contrast, BMP-2 was 
found to inhibit Wnt signaling in mouse MSCs. In this context, an interaction between 
Smad1 and Dvl, occurring in the presence of BMP-2, prevented nuclear translocation of 
β-catenin [141]. It has been suggested that signaling between the pathways is further 
modulated via Axins and GSK3-β. Active canonical Wnt signaling increases the expression 
of Axin. In contrast, TGF-β-induced Smad signaling decreases its expression [142], and in 
doing so it releases a brake on canonical Wnt signaling. Both proteins were found to be 
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essential for Smad3 phosphorylation [143]. Another study showed that binding of 
non-phosphorylated Smad3 to Axin and GSK3-β results in its basal degradation [144]. In 
line, it has been previously described that Wnt and WISP1 can inhibit Smad2 phosphory-
lation in human bone marrow stromal cells [145], while inducing Smad1/5/8 signaling [146, 
147], which can affect the chondrocyte phenotype (these interactions are shown at the 
right side of the cytoplasmic compartment in Figure 3).
Figure 3   Profound crosstalk between TGF-β and canonical Wnt signaling is present on 
various levels in the cell.
A schematic overview of the many interactions that TGF-β and canonical Wnt signaling have, both 
outside and inside the cell. Proteins involved in the Wnt signaling pathway are depicted in grey, with 
β-catenin as a central protein in canonical Wnt signaling depicted in green. Furthermore, proteins 
involved in TGF-β signaling are indicated in blue. Additionally, extracellular modulators of cell 
signaling are shown in yellow. Finally, WISP1 is a Wnt/β-catenin-induced protein that plays a central 
role and is depicted in orange.
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Interactions in the nucleus
In addition to their cytoplasmic interaction, the Wnt and TGF signaling pathways 
communicate within the nucleus (see Figure 3, nuclear compartment) wherein they 
 synergistically regulate target genes. Co-regulation by these pathways has been 
established for several genes involved in developmental processes [148-151] as well as 
during tumor development and progression [152, 153]. A study in mouse gastric cancer 
cells shows that the mouse gastrin promoter is synergistically regulated by the Wnt and 
TGF pathway. Smad3/Smad4 and LEF/TCF can thereby mutually act as co-factors while 
their interaction is stabilized by the p300 co-activator protein. Notably, either the Smad or 
LEF/TCF binding side is sufficient to recruit the transcriptional activation complex [154]. 
Synergistic activation of LEF1/TCF by the TGF-β and Wnt signaling pathways was confirmed 
by Letamendia et al. [155]. Furthermore, Smads and Wnts regulate their expression inter-
dependently, because β-catenin was found to inhibit TGF-β signaling in chondrocytes [142]. 
In turn, Li et al. [156] demonstrated that Smad3 signaling could induce β-catenin signaling 
in murine neonatal sternal primary chondrocytes. 
Clear crosstalk between canonical Wnt signaling and TGF-β signaling that affects the disease 
outcome has been demonstrated in fibrotic disorders, and this might similarly apply to OA 
pathology. While TGF-β is a well-known pro-fibrotic factor, several studies have shown 
Wnt-activation in TGF-β-induced fibrogenesis [157, 158]. Akhmetshina et al. [158] demonstrated 
that TGF-β stimulates canonical Wnt signaling in cultured fibroblasts. TGF-β-mediated 
activity of β-catenin has previously been shown to be induced via Smad3 [157]. 
Furthermore, inhibition of the canonical Wnt signaling pathway effectively blocked TGF-β 
receptor 1-driven fibrosis [159], whereas Wnt signaling was activated downstream of TGF-β 
in fibroblasts during wound repair [160]. Furthermore, TGF-β induced WISP1 expression 
in pulmonary fibrosis and liver fibrosis [161, 162]; TGF-β itself was found to be regulated 
by the microRNA miR-92a [162]. Furthermore WISP1 showed upregulated gene expression 
in TGF-β-induced myofibroblast differentiation [163], strengthening the purported role 
of crosstalk between TGF and Wnt in fibrotic processes. 
Altogether these findings indicate that communication between TGF and Wnt signaling 
proteins plays an important role in processes that act in the regulation of joint tissue 
homeostasis and are therefore likely to be important in the development of OA pathology. 
Crosstalk was found not only in cartilage, influencing chondrogenesis and chondrocyte 
hypertrophy, but was furthermore found in fibrogenesis and osteogenesis. Affecting all 
tissues involved in the whole joint disease OA, crosstalk between TGF and Wnt signaling 
may have the exciting opportunity for therapeutic purposes. 
However, since Wnt signaling is extremely complex and tightly regulated and has essential 
functions in many biological processes, targeting of upstream Wnt signaling is likely to 
produce undesired side effects. Thus, a downstream target, which has been shown to 
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modulate the OA-related effects induced by Wnt signaling, might be a more appropriate 
therapeutic target, less likely to produce side-effects. In this context, WISP1 has drawn 
increasing attention as a more feasible target for OA therapy.
WISP1 as central mediator of Wnt signaling in osteoarthritis pathology?
WISP1 (CCN4) is one of six members of the cysteine-rich CNN (connective tissue growth 
factor, Cyr61, NOV) family which are characterized by four distinct functional domains: 
next to an insulin-like growth factor–binding protein–like module (IGFBP), all members 
except CCN5 consist of a von-Willebrand factor type C repeat (VWC), a cysteine-rich 
C-terminal (CT) module and a thrombospondin type 1 repeat (TSP1). The CCN protein family 
has been assigned to the group of matricellular proteins, characterized by their function in 
extra cellular signal modulation and coordination [164]. Various biologic processes have 
been indicated to be modulated by CCN proteins; among others tumorigenesis, chondro-
genesis, osteogenesis, angiogenesis, apoptosis and hematopoiesis [165]. Given the many 
processes that CCN proteins are implicated in, it is evident that they are furthermore involved 
in numerous pathologies, including various cancers and fibrotic disorders [166-169].
The importance of WISP1 in the context of skeletogenesis has been demonstrated, since 
a particularly high expression of WISP1 was found at sites of new bone formation and in 
healing fracture calluses. Additionally, WISP1 was shown to promote bone morphogenetic 
protein (BMP)2-mediated osteoblast differentiation in vitro while repressing chondrogenic 
 differentiation [170]. 
Recently, WISP1 has gained attention as a promising target for OA therapy research, 
because a SNP in WISP1 has been associated with spinal OA, and in particular with the 
severity of endplate sclerosis [171]. Additionally, an earlier study [32] demonstrated that 
WISP1 was significantly upregulated in experimental human OA cartilage and synovium. 
Since no upregulation of Wnt proteins could be detected in OA cartilage [32, 91], it was 
suggested that WISP1 was produced as a response to Wnts that have diffused into the 
cartilage after expression in other tissues such as synovium.
Linking WISP1 expression to cartilage destruction, WISP1 was shown to trigger the release 
of matrix-modulating enzymes such as MMPs and aggrecanases from macrophages and 
chondrocytes independent of IL-1 [32]. Moreover, in line with induction of canonical Wnt 
signaling by Wnt3a, we describe in Chapter 5 that WISP1 skews TGF-β-induced Smad 
signaling towards dominant signaling via Smad1/5/8, which can result in increased 
hypertrophic differentiation of chondrocytes. Previously, WISP1 has been shown to 
regulate the TGF-β pathway to control osteoblast function in human bone marrow 
stromal cells (hBMSC) [145]. Additionally, a study by Ono et al. [146] shows that WISP1 can 
potentiate BMP-2 effects on osteogenesis by increasing Smad1/5/8 phosphorylation. The 
same study demonstrated that WISP1 potentiated osteogenesis in transgenic mice.
Additional studies suggest a critical role of WISP1 in synovial tissue. WISP1 was found to 
stimulate a pro-inflammatory response in macrophages of human adipose tissue and to 
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increase the expression of IL-6 in human synovial fibroblasts, via activation of PI3K, Akt 
and NFκB [172]. Furthermore, WISP1 induced the expression of vascular cell adhesion 
molecule-1 (VCAM-1) in human OA synovial fibroblasts [173], promoting monocyte 
adhesion. This could promote synovitis, because mononuclear cell migration has 
previously been identified as an important modulator in synovial inflammation [174, 175]. 
Furthermore, WISP1 plays a role in fibrotic processes, in which it is shown to stimulate 
fibroblast proliferation along with matrix protein expression in cardiac fibroblasts [176]. 
An additional study revealed WISP1 as a potential therapeutic target in pulmonary fibrosis 
modulating the expression of genes known to be involved in fibrosis towards an 
attenuation of lung fibrosis [166].
These data make it likely that WISP1 is involved in the induction of OA-associated processes, 
such as cartilage damage and osteophyte formation, changes in the subchondral bone, 
and fibrogenesis and inflammation of the synovium. Therefore WISP1 might be an 
appealing downstream target of canonical Wnt signaling to study in the field of OA. These 
implications about how WISP1 might be involved in the induction of OA pathology are 
shown in Figure 4. However, the exact pathway by which WISP1 modulates the tissues in 
Figure 4   Proposed implications for WISP1 in the osteoarthritic joint.
The Wnt/β-catenin-induced protein WISP1 is strongly overexpressed in both the synovium and 
cartilage during experimental and human OA. Based on the literature, we propose that WISP1 is 
likely to play a role in many processes seen during OA. These include the induction of chondrocyte 
hypertrophy and cartilage degeneration (the latter via increased production of proteases that can 
break down the cartilage matrix). In addition, WISP1 has been shown to induce fibrogenesis and 
inflammation by both monocyte adhesion and cytokine production. Finally, WISP1 is a well-known 
inducer of osteoblasts differentiation and a potent inducer of osteogenesis, which can result in 
increased osteophyte formation and sclerosis of the subchondral bone in the joint.
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the joint is still largely unknown. Progress in understanding the underlying mechanism of 
WISP1-induced joint destruction might reveal an attractive alternative therapeutic approach.
Conclusion
This overview shows that an imbalance of Wnt signaling has been associated with the 
development of OA and mainly β-catenin-dependent canonical signaling has been 
associated with OA-related processes and the resulting pathology. This makes the 
canonical Wnt signaling pathway a possible tool for the reestablishment of joint 
homeostasis. However, due to the complexity of the pathway, extreme care should be 
taken when interfering with proteins of the upstream Wnt signaling cascade, prone to 
affect other biological processes or to trigger undesired side effects. In this thesis we will 
further build on the existing knowledge about the role of Wnt signaling in OA and will 
offer new avenues of research for the possible treatment of this disease. 
Objective and outline of this thesis
The objective of the research described in this thesis is to enhance our knowledge about 
the role of Wnt signaling in OA, the world’s most common degenerative joint disease, 
which causes a huge burden on both the individual patient and the society as a whole. No 
disease-modifying treatments are available, urging for more research into the mechanisms 
underlying the eventual pathology that the disease is characterized by, with cartilage 
degeneration being considered the main hallmark. Many people today consider OA to be 
a recapitulation of developmental processes later on life. This makes the Wnt signaling 
pathway, which is strongly involved in the development of many tissues in the joint, an 
interesting pathway to consider in the field of OA research.  
Our lab previously showed a strong upregulation of several of the Wnt ligands in the 
synovial tissue during two experimental animal models of OA. Moreover, in the same 
study, we revealed a clear upregulation of the expression of WISP1, a target of canonical 
Wnt signaling, both in the synovium and cartilage. Here, we elucidate the consequences 
of this increased expression of Wnts and WISP1, which are presented in the various 
chapters of this thesis.
First, we sought to determine whether the increased expression of the Wnt ligands and 
WISP1 in the synovium was the result of stimulation by the alarmins S100A8/A9, which 
were shown to have coinciding upregulation with the Wnt ligands during experimental 
OA (Chapter 2 and Chapter 3). To this end, we first investigated the activating role of 
recombinant S100A9 on human OA synovial tissue and the main cell types that are present 
in the synovium (Chapter 2) in which we also included the activation of the Wnt signaling 
pathway. In addition, we determined the activity of canonical Wnt signaling in human 
synovium after inhibition of S100A9 using the well-described S100A9 blocker paquinimod. 
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In Chapter 3, we build on these findings by studying whether S100A8/A9 also caused 
activation of Wnt signaling in vivo. To study this, recombinant S100A8 protein was injected 
into the knee joint of a naïve mouse. To translate this in to a situation more relevant to OA, 
we studied whether induction of experimental OA in mice lacking S100A9 decreased the 
activation of canonical Wnt signaling in the joint. Finally, we determined whether part of 
the S100A8/A9 effects are mediated via activation of the canonical Wnt signaling pathway. 
Next, we set out to determine the consequences of increased Wnt expression in the 
synovial tissue on the integrity of the cartilage (these results are described in Chapter 4). 
To this end, various Wnt ligands and WISP1 were overexpressed in the synovium using 
adenoviral vectors and the effects of this overexpression on cartilage degeneration were 
investigated. To determine whether the effects found were the result of increased 
production of cartilage-degrading enzymes, we determined the presence of matrix 
neoepitopes that are the result of protease activity in the cartilage. 
To further investigate the outcome of increased synovial expression of Wnts, in Chapter 5 
we inhibited Wnt signaling in the joint during experimental OA using a mouse strain in 
which we can overexpress the Wnt inhibitor DKK1 in an inducible manner. We evaluated 
the effects of reduced canonical Wnt signaling on degeneration of the articular cartilage.
In the following chapters, we sought to determine possible mechanisms by which 
Wnt signaling induces joint pathology during OA. First, in Chapter 6, we evaluated the 
possibility that Wnt signaling might lead to cartilage degeneration via crosstalk with 
the TGF-β signaling pathway, which has been shown to be of central importance in 
maintaining chondrocyte homeostasis. To investigate this possibility, we determined 
whether Wnt/WISP1 signaling skewed the TGF-β signaling pathway from the chondro-
protective Smad2/3 signaling route towards dominant signaling via Smad1/5/8, which 
has been shown to stimulate hypertrophy-like differentiation of chondrocytes. In addition, 
we determined if skewing occurred via the canonical Wnt signaling route. 
Our next step was to determine the outcome of increased Wnt signaling at the site of the 
increased Wnt ligands production itself, the synovial tissue (of which the results are 
described in Chapter 7). First, the relation between the expression of various members of 
the Wnt signaling pathway at baseline and disease progression of OA was evaluated using 
synovial biopsies from individuals enrolled in the CHECK study. In this cohort study, a wide 
range of parameters in patients with early symptomatic OA were followed over time. 
Furthermore, we studied the expression of proteases in human end-stage OA synovial tissue 
after stimulation of Wnt signaling or inhibition of Wnt signaling using FRZB and DKK1. 
As a last step and possible mechanism as of how Wnt signaling might lead to joint 
destruction, we zoomed in on WISP1, a protein that is induced by canonical Wnt signaling 
(Chapter 8). To this end, we determined whether there was a relation between the 
expression of WISP1 at baseline and disease progression of OA using synovial tissue from 
the CHECK study. Furthermore, in this study we investigated the importance of WISP1 in 
both spontaneous and induced experimental models of OA in mice. Moreover, we studied 
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whether absence of WISP1 during experimental OA resulted in decreased expression 
levels of proteases and decreased protease activity in the cartilage. Finally, Chapter 9 
summarizes and discusses the findings that are described in this thesis and offers final 
considerations about the role of Wnt signaling in OA.
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CHAPTER 2
Abstract
Objective. The alarmins S100A8 and S100A9 have been shown to regulate synovial 
activation, cartilage damage and osteophyte formation in osteoarthritis (OA). Here we 
investigated the effect of S100A9 on the production of pro-inflammatory cytokines and 
matrix metalloproteases (MMPs) in OA synovium, granulocyte macrophage colony- 
stimulating factor (GM-CSF)-differentiated/macrophage colony-stimulating factor (M-CSF)- 
differentiated macrophages and OA fibroblasts. Methods. We determined which cell 
types in the synovium produced S100A8 and S100A9. Furthermore, the production of 
pro-inflammatory cytokines and MMPs, and the activation of canonical Wnt signaling were 
determined in human OA synovium, OA fibroblasts and monocyte-derived macrophages 
following stimulation with S100A9. Results. We observed that S100A8 and S100A9 were 
mainly produced by GM-CSF-differentiated macrophages present in the synovium, and 
to a lesser extent by M-CSF-differentiated macrophages, but not by fibroblasts. S100A9 
stimulation of OA synovial tissue increased the production of the pro-inflammatory 
cytokines interleukin (IL)-1β, IL-6, IL-8 and tumor necrosis factor-α. Additionally, various 
MMPs were upregulated after S100A9 stimulation. Experiments to determine which cell 
type was responsible for these effects revealed that mainly stimulation of GM-CSF- 
differentiated macrophages and to a lesser extent M-CSF-differentiated macrophages 
with S100A9 increased the expression of these pro-inflammatory cytokines and MMPs. 
In contrast, stimulation of fibroblasts with S100A9 did not affect their expression. Finally, 
stimulation of GM-CSF-differentiated, but not M-CSF-differentiated macrophages with 
S100A9 activated canonical Wnt signaling, whereas incubation of OA synovium with the 
S100A9-inhibitor paquinimod reduced the activation of canonical Wnt signaling. 
Conclusion. Predominantly mediated by M1-like macrophages, the alarmin S100A9 
stimulates the production of pro-inflammatory and catabolic mediators and activates 
canonical Wnt signaling in OA synovium.
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Introduction
Synovial inflammation is observed in a large subgroup of patients with osteoarthritis (OA) 
and it is believed to contribute to OA pathology [1, 2]. The synovial intima layer consists of 
mainly 2 cell-types: the macrophage-like (type A) and fibroblast-like synoviocytes (type B). 
Although fewer synovial macrophages are present in OA compared with rheumatoid 
arthritis (RA), they are crucial for the production of pro-inflammatory cytokines, such as 
interleukin (IL)-6 and IL-8, and cartilage matrix-degrading enzymes, matrix metalloproteinases 
(MMP)-1, MMP-3 and MMP-9 [3]. Previous studies showed that selective depletion of synovial 
macrophages during experimental OA largely reduces cartilage damage and osteophyte 
formation, 2 major hallmarks of OA [4, 5]. Multiple types of macrophages can be distinguished, 
where the distinction into classically activated M1 and alternatively activated M2 
macrophages is often used [6, 7]. M1-like macrophages can produce numerous pro- 
inflammatory cytokines, such as tumor necrosis factor-α (TNF-α) and IL-1β, and express 
MHC class II and CD86 receptors, whereas M2-like macrophages are characterized by the 
production of anti-inflammatory cytokines, such as IL-10 and IL-1Ra, and have been shown 
to express scavenger receptor CD163 and mannose receptor (CD206) [8, 9]. 
Activation of the synovium during OA induces the release of large amounts of the alarmins 
S100A8 and S100A9, which can easily be measured in synovial fluid as well as in serum 
[10, 11]. S100A8 and S100A9 proteins are pro-inflammatory mediators produced by myeloid 
cells, such as monocytes and activated macrophages, and have been shown to stimulate 
cells through Toll-like receptor 4 (TLR4) [12]. They are implicated in multiple rheumatic 
diseases [13, 14]. Previously, our group mainly studied the involvement of synovial S100A8 
and S100A9 production in the development of OA. Using in vivo models of OA, we observed 
that S100A8 and/or S100A9 promote synovial activation, cartilage degradation and 
osteophyte formation [11, 15]. Treatment with the quinoline-3-carboxamide paquinimod 
(ABR-215757), which can inhibit the binding of S100A9 to TLR4 and receptor for advanced 
glycation endproducts (RAGE receptors) [16], reduced the OA pathology [17]. Finally, we 
described that the alarmins S100A8 and S100A9 induce canonical Wnt signaling [18], 
which has been shown to be detrimental for cartilage [19]. 
However, although in these studies synovial production of S100A8 and S100A9 was found 
to be detrimental for the joint integrity, to date the effects of these proteins on the 
synovium and the main cell types residing in this tissue remained elusive. Therefore, to 
deepen our understanding of S100A9 involvement in the OA joint, in our current 
descriptive study we analyzed the effects of S100A9 on whole synovial tissue. Furthermore, 
we investigated S100A8 and S100A9 production in fibroblasts and both granulocyte 
macrophage colony-stimulating factor (GM-CSF)-differentiated and macrophage colo-
ny-stimulating factor (M-CSF)-differentiated macrophages, representing the main cell 
types present in the synovial lining layer. Finally, we zoomed in to the activation of 
fibroblasts and GM-CSF/M-CSF-differentiated macrophages by S100A9 stimulation.
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Materials and methods
Human OA synovium for microarray analysis
Anonymized human synovium was obtained from patients with end-stage OA undergoing 
total knee or hip joint replacement surgery (n=12). Control synovium from patients with 
acute knee joint trauma was obtained at the time of arthroscopic examination (n=6). The 
study protocol was approved by the local ethics committee (Commissie Mensgebonden 
Onderzoek Arnhem – Nijmegen; approval number 2004/009).
Microarray analysis
Preparation of complementary DNA and subsequent microarray analysis was done as 
described previously [20]. Generation of biotinylated complementary RNA, hybridization, 
and subsequent staining of MOE 430_2 oligonucleotide arrays (Affymetrix) was performed 
according to the Affymetrix Expression Analysis Technical Manual for 1-cycle amplification. 
Arrays were scanned using a laser scanner (GeneChip Scanner; Affymetrix) and analyzed 
using Affymetrix GeneChip Operating Software, version 1.4. Array normalization, expression 
value calculation, and clustering analysis were performed using DNA-Chip Analyzer 
(dChip) software, version 1.3 (www.dchip.org).
Human end-stage OA synovium
Biopsies were taken from synovium obtained anonymously from patients with end-stage 
OA undergoing arthroplasty and used for stimulation studies. Three randomized biopsies 
per well were stimulated in quadruple for 24 h with 1 µg/mL recombinant human (rh) 
S100A9. This dose and time point were previously shown to be effective [21]. Other 
biopsies were incubated with the quinoline-3-carboxamide paquinimod (ABR-215757) for 
24 h. A third group of biopsies was directly fixed in formalin and afterward embedded in 
paraffin. Finally, additional biopsies were used for spontaneous outgrowth of fibroblast- 
like synoviocytes. Nonadherent cells were washed away daily for 7 days. Fibroblast cultures 
showed high expression of the fibroblast markers vimentin, collagen type I, and proteo - 
glycan 4, as determined by quantitative real-time polymerase chain reaction (qRT-PCR). 
Moreover, cultures were negative for expression of the endothelial marker CD31 and Fc-γ 
receptor I, which is expressed in immune cells (data not shown). Isolated fibroblasts were 
used between passages 6 and 10 and were stimulated for 24 h with 1 µg/mL rhS100A9. 
After stimulation, tissue was lysed in RLT buffer (Qiagen) and cells were lysed in TRI-reagent 
(Sigma) for RNA isolation. Supernatants were stored at -20 °C for Luminex analysis. 
Differentiation and stimulation of human macrophages
Peripheral blood mononuclear cells (PBMCs) were obtained from healthy volunteers after 
density gradient centrifugation with Ficoll. Monocytes were isolated by magnetic-activated 
cell sorting (MACS) with specific CD14+ magnetic beads (Miltenyi Biotec). Monocytes 
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were differentiated into macrophages by adding 50 ng/mL rhGM-CSF or 20 ng/mL rhM-CSF 
(R&D Systems), for 6 days with changing of the medium halfway. Mature macrophages 
were stimulated for 24 h with 1 µg/mL rhS100A9, after which cells were lysed in TRI-reagent 
for RNA isolation. Supernatants were collected and stored at -20 °C to be measured for 
protein release by Luminex.
RNA isolation and qRT-PCR
RNA was isolated from OA fibroblasts and differentiated macrophages using TRI-reagent, 
as described previously [22]. OA synovium pieces were first homogenized with the MagNA 
Lyser (Roche), 5 times for 20 seconds at 6500 rpm. Afterward, RNA was isolated using the 
RNeasy-kit (Qiagen) according to the manufacturer’s protocol. RNA was reverse transcribed 
to cDNA and qRT-PCR was performed with specific primers and the SYBR Green Master 
mix in the StepOnePlus real-time PCR system (Applied Biosystems) as described previously 
[22]. Expression levels are minus delta Ct (-ΔCt) values, normalized to the reference gene 
GAPDH.
Multiplex cytokine and MMP protein measurement with Luminex
To determine protein levels of MMPs (MMP-1, MMP-3, and MMP-9) and cytokines/
chemokines (IL-6, IL-8 and TNF-α) in culture medium, Luminex multianalyte technology 
on the Bio-Plex 100 system (Bio-Rad) was used in combination with multiplex MMP/
cytokine kits (Milliplex from Millipore), according to the Milliplex protocol. 
S100A8 and S100A9 proteins and ELISA
Recombinant human S100A9 was expressed and purified as described previously [23]. The 
protein was tested to be endotoxin-free (using the Limulus amoebocyte cell lysate 
(BioWhittaker)) and recombinant S100A9 protein lost its activity after heat-inactivation at 
80°C for 30 min, whereas lipopolysaccharide activity has been shown not to be changed 
at that temperature [12]. S100A8/A9 concentrations were determined in supernatants of 
CD14+ monocytes and differentiated macrophages by a sandwich enzyme-linked 
immunosorbent assay (ELISA) specifically for human S100A8/A9, which has been produced 
in-house, as described previously [24].
Immunohistochemistry
Paraffin-embedded human end-stage OA synovial tissue was cut into 7 μm sections. 
Afterward, immunostaining for CD68 (a common macrophage marker), CD86 (a M1-like 
macrophage marker), and CD163 (a M2-like macrophage marker) was performed. Antigen 
retrieval was performed using citrate buffer, after which the sections were stained with 
primary anti-human CD68 (clone KP1, Dako), anti-human CD86 (clone EP1158Y, Abcam) 
and anti-human CD163 (clone 10D6, Abcam) for 1 h at room temperature. Immunoglobulin 
G (IgG) isotype controls were included to verify antibody specificity. Afterward, sections 
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were incubated with biotinylated secondary antibodies (Vector Laboratories), followed by 
an avidin-streptavidin-peroxidase (Vector Laboratories) amplification step. Subsequently, 
peroxidase binding was visualized using diaminobenzidine and sections were counterstained 
with hematoxylin.
Statistics
Statistical differences were calculated with Student’s t-test or a one-way ANOVA with 
Tukey post-test, using Graph Pad Prism 5 (GraphPad Software). P < 0.05 was considered 
significant. Statistical analysis for array-based gene expression was performed using dChip 
software. The t statistic was computed as (mean1 – mean2)/√(SE(mean1)2 + SE(mean2)2); 
its value is calculated based on the t distribution, and the degree of freedom is set 
according to Welch modified two sample t test [25].
Results
Pro-inflammatory and catabolic effects after stimulation  
of total OA synovium with S100A9
Previously, we described that S100A8 and S100A9 mRNA were increased in OA synovium 
compared with control synovium from patients in which acute joint trauma was suspected 
(11 and 10 fold compared with control synovium [11]). Here, we determined the effects of 
S100A9 on the production of pro-inflammatory and catabolic mediators in OA synovial 
tissue. Therefore, we stimulated human end-stage OA synovial biopsies, which mainly 
consist of fibroblasts and macrophages, with recombinant S100A9 for 24 h. Because it has 
been shown that S100A8 and S100A9 give comparable results, we only used S100A9 in our 
current study because that is the most potent stimulator of human cells [26]. S100A9 
significantly induced mRNA expression of the pro-inflammatory cytokines IL1B, IL6 and IL8 
(24.3, 6.4 and 6.5 fold increases compared with non-stimulated samples, calculated as 
2ΔΔCt), whereas TNFA mRNA expression was not significantly increased. Further, S100A9 
stimulation increased the expression of the catabolic MMP9 (3.1 fold increase compared 
with non-stimulated samples, calculated as 2ΔΔCt), but not of MMP1, and MMP3 (Figure 1A). 
Luminex analysis showed that the protein release of IL-6, IL-8 and TNF-α was upregulated 
by S100A9 (9, 14 and 22 fold increases compared with non-stimulated samples), whereas 
IL-1β protein could not be detected (Figure 1B). 
Presence of M1-like and M2-like macrophages in OA synovium
Macrophages account for a substantial part of the cells in the synovial lining layer and 
have an activated phenotype in OA synovial tissue. However, little is known about their 
exact activation status. Hence, we investigated gene expression of M1-like and M2-like 
markers in human end-stage OA synovial tissue and healthy control synovium using 
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microarray analysis. We observed increased expression of the M1-like macrophage markers 
CD86, CCL3 and CCL5 in the OA synovial tissue (1.8, 2.52 and 1.97 fold compared with 
healthy synovium), whereas the M1-like macrophage-associated transcription factor IRF5 
showed a trend toward increased expression. Additionally, we observed increased 
expression of the M2-like macrophage markers CD206, IL10 and IL1RN (2.18, 2.32 and 2.1 fold 
vs. healthy synovium), whereas the expression of CD163 was present but not significantly 
altered in OA synovium. These results indicate elevated presence of both M1-like and 
Figure 1   Increased production of pro-inflammatory mediators and proteases in OA 
synovium upon stimulation with S100A9.
Biopsies from synovial tissue, obtained from end-stage osteoarthritis patients undergoing arthroplasty 
of hip or knee, were stimulated ex vivo with 1 µg/mL S100A9 (n = 6). After 24 h, significantly increased 
expression of the pro-inflammatory cytokines IL1B, IL6, and IL8, but not of TNFA after stimulation with 
S100A9, was observed as determined by qualitative real-time PCR. Additionally, expression of the 
protease MMP9, but not MMP1 and MMP3 was significantly increased (A). The protein release of IL-6, 
IL-8 and TNF-α was upregulated by S100A9, whereas IL-1β protein could not be detected (B). Bars 
show the mean ± SD values. * = P < 0.05; ** = P < 0.01; *** = P < 0.001 versus nonstimulated samples 
(NS) as measured by Student’s t-test. OA: osteoarthritis; IL: interleukin; TNF-α: tumor necrosis factor-α; 
MMP: matrix metalloprotease.
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M2-like macrophages in OA synovium. Next, we confirmed our microarray results with 
immunohistochemistry on paraffin-embedded sections of human end-stage OA synovium. 
Staining of consecutive sections for the classic macrophage markers CD68 (common 
macrophage marker), CD86 (M1-like macrophages) and CD163 (M2-like macrophage 
marker) indicates that, likely, a mixture of M1-like and M2-like macrophages is present in 
the lining layer of OA synovium (Figure 2A). In the same areas where these macrophage 
markers were present, we observed expression of S100A8 and S100A9 (Figure 2B).
Expression and secretion of S100A8 and S100A9 in high amounts  
by GM-CSF-differentiated macrophages and to a lesser extent by M-CSF-
differentiated macrophages
Our next step was to elucidate which cells in the synovium were the main producers of 
S100A8 and S100A9. The synovial lining layer mainly consists of fibroblasts and both 
M1-like and M2-like macrophages. To investigate the relative involvement of these various 
cell types in the production of S100A8 and d S100A9, we isolated fibroblasts from OA 
synovial tissue and differentiated human CD14+ monocytes into mature macrophages 
using GM-CSF or M-CSF. Gene expression of both S100A8 and S100A9 was not detectable 
in fibroblasts (Figure 2C). Further, S100A8 and S100A9 mRNA expression was significantly 
higher in GM-CSF-differentiated macrophages compared with macrophages differentiated 
with M-CSF (73.2 and 3.4 fold compared with M-CSF-differentiated macrophages). In line, 
GM-CSF-differentiated macrophages produced significantly higher amounts of S100A8/
A9 protein compared with M-CSF-differentiated cells (2.6 fold increase compared with 
M-CSF-differentiated macrophages), and the production of S100A8/A9 protein was 
comparable to monocytes (Figure 2D). It has been described that TLR4 is the main ligand 
for S100A8 and S100A9 proteins in a variety of cell types [12, 21, 26]. Therefore, we 
determined the TLR4 expression levels on both fibroblasts and macrophages. TLR4 mRNA 
production was not significantly different between GM-CSF and M-CSF-differentiated 
macrophages but was significantly lower in fibroblasts (Figure 2E). Next, we proceeded 
with evaluating the relative contribution of fibroblasts and both GM-CSF and M-CSF-dif-
ferentiated macrophages to S100A9-induced upregulation of pro-inflammatory and 
catabolic factors in OA synovial tissue.
No effects on fibroblasts after stimulation with the alarmin S100A9
First, we isolated fibroblasts from end-stage OA synovial tissue and subsequently 
stimulated them with S100A9 protein for 24 h. Analysis of qRT-PCR showed no effect of 
S100A9 on mRNA expression of IL1B, IL6 and IL8, or on MMP1, MMP3 and MMP9 (Figure 3A). 
TNFA expression could not be detected in OA synovial fibroblasts. On the protein level, 
S100A9 slightly upregulated IL-8 protein release, yet not significantly (2.4 fold increase 
compared with non-stimulated samples), but not IL-6 (1.2 fold increase compared with 
non-stimulated samples), whereas TNF-α and IL-1β could not be detected (Figure 3B). 
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Figure 2   S100A8 and S100A9 are expressed and released mainly by GM-CSF-differentiated 
M1-like macrophages and to a lesser extent by M-CSF-differentiated M2-like 
macrophages, which are both present in OA synovial tissue.
Consecutive sections of OA synovia were stained with antibodies against CD68 (a common 
macrophage marker), CD86 (as marker for M1-like macrophages), CD163 (as marker for M2-like 
macrophages) or isotype IgG. Representative photomicrographs from three donors are presented. 
Clear expression of all markers was present in the synovial lining layer, suggesting the presence of 
both M1-like and M2-like macrophages in human OA synovium (A) (original magnification x 200, 
inset original magnification x 1000). In the same areas, we observed expression of both S100A8 and 
S100A9 (B) (original magnification x 1000). Expression of S100A8 and S100A9 was undetectable (UD) 
in fibroblasts (n=5), whereas monocytes and GM-CSF-differentiated macrophages, and to a lesser 
extent M-CSF-differentiated macrophages expressed both alarmins, determined by quantitative 
real-time PCR (n=11) (C). Furthermore, S100A8/A9 proteins levels were significantly higher in GM-
CSF-differentiated macrophages, compared with M-CSF-differentiated cells (D). Expression of TLR4, 
the main receptor for S100A8 and S100A9 in multiple cell types, was lower in fibroblasts compared 
with macrophages, whereas no significantly different expression was observed between GM-CSF 
and M-CSF-differentiated macrophages, as determined by quantitative real-time PCR (E). Bars show 
the mean ± SEM values. * = P < 0.05; *** = P < 0.001 versus nonstimulated samples (NS) as measured 
by one-way ANOVA with Tukey post-test.
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Pro-inflammatory and catabolic effects after stimulation of GM-CSF-
differentiated macrophages with S100A9 
In the next set of experiments, we sought to determine whether S100A9 stimulation of 
macrophages, the other main cell type in the synovium, could account for the effects 
observed in synovial biopsies. Therefore, we differentiated human CD14+ monocytes into 
macrophages using GM-CSF or M-CSF and stimulated them with S100A9 for 24 h. First, we 
determined whether our polarization by GM-CSF or M-CSF was successful. Figure 4A 
shows that, indeed, INHBA and MMP12 as markers of GM-CSF-differentiated M1-like 
macrophages were higher in GM-CSF-differentiated cells compared with M-CSF-differentiated 
cells. In contrast, the anti-inflammatory marker IL10 was significantly higher expressed in 
M-CSF-differentiated macrophages compared with cells that were differentiated with 
GM-CSF. S100A9 stimulation of GM-CSF-differentiated macrophages significantly 
upregulated mRNA levels of the pro-inflammatory cytokines IL1B, IL6 and IL8 (27.7, 12.8 and 
16.8 fold increases compared with non-stimulated samples, calculated as 2ΔΔCt), whereas 
the mRNA expression of TNFA was not significantly different. Moreover, MMP1, MMP3 and 
MMP9 mRNA were also significantly upregulated (8.1, 6.1 and 2.9 fold increases compared 
Figure 2   Continued.
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with non-stimulated samples, calculated as 2ΔΔCt) (Figure 4B). On the protein level, IL-6, 
IL-8 and TNF-α were highly upregulated by S100A9 (44.8, 7.9 and 106.4 fold increases 
compared with non-stimulated samples), whereas IL-1β, could not be detected on the 
protein level (Figure 4C).
Figure 3   No effects on pro-inflammatory cytokine and MMP expression in fibroblasts 
after stimulation with S100A9.
OA fibroblasts were isolated from synovial biopsies of end-stage OA patients undergoing arthroplasty 
of hip or knee and stimulated with 1 µg/mL S100A9. S100A9 did not change expression of cytokines 
IL1B, IL6 and IL8, nor of MMP1 and MMP3, as determined by quantitative real-time PCR. Expression of 
TNFA and MMP9 was below detection level (n = 5) (A). Additionally, determination of protein levels 
by Luminex multiplex analysis did not show increased release of the cytokines IL-6 and IL-8 by OA 
fibroblasts upon S100A9 stimulation, whereas IL-1β and TNF-α could not be detected (B). Bars show 
the mean ± SEM values. No significant differences between S100A9 and nonstimulated samples (NS) 
were found as determined by Student’s t-test.
NS S100A9
A
OA broblasts - mRNA levels cytokines
B
IL-6
NS S100A9
0
200
400
600
800
1000
pg
/m
L
IL-8
NS S100A9
0
50
100
150
200
pg
/m
L
MMP1 MMP3 MMP9
-14
-12
-10
-8
-6
-4
-2
m
RN
A 
ex
pr
es
si
on
 (-
∆C
T)
NS S100A9
OA broblasts - mRNA levels MMPs
IL1B IL6 IL8 TNFA
-14
-12
-10
-8
-6
-4
-2
m
RN
A 
ex
pr
es
si
on
 (-
∆C
T)
UD
46
CHAPTER 2
Figure 4   Increased expression of pro-inflammatory cytokines and MMPs in GM-CSF-
differentiated macrophages after stimulation with S100A9.
Human CD14+ monocytes were differentiated into macrophages with GM-CSF or M-CSF for 6 days and 
stimulated with 1 µg/mL S100A9 for 24 h (n = 6). Differentiation with GM-CSF resulted in significantly 
increased expression of INHBA and MMP12 compared with differentiation with M-CSF. In contrast, 
IL10 was significantly higher expressed in M-CSF-differentiated macrophages compared with cells 
that were differentiated with GM-CSF, confirming a successful polarization of our cells in vitro (A). 
S100A9 stimulation significantly increased the expression of the pro-inflammatory cytokines IL1B, 
IL6 and IL8, as determined by quantitative real-time PCR, whereas mRNA expression of TNFA was not 
increased. In addition, the expression of MMP1, MMP3 and MMP9 was upregulated (B). Furthermore, 
protein levels of IL-6, IL-8 and TNF-α were significantly increased after S100A9 stimulation (C). Bars 
show the mean ± SEM values. * = P < 0.05; ** = P < 0.01; *** = P < 0.001 versus GM-CSF-differentiated 
macrophages (A) or nonstimulated samples (NS) (B and C) as measured by Student’s t-test.
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Pro-inflammatory effects after stimulation of M-CSF-differentiated 
macrophages with S100A9 are less profound compared with GM-CSF-
differentiated macrophages
Interestingly, S100A9 stimulation of the reparative M-CSF-differentiated macrophage also 
significantly increased mRNA levels of the pro-inflammatory cytokines IL1B and IL8 (22.0, 
4.3 and 7.2 fold increases compared with non-stimulated samples, calculated as 2ΔΔCt) but 
not IL6 and TNFA. In contrast to GM-CSF-differentiated macrophages, MMP1, MMP3 and 
Figure 5   Increased expression of pro-inflammatory cytokines and MMPs in  
M-CSF-differentiated macrophages, though to a lesser extent than in GM-CSF-
differentiated macrophages, upon S100A9 stimulation.
Human CD14+ monocytes were differentiated into macrophages with M-CSF for 6 days and stimulated 
with 1 µg/mL S100A9 for 24 h (n = 6). The expression of IL1B, IL6 and IL8 was upregulated after 
S100A9 stimulation, as determined by quantitative real-time PCR, whereas TNFA was not increased. 
In contrast, mRNA expression of MMP1, MMP3 and MMP9 were not upregulated by S100A9 in 
M-CSF-differentiated macrophages (A). On protein level, S100A9 significantly upregulated cytokine 
release of IL-6, IL-8 and TNF-α by macrophages that were differentiated with M-CSF, although the 
absolute levels of IL-6 and TNF-α were lower as by GM-CSF-differentiated macrophages (B). Bars 
show the mean ± SEM values. * = P < 0.05; ** = P < 0.01; *** = P < 0.001 versus nonstimulated samples 
(NS) as measured by Student’s t-test.
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MMP9 mRNA expression levels were not increased in cells differentiated with M-CSF after 
stimulation with S100A9 (Figure 5A). On protein level, S100A9 also elevated the release of 
pro-inflammatory cytokines IL-6, IL-8 and TNF-α (15.3, 12.9 and 262.9 fold increases 
compared with non-stimulated samples). However, absolute protein concentrations were 
considerably lower for IL-6 and TNF-α, but not IL-8, in M-CSF compared with GM-CSF- 
differentiated cells (Figure 5B).
Figure 6   Activation of canonical Wnt signaling by S100A9.
GM-CSF (n = 8) and M-CSF-differentiated macrophage (n = 7) were stimulated with 1 µg/mL S100A9 
for 24 h. To determine activation of canonical Wnt signaling, the expression of WISP1, a canonical Wnt 
signaling-induced gene was determined. Stimulation of macrophages differentiated with GM-CSF 
with S100A9 significantly upregulated WISP1 expression, as determined by quantitative real-time 
PCR. In contrast, WISP1 expression was not detectable or not affected by S100A9 stimulation in 
M-CSF-differentiated macrophages (A). Furthermore, S100A9 was inhibited in synovial biopsies from 
end-stage OA patients (n = 8) for 24 h using 350µM paquinimod (ABR-5757). WISP1 expression was 
significantly decreased in the paquinimod-treated samples (B). Bars show the mean ± SEM values. * 
= P < 0.05 versus nonstimulated samples (NS) as measured by Student’s t-test.
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S100A9 results in enhanced Wnt signaling in GM-CSF, but not M-CSF-
differentiated macrophages
In a previous study we showed that S100A8 and S100A9 can increase canonical Wnt 
signaling in human macrophages, but not fibroblasts. Here, we tested whether the 
increased Wnt signaling was the result of S100A9 stimulation of GM-CSF or M-CSF-differ-
entiated macrophages. S100A9 stimulation of GM-CSF-differentiated cells for 24 h resulted 
in significantly increased expression of WISP1, is a telltale sign of active canonical Wnt 
signaling, whereas WISP1 expression was either not detectable in non-stimulated and 
S100A9-stimulated M-CSF-differentiated macrophages or was not increased after 
incubation with S100A9 (Figure 6A). Next, we tested our hypothesis that OA synovium 
has high production of S100A8 and S100A9, thus resulting in Wnt signaling, by incubating 
OA synovial biopsies with paquinimod, thereby inhibiting the action of S100A9. This 
resulted in a significantly decreased expression of WISP1, indicating a reduction in 
canonical Wnt signaling as the result of inhibition of S100A9 (Figure 6B).
Discussion
In our current study we show that the alarmins S100A8 and S100A9 are mainly produced 
by the pro-inflammatory GM-CSF-differentiated macrophages. Further, we show that 
stimulation of human OA synovium with S100A9 induces the production of both pro-in-
flammatory and catabolic mediators, in addition to activation of canonical Wnt signaling. 
Further experiments showed that mainly GM-CSF-differentiated macrophages and to a 
lesser extent macrophages differentiated with M-CSF but not fibroblasts account for this 
increased production in the synovial tissue.
The data in our study indicate the presence of both M1-like and M2-like macrophages in 
OA synovium. However, the macrophage markers CD86 and CD206 can also be expressed 
by other immune cells, such as dendritic cells and B-cells. Nonetheless, clear presence of 
dendritic cells and B-cells in the synovial lining and involvement in the pathology of OA 
has never been clearly demonstrated. Moreover, Fahy et al. showed combined presence of 
CD86 (M1-like macrophage marker) and CD206 (M2-like macrophage marker) in OA 
synovium by histology [27]. In spondyloarthritis and rheumatoid arthritis both types are 
present as well [28]. Together with our data, this suggests the presence of both M1-like 
and M2-like macrophages in arthritic synovium. 
From several studies it seems clear that macrophages in OA exhibit an activated 
phenotype, producing among others IL-6, IL-8 and vascular endothelial growth factor 
(VEGF). Moreover, OA synovial cell cultures depleted of macrophages no longer produce 
IL-1β and TNF-α [3, 29], suggesting that the macrophage is the major cell type regulating 
the release of pro-inflammatory factors in OA synovial activation. This is in line with our 
finding that mainly stimulation of macrophages with S100A9 results in increased 
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expression of various pro-inflammatory and catabolic factors, which have been implicated 
in OA development. In contrast to the increased protein levels of TNF-α, we did not find 
increased mRNA expression after 24 h of stimulation. However, it has been described that 
TNF-α is an early-response protein and mRNA might be increased at earlier time points 
[30]. IL1B was clearly upregulated on the mRNA level, whereas we could not detect IL-1β 
protein in the culture supernatant. This, however, might be the result of our in vitro 
approach. It has been shown that secretion of IL-1β by processing in the inflammasome is 
based on a two-hit system. The first signal can be provided by TLR4 signaling, which 
increases the production of IL1B mRNA and pro-IL-1β protein and additionally primes the 
inflammasome. A second signal that activates the inflammasome, such as crystals or ATP, 
is required to activate the inflammasome to process the proform of IL-1β into the mature 
form and excrete this protein [31, 32].
Additionally, MMP protein levels were too low to detect with Luminex analysis in the 
majority of synovium donors and in the fibroblast and macrophages cultures, probably 
because of the low number of cells. However, we previously described that inhibition of 
S100A9 with the quinoline-3-carboxamide paquinimod (ABR-215757) resulted in a 
significant decrease of the S100A9-induced production of various MMPs [17].
In our study, we show that S100A8 and S100A9 are preferentially expressed and produced 
by GM-CSF-differentiated macrophages, even as high as monocytes, known to be potent 
producers of S100A8 and S100A9 proteins [33]. In line with our results, a recent mouse 
study by Dessing et al. also showed that also murine bone-marrow derived M1-like 
macrophages expressed more S100A8 and S100A9 mRNA than M2-like cells. Moreover, they 
show that S100A9 -/- bone marrow cells preferentially differentiate into arginase-1 positive 
M2 type macrophages, suggesting that the absence of S100-proteins skews macrophages 
to an M2-like phenotype [34]. Moreover, we did not observe S100A8 and S100A9 expression 
in fibroblasts. This is in contrast with a previous study that showed S100A8 and S100A9 
mRNA expression and S100A8/A9 protein expression by isolated OA and RA fibroblasts 
[35]. However, isolated cells from human synovial tissue were used between passages 3 
and 9, which could imply that other cell types (e.g. fibrocytes) could be responsible for the 
low S100A8/A9 expression. Therefore, in our study, fibroblasts isolated from human OA 
synovium were not used before passage 6. Moreover, the protein levels that were 
produced were very low (500 fold lower compared with our GM-CSF-differentiated 
macrophages). 
We also show that S100A9 acts most potently on GM-CSF-differentiated macrophages, 
but also stimulates the expression of pro-inflammatory cytokine in macrophages 
differentiated with M-CSF, yet to a lesser extent. Pro-inflammatory M1 and reparative M2 
macrophages represent the two extremes of the spectrum of macrophage activation, 
with a lot of intermediate activation states. It is generally accepted that M1 macrophages 
are involved in pro-inflammatory responses. It has been shown that mainly M1 
macrophages have critical roles in host defense against infection, but these cells are also 
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implicated in many inflammatory diseases, such as atherosclerosis, obesity and rheumatoid 
arthritis [36-38]. In contrast to macrophages, we did not observe significant effects of 
S100A9 on synovial fibroblasts. This difference in potency between macrophages and 
fibroblasts might be due to the different expression levels of TLR4, as we show by qRT-PCR. 
However, this does not explain the differences observed between GM-CSF and M-CSF-dif-
ferentiated macrophages. It was previously shown that S100A8 and S100A9 effects were 
mainly mediated by TLR4 signaling [12, 21]. Some studies report the interaction of S100A8 
and/or S100A9 with RAGE [39], yet signaling through RAGE was only reported for the S100 
family members S100A11 and S100A4 [40, 41]. TLR4 expression in synovial fibroblasts 
however is not completely absent, and S100A8 and S100A9 consequently could still have 
some effects. Therefore, the differences in response between macrophages and fibroblasts 
as reported here might derive from the various signaling pathways that can be activated 
by binding of a ligand to TLR4. Previously, we described that TLR4 signaling in fibroblasts 
was specifically independent of transforming growth factor-β-activated kinase (TAK1) [42], 
whereas TAK1 was a key regulator of TLR-mediated activation of nuclear factor-κB (NF-κB) 
and mitogen-activated protein kinase (MAPK) pathways in macrophages. This could 
explain the divergent effects we observed between fibroblasts and macrophages upon 
stimulation with S100A9 in our study. Moreover, S100A8 and S100A9 have been shown to 
act through the TAK1-NFκB pathway [43]. Possibly, TLR4 signaling through the MyD88-TAK1 
dependent pathway might be less dominant or even ablated in fibroblasts. Additionally, 
differences in co-receptors, such as CD14 and MD2, might affect the TLR4 signaling in the 
different cell types.
Our study indicates that S100A8 and S100A9 can induce a pro-inflammatory environment 
in OA synovium through stimulation of GM-CSF-differentiated macrophages and, to a 
lesser extent, M-CSF-differentiated macrophages, which possibly contributes to the joint 
destruction that is found during OA. Considering the longtime expression of S100A8 and 
S100A9 in the synovium during OA, targeting these proteins could be an interesting 
option for future OA therapies.
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Abstract
Objective. Both alarmins S100A8/A9 and canonical Wnt signaling have been found to 
play active roles in the development of experimental osteoarthritis (OA). However, what 
activates canonical Wnt signaling remains unknown. This study was undertaken to 
investigate whether S100A8 induces canonical Wnt signaling and whether S100 proteins 
exert their effects via activation of Wnt signaling. Methods. Expression of the genes for 
S100A8/A9 and Wnt signaling pathway members was measured in an experimental OA 
model. Selected Wnt signaling pathway members were overexpressed, and levels of 
S100A8/A9 were measured. Activation of canonical Wnt signaling was determined after 
injection of S100A8 into naive joints and induction of collagenase-induced OA in 
S100A9-deficient mice. Expression of Wnt signaling pathway members was tested in 
macrophages and fibroblasts after S100A8 stimulation. Canonical Wnt signaling was 
inhibited in vivo to determine if the effects of S100A8 injections were dependent on Wnt 
signaling. Results. The alarmins S100A8/A9 and members of the Wnt signaling pathway 
showed coinciding expression in synovial tissue in an experimental OA model. Synovial 
overexpression of selected Wnt signaling pathway members did not result in increased 
expression of S100 proteins. In contrast, intraarticular injection of S100A8 increased 
canonical Wnt signaling, whereas canonical Wnt signaling was decreased after induction 
of experimental OA in S100A9-deficient mice. S100A8 stimulation of macrophages, but 
not fibroblasts, resulted in increased expression of canonical Wnt signaling members. 
Overexpression of Dkk1 to inhibit canonical Wnt signaling decreased the induction of 
matrix metalloproteinase 3, interleukin-6, and macrophage inflammatory protein 1α after 
injection of S100A8. Conclusion. Our findings indicate that the alarmin S100A8 induces 
canonical Wnt signaling in macrophages and murine knee joints. The effects of S100A8 
are partially dependent on activation of canonical Wnt signaling.
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Introduction
Osteoarthritis (OA) is a joint disease with degeneration of the articular cartilage as its main 
hallmark. However, the view of OA is shifting from a disease involving only the cartilage to 
a disease of the entire joint, where important roles are attributed to the subchondral bone 
and the synovium. Activation of resident cells and synovial inflammation are two processes 
that are associated with increased production of pro-inflammatory mediators, which is 
thought to be actively involved in the pathogenesis of OA [1-3]. Synovial activation and/or 
inflammation is present in ~50% of OA patients, and several studies have found that they 
correlate with cartilage damage [4, 5]. 
Previous studies in our laboratory have shown that the expression of several members of 
the Wnt signaling pathway was strongly increased in joints with experimental OA, with 
Wnt16 being the most profoundly upregulated Wnt ligand. Furthermore, we found 
Wnt-1–inducible signaling pathway protein 1 (WISP1), a main downstream target of the 
β-catenin-dependent canonical Wnt signaling pathway, to be increased in both the 
synovium and the cartilage [6]. Various studies have linked Wnt signaling to the pathology 
of OA. Genetic studies showed that polymorphisms in the gene encoding the Wnt 
inhibitor Frzb, which result in decreased affinity for Wnt ligands, are associated with hip 
OA [7-9]. Moreover, Zhu et al showed that β-catenin signaling disturbed by conditional 
activation or knockdown in the cartilage results in cartilage destruction [10, 11]. We 
recently demonstrated that adenoviral overexpression of Wnt8a and Wnt16, both resulting 
in canonical Wnt signaling, leads to early erosive cartilage lesions as early as 7 days after 
overexpression [12]. In addition, we have shown that canonical Wnt signaling skews 
transforming growth factor β (TGFβ) signaling, which is of central importance for 
maintaining cartilage homeostasis, toward a route that results in chondrocyte terminal 
differentiation [13]. However, what induces the strong expression of members of the Wnt 
signaling pathway in OA tissues remains to be elucidated.
Other studies in our laboratory point toward a central role for the highly produced 
alarmins S100A8 and S100A9 in inflammatory OA. These proteins belong to the family of 
damage-associated molecular patterns and are produced mainly by monocytes, activated 
macrophages, and neutrophils [14, 15]. The alarmins S100A8/A9 are present in large 
quantities in the synovial fluid of patients with rheumatoid arthritis (RA), and these levels 
are correlated with disease activity and damage in RA [16-18]. The presence of S100A8/A9 
has recently been described in experimental OA and in both serum and synovial fluid 
from OA patients [16, 19, 20]. Our group previously showed that S100A8/A9 are strongly 
produced in experimental OA and that exposure to recombinant S100A8/A9 proteins 
stimulates the release of various cytokines and activated matrix metalloproteinases 
(MMPs) by human OA chondrocytes [21]. Moreover, osteophyte formation was found to 
be aggravated in experimental OA by S100A8/A9 proteins, and serum levels at baseline 
were shown to be predictive of osteophyte progression in a human cohort study of early 
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symptomatic OA [22]. In addition, S100A9-deficient mice showed amelioration of disease 
in collagenase-induced OA, but not in the destabilization of the medial meniscus 
experimental model [20]. One of the most obvious differences between these models is 
the level of synovial inflammation, which is much higher in collagenase-induced OA.
In the present study, we aimed to determine whether the alarmins S100A8/A9 and 
canonical Wnt signaling have an interrelationship in OA. We therefore investigated 
whether Wnt signaling induces S100 expression and vice versa. We also evaluated whether 
activation of canonical Wnt signaling was required for the effects of S100A8/A9 on the 
synovium by blocking canonical Wnt signaling in vivo. 
Materials and methods
Animals and in vivo experiments
Male C57Bl/6J mice were obtained from Janvier. Collagenase-induced OA was induced as 
described previously by 2 intraarticular injections of 1 unit of bacterial collagenase in 
C57Bl/6J mice and S100a9-knockout mice, which in addition lack active S100A8 protein 
and were backcrossed to a C57Bl/6 background for more than 12 generations [23, 24]. 
In addition, members of the Wnt signaling pathway were overexpressed with the use of 
adenoviral vectors in C57Bl/6J mice (Janvier). B6.Cg-Gt(ROSA)26Sortm1(rtTA*M2)Jae/J (rtTA) mice 
were obtained from The Jackson Laboratory and backcrossed with tetO-Dkk1 mice that 
were a kind gift from Sarah Miller (University of Pennsylvania, Philadelphia) to create mice 
that contained both transgenes, resulting in inducible Dkk1-transgenic mice. Recombinant 
murine S100A8 protein was expressed and purified in our facilities as described previously 
and was tested to confirm that it was free of lipopolysaccharide [25]. Recombinant S100A8 
(5 μg) in a total volume of 6 μl was injected intraarticularly into knee joints of either naive 
wild-type mice or Dkk1-transgenic mice that were fed either a normal diet or a diet 
containing 575 mg/kg doxycycline hyclate (Sigma-Aldrich) to induce overexpression of 
Dkk1. As a control for the S100A8 protein injections, 5 μg of bovine serum albumin (BSA) in 
a volume of 6 µL was injected into the contralateral knee joint. Mice were housed in 
filter-top cages with woodchip bedding under standard pathogen-free conditions and 
fed a standard diet and tap water ad libitum. All animal studies were conducted according 
to Dutch law and approved by the local Animal Experimentation Committee.
Construction of adenoviral vectors
Adenoviral vectors were designed to overexpress Wnt8a and Wnt16 using a method 
described previously [26]. As a control we used an adenoviral vector that contained 
luciferase. The complete coding sequences were cloned from human (Wnt8a) or mouse 
(Wnt16) complementary DNA (cDNA). To achieve overexpression in vivo, we injected 1x107 
plaque-forming units into mouse knee joints.
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Cell culture and in vitro experiments
Murine bone marrow cells were differentiated toward macrophages in Dulbecco’s 
modified Eagle’s medium (DMEM; Invitrogen), supplemented with 10% fetal calf serum 
(FCS), sodium pyruvate, 100 units/mL penicillin, and 100 μg/mL streptomycin in the 
presence of 15 ng/mL macrophage colony-stimulating factor (R&D Systems) for 6 days. 
Murine 3T3 fibroblasts were cultured in DMEM, supplemented with 5% FCS, sodium 
pyruvate, 100 units/mL penicillin, and 100 μg/mL streptomycin. Human monocytes were 
isolated from buffy coat cells of healthy donors using CD14 microbeads (Miltenyi Biotec) 
according to the manufacturer’s protocol. Monocytes were differentiated toward 
macrophages with 800 units/mL of granulocyte-macrophage colony-stimulating factor 
(R&D Systems) for 6 days in RPMI-1640 medium (Invitrogen), supplemented with 10% FCS, 
L-glutamin, 100 units/mL penicillin and 100 μg/mL streptomycin. Human primary fibro-
blast-like synoviocytes were grown out of synovium, obtained after joint replacement 
surgery, and cultured in basal medium Eagle (Invitrogen), supplemented with 10% FCS, 
sodium pyruvate, 100 units/mL penicillin, and 100 μg/mL streptomycin. All cell types were 
stimulated for 24 h with 1 μg/mL of recombinant S100A8 or S100A9. 
RNA isolation and quantitative real-time polymerase  
chain reaction (qRT-PCR)
Murine synovial biopsy specimens were obtained by isolation of the synovial tissue from 
mouse knee joints, followed by the acquisition of punch biopsy specimens from the tissue 
adjacent to the patella. Subsequently, these biopsy specimens were homogenized in RLT 
buffer using the MagNA Lyser (Roche), followed by RNA isolation using the RNeasy Fibrous 
Tissue Mini kit (Qiagen) with a proteinase K step according to the manufacturer’s protocol. 
All other RNA isolations were performed using TRI Reagent (Sigma-Aldrich) according to 
the manufacturer’s protocol. The RNA concentration was determined using a NanoDrop 
spectrophotometer and subsequently reverse transcribed into cDNA as previously 
described [21]. The cDNA was diluted 20x and gene expression was measured using validated 
primers specific for cDNA. Primer sequences were as follows: for murine Gapdh, forward 
5’-GGCAAATTCAACGGCACA-3’ and reverse 5’-GTTAGTGGGGTCTCGCTCCTG-3’; for murine 
S100a8, forward 5’-TGTCCTCAGTTTGTGCAGAATATAAAT-3’ and reverse 5’-TTTATCACCATC-
GCAAGGAACTC-3’; for murine S100a9, forward 5’-GGCAAAGGCTGTGGGAAGT-3’ and reverse 5’- 
CCATTGAGTAAGCCATTCCCTTTA-3’; for murine Wnt16, forward 5’-CCAAGGAGACAGCAT-
TCATTTATG-3’ and reverse 5’-CTGCATGACCTGGTGACAGAGT-3’; for murine Wisp1, forward 
5’-CCACTCGGATCTCTAACGTCAA-3’ and reverse 5’-TCCCTGCCTTGATGTGTAGT-3’; for murine 
Dkk1, forward 5’-AAAATATATCACACCAAAGGACAAGAAG-3’ and reverse 5’-GGACCAGAAGTG- 
TCTTGCACAA-3’; for murine Mmp3, forward 5’-TGAAGCCACCAACATCAGGA-3’ and reverse 
5’-TGGAGCTGATGCATAAGCCC-3’; for murine interleukin-6 (Il6), forward 5’-CAAGTCGGAGGCT-
TAATTACACATG-3’ and reverse 5’-ATTGCCATTGCACAACTCTTTTCT-3’; for murine macrophage 
inflammatory protein 1α (Mip1α), forward 5’-TCTTCCGGCTGTAGGAGAAGC-3’ and reverse 
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5’-CAAGTCTTCTCAGCGCCATATG-3’; for murine keratinocyte- derived chemokine (Kc), forward 
5’-TGGCTGGGATTCACCTCAA-3’ and reverse 5’-GAGTGTGGCTATGACTTCGGTTT-3’; for murine 
Il10, forward 5’-ATTTGAATTCCCTGGGTGAGAA-3’ and reverse 5’-ACACCTTGGTCTTGGAGCTTAT-
TAA-3’; for murine Il1b, forward 5’-GGACAGAATATCAACCAACAAGTGATA-3’ and reverse 
5’-GTGTGCCGTCTTTCATTACACAG-3’; for human GAPDH, forward 5’-ATCTTCTTTTGCGTCG-
CCAG-3’ and reverse 5’-TTCCCCATGGTGTCTGAGC-3’; for human WNT16, forward 5’-AAAGAAAT- 
GTTTCCCTGCCC-3’ and reverse 5’-GACATTTTCCATGGGTTTGC-3’; for human WISP1, forward 
5’-CCTGCTTGGGGTTCATAGGA-3’ and reverse 5’-TGGGTCTCTCAAGGCTCTGT-3’. Real time 
qRT-PCR reactions were performed using SYBR Green Master Mix (Applied Biosystems) 
with the following amplification protocol: 10 min at 95°C, followed by 40 cycles of 15 
seconds at 95°C and 1 minute at 60°C using a StepOnePlus real-time PCR system (Applied 
Biosystems). Melting curves were included to confirm specific amplification of the genes. 
Expression levels are presented as –ΔCt, corrected for Ct values of the reference gene 
GAPDH of the same sample or ΔΔCt, corrected for GAPDH Ct values of the same sample 
and negative controls. Left knee joints without induction of experimental OA were used 
as a negative control for the time course of the collagenase-induced OA model. For 
experiments with adenoviral overexpression of Wnt members, we used the contralateral 
knee joints with overexpression of the control virus containing luciferase as a control. 
Injections of 5 µg of BSA were used as negative controls for injections of recombinant 
S100A8 in both naive and Dkk1-transgenic mice. For the in vitro stimulation of macrophages 
and fibroblasts, we used unstimulated samples as negative controls.
Immunohistochemistry
Total murine knee joints were fixed in formalin and cut into 7 μm sections. Afterward, 
immunostaining for S100A8 and β-catenin was performed. Sections were stained with 
primary anti-mouse S100A8 (made in our facilities [27]) overnight. In order to stain for 
β-catenin, sections were incubated with anti-mouse β-catenin (Santa Cruz Biotechnology) 
for 30 min at room temperature. IgG isotype controls were included to verify antibody 
specificity. Biotinylated secondary antibodies (Dako) were used, followed by avidin-strepta-
vidin-peroxidase (Elite kit; Vector Laboratories) and peroxidase binding was visualized 
using diaminobenzidine. Sections were counterstained with hematoxylin. Staining was 
scored arbitrarily or using the Leica Application Suite software (Leica Microsystems) for 3 
sections per joint. The surface area staining positive was corrected for the total area that 
was measured. Representative images of immunohistochemical stainings are shown.
Statistical analysis
Statistical analysis was performed using GraphPad Prism version 5.0 (Graphpad Software). 
Differences between groups were tested using Student’s t-test, Mann-Whitney test, or 
one-way analysis of variance (ANOVA), followed by a Dunnett’s post test. P-values less 
than 0.05 were considered significant. Results are expressed as the mean ± SEM.
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Results
Coinciding expression of the alarmins S100A8/A9 and members  
of the Wnt signaling pathway in experimental OA
First, we determined the expression patterns of the alarmins S100a8 and S100a9 and 
members of the Wnt signaling pathway during the course of collagenase-induced OA. 
Quantitative PCR analysis of mouse synovial tissue showed strong upregulation of Wnt16 
and Wisp1, a downstream target of canonical Wnt signaling, in joints with OA compared to 
contralateral joints without OA, at several time points after OA induction (Figure 1). The 
increased expression of the members of the canonical Wnt signaling pathway coincided 
with increased expression of S100a8 and S100a9. However, other important mediators in 
experimental OA showed different kinetics. Il1b gene expression was strongly increased 
on day 7, but showed a steep decline over time. The members of the Wnt signaling 
pathway and the alarmins S100A8/A9 did not show this steep decline between day 7 and 
day 21 after induction of collagenase-induced OA. In contrast, the expression of the anti- 
inflammatory cytokine Il10 was hardly regulated in collagenase-induced OA.
Canonical Wnt signaling does not induce S100 expression
The coinciding expression of S100a8 and S100a9 and members of the Wnt signaling 
pathway gave rise to the question of whether an interrelationship between these proteins 
Figure 1   Increased expression of the alarmins S100A8/A9 and members of the Wnt 
signaling pathway in experimental osteoarthritis (OA).
Levels of the alarmins S100a8 and S100a9, Wnt16, and Wnt-1–inducible signaling pathway protein 1 
(Wisp1), a downstream target of canonical Wnt signaling, were strongly increased in the synovium of 
mouse knee joints with collagenase-induced OA compared to control contralateral knee joints, as 
determined by quantitative real-time polymerase chain reaction. Interleukin-1β (Il1b) expression was 
strongly increased on day 7 after induction, but showed a steep decline over time. Il10 expression 
was hardly regulated throughout the model, consistent with the findings of previous studies [6, 20]. 
Bars show the mean ± SEM ΔΔCt values (n = 10 mice with OA and 10 control mice per time point). 
* = P < 0.05; † = P < 0.01; ‡ P < 0.001 versus contralateral control joints without experimental OA.
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was present in our experimental OA model. In order to determine if Wnt signaling 
increased the production of S100 proteins, we overexpressed Wnt8a and Wnt16 in mice in 
vivo with adenoviral vectors and used luciferase as a control. We chose Wnt8a and Wnt16 
as examples of Wnt ligands that are known to signal via the canonical route. We have 
previously shown that intraarticular injection of these adenoviruses specifically targeted 
the synovium, which resulted in strongly increased expression of the target genes and 
accumulation of β-catenin in the joints as a telltale sign of active canonical Wnt signaling 
[12]. However, in the present study, overexpression of Wnt8a or Wnt16 in the mouse 
synovium did not result in increased expression of S100a8 and S100a9 messenger RNA 
after 3 days (Figure 2A) or after 7 days (Figure 2B). In addition, we performed immuno-
Figure 2   Effect of synovial overexpression of selected Wnt signaling pathway members 
on the expression of S100A8/A9.
A and B, Levels of mRNA for S100a8 and S100a9 3 days (A) and 7 days (B) after overexpression of 
Wnt8a and Wnt16 in the mouse synovium. Adenoviral overexpression of Wnt8a and Wnt16, two 
members of the Wnt signaling pathway that are known to signal via the canonical route, did not 
increase the expression of either S100a8 or S100a9 compared to the control virus AdLuc 3 days or 7 
days after overexpression, as determined by quantitative real-time polymerase chain reaction. Sym-
bols represent individual mice; horizontal and vertical lines show the mean ± SEM ΔΔCt values (n = 6 
mice per group). C, Immunohistochemical staining for S100A8, showing that synovial overexpression 
of Wnt8a and Wnt16 did not result in increased S100A8 protein expression in the mouse synovium 
compared with overexpression of the control virus containing luciferase, 7 days after overexpression. 
As a positive control for increased expression of S100A8, we used a mouse knee joint that was har-
vested 7 days after the induction of collagenase-induced osteoarthritis. Original magnification × 100.
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histochemical staining for S100A8 on sections from total mouse knee joints 7 days after 
overexpression. S100A8 expression was not increased as the result of canonical Wnt 
signaling (Figure 2C).
Induction of canonical Wnt signaling by injection of S100A8 into  
mouse knee joints
After determining that increased Wnt signaling did not result in increased expression of 
S100 proteins in the synovium, we investigated whether S100A8 increased Wnt signaling. 
We injected 5 μg of S100A8 protein into the naive knee joints of wild-type mice and 
injected 5 μg of BSA into the contralateral knee joints as a control protein. As shown in 
Figure 3A, Wnt16 expression was significantly increased in the synovium of S100A8-inject-
ed joints compared to the BSA injected control joints 3 days after injection (5.2 times 
increase, calculated as 2ΔΔCt). The time point of 3 days after injection, when only minor 
synovial activation was present, was chosen in order to minimize indirect effects via 
increased cellularity as a result of the S100A8 injections. To test whether the increased 
expression of Wnt16 resulted in increased canonical Wnt signaling, we performed immu-
nohistochemical staining for β-catenin, a trademark of canonical Wnt signaling, on total 
mouse knee joint sections. Increased accumulation of β-catenin was observed in both the 
cartilage (Figure 3B) and the synovium (Figure 3C), indicating that S100A8 induced 
canonical Wnt signaling in the joint. Next, we investigated whether this led to increased 
expression of Wisp1, a central downstream target of canonical Wnt signaling we previously 
Figure 2   Continued.
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Figure 3   Increased canonical Wnt signaling in naive mouse knee joints injected with 
S100A8.
A, Significantly increased expression of Wnt16 in the synovium of mouse knee joints injected with 5 μg 
of S100A8 compared with control mouse knee joints injected with 5 μg of bovine serum albumin 
(BSA), as determined by quantitative real-time polymerase chain reaction (qRT-PCR) 3 days after 
injection. Symbols represent individual mice; horizontal and vertical lines show the mean ± SEM 
ΔΔCt values (n = 11 mice per group). B and C, Immunohistochemical staining showing increased 
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found to be increased in experimental OA. Figure 3D shows that Wisp1 expression was 
indeed significantly increased in the synovium after the injection of S100A8 into the 
mouse knee joint (2.1 times increase, calculated as 2ΔΔCt).
Induction of canonical Wnt signaling by alarmins S100A8/A9  
in experimental OA
In the next experiment, we further substantiated our finding that S100 proteins induced 
canonical Wnt signaling in OA. We initiated collagenase-induced OA in wild-type mice 
and S100a9-knockout mice, which do not express S100A8 protein in peripheral myeloid 
cells. As shown in Figure 4A, the accumulation of β-catenin was reduced in the cartilage 
of S100a9-deficient mouse joints on day 7 after induction. In addition, we observed 
reduced β-catenin accumulation in the synovium (Figure 4B). Next, we scored the 
β-catenin accumulation in both the cartilage and the synovium. For the synovium, we 
determined the number of strongly positive cells in the synovial intima lining layer and 
the total accumulation in the subintima layer (Figure 4C). All showed significantly reduced 
staining for β-catenin accumulation in the S100a9-knockout mice (38%, 27% and 32% 
decrease versus wild-type controls for the cartilage, subintima, and intima, respectively). 
These data indicate that the absence of S100 proteins results in decreased canonical Wnt 
signaling in experimental OA.
Increased Wnt signaling after stimulation of murine and human 
macrophages, but not fibroblasts, with S100A8
In order to investigate whether S100A8/A9 directly stimulated the expression of Wnt 
signaling pathway members in vitro, we stimulated both murine and human macrophages 
and fibroblasts with recombinant S100A8/A9 proteins. We found that without stimulation, 
Wnt16 was not detectable in murine bone marrow macrophages. However, stimulation 
with 1 μg/mL of recombinant S100A8 for 24 h resulted in detectable levels of Wnt16 and 
significantly increased expression of Wisp1 (Figure 5A). In contrast, stimulation with 
S100A8 did not alter the expression of Wnt16 or Wisp1 in murine fibroblasts (Figure 5B). 
To translate our findings to humans, we stimulated human macrophages and primary 
synovial fibroblasts from various donors with 1 μg/mL of S100A8 or S100A9 for 24 h. 
Human macrophages showed significantly increased expression of both WNT16 and 
accumulation of β-catenin, a hallmark of canonical Wnt signaling, in the cartilage (B) and in the 
synovium (C) of mouse knee joints injected with S100A8 compared to those injected with BSA, 
3 days after injection. Original magnification × 400. D, Significantly increased expression of Wnt- 
1–inducible signaling pathway protein 1 (Wisp1), a downstream target of canonical Wnt signaling, 
in the synovium, as determined by qRT-PCR 3 days after injection of S100A8. Symbols indicate 
individual mice; horizontal and vertical bars show the mean ± SEM ΔΔCt values (n = 11 mice per 
group). * = P < 0.05; ** = P < 0.01 versus BSA.
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WISP1 after stimulation with S100A8, but not S100A9, whereas no changes in expression 
were found in human synovial fibroblasts upon stimulation (Figure 5C).
Decreased effects of S100A8 after inhibition of canonical Wnt signaling
Finally, to determine if S100A8 injections exerted their effects via the induction of canonical 
Wnt signaling, we injected 5 µg of BSA or S100A8 into the knee joints of inducible Dkk1 
transgenic mice that were fed either a normal diet or a diet supplemented with 
Figure 4   Reduction in canonical Wnt signaling in S100a9-knockout (S100a9-/-) mice 
with experimental osteoarthritis (OA).
A and B, Immunohistochemical staining showing reduced accumulation of β-catenin in the cartilage 
(A) and synovium (B) 7 days after induction of collagenase-induced OA in S100a9-knockout mice 
that also lack functional S100A8. Original magnification × 400. C, Scoring of β-catenin accumulation in 
the cartilage and synovium from mice with collagenase-induced OA. There was a significant reduction 
in staining in cartilage, less strongly stained cells in the synovial lining, and reduced staining in the 
synovial subintima. Bars show the mean ± SEM degree of staining relative to wild-type (WT) control 
mice (n = 10 mice per group). * = P < 0.05; ** = P < 0.01.
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Figure 5   Induction of canonical Wnt signaling in macrophages, but not in fibroblasts,  
by S100A8.
A, Levels of Wnt16 and Wnt-1–inducible signaling pathway protein 1 (Wisp1) in murine bone marrow 
macrophages that were left unstimulated (NS) or stimulated with 1 μg/mL of S100A8. Wnt16 
expression was not detectable (ND) in unstimulated macrophages, whereas stimulation with 1 
μg/mL of S100A8 resulted in detectable levels of Wnt16 and significantly increased the expression 
of the downstream marker Wisp1 after 24 h, as determined by quantitative real-time polymerase 
chain reaction (qRT-PCR). B, Levels of Wnt16 and Wisp1 expression in murine 3T3 fibroblasts left 
unstimulated or stimulated with S100A8. Wnt16 and Wisp1 expression were not altered by stimulation 
with S100A8. C, Significantly increased expression of both WNT16 and WISP1 in human macrophages, 
but not human synovial fibroblasts, obtained from healthy donors and stimulated with 1 μg/mL 
of S100A8, as determined by qRT-PCR. Stimulation with S100A9 did not affect gene expression. 
Symbols represent individual samples; horizontal and vertical lines show the relative mean ± SEM. 
* = P < 0.05 versus unstimulated cells.
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Figure 6   Reduction in the effects of S100A8 injections in mice after inhibition of 
canonical Wnt signaling.
A, Induction of Dkk1 transgene expression in the synovium in inducible Dkk1–transgenic mice 
fed a diet supplemented with doxycycline (dox). B, Significant increases in the expression of 
matrix metalloproteinase 3 (Mmp3), interleukin-6 (Il6), keratinocyte-derived chemokine (Kc), and 
macrophage inflammatory protein 1α (Mip1α) in the synovium after intraarticular injection of 5 μg of 
S100A8, as determined by quantitative real-time polymerase chain reaction. Inhibition of canonical 
Wnt signaling by means of overexpression of Dkk1 blocked the S100A8-dependent upregulation 
of Mmp3, Il6, and Kc, whereas the upregulation of Mip1α was reduced but still significant. Increased 
expression of Dkk1 did not influence basal expression of any of the genes examined. Symbols 
represent individual mice; horizontal and vertical lines show the mean ± SEM −ΔCt values (n = 8 mice 
per group). * = P < 0.05; ** = P < 0.01; *** = P < 0.001. BSA=bovine serum albumin (control); NS = not 
significant.
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doxy-cycline, which resulted in strongly increased expression of Dkk1, for 7 days (Figure 6A). 
Gene expression after injection of the control protein BSA was not altered for any of the 
genes shown in Figure 6 when doxycycline was administered via food, showing that 
both doxycycline and overexpression of Dkk1 did not affect basal gene expression. Figure 6B 
shows that injection of 5 µg of S100A8 resulted in significantly increased expression of 
various cytokines/chemokines and MMPs 3 days after injection (3.6, 1.9, 2.1 and 12.4 times 
for Mmp3, Il6, Kc, and Mip1α, respectively). These proteins are well-known targets of S100A8/
A9 and are thought to be involved in the pathology of OA. However, injection of S100A8 
in mice with overexpression of Dkk1, and thus inhibition of canonical Wnt signaling, 
did not increase the expression of Mmp3, Il6, or Kc, whereas the induction of Mip1α was 
less profound compared to mice with normal Dkk1 levels. These findings indicate that the 
effects of S100A8 are partly mediated by activation of canonical Wnt signaling.
Discussion
In the present study, we showed that levels of both the alarmins S100A8/A9 and members 
of the Wnt signaling pathway are increased during experimental OA, and that these 
factors have coinciding expression. Furthermore, we found that S100A8/A9 induces 
canonical Wnt signaling in both naive mouse knee joints and mouse knee joints in which 
experimental OA was induced. Finally, we provided evidence that S100A8 exerts its effects 
at least partly via the activation of canonical Wnt signaling. 
We and others have shown that strongly increased Wnt signaling is present in joints with 
experimental OA [6, 28]. However, what causes this increased expression remains unknown. 
A study by Lambert et al showed that in inflamed areas of the synovial membrane, 
differences in expression of Wnt signaling members pointed toward increased canonical 
signaling compared to normal areas within the same OA joints. In addition, the authors 
describe an upregulation of S100A9 in these more inflamed areas. This highlights our 
finding that the increased expression of S100A8/A9 coincided with elevated expression of 
members of the canonical Wnt signaling pathway and that the highest expression was 
found in inflamed tissue [29]. We have previously shown that the alarmins S100A8/A9 are 
crucial in mediating joint destruction and that they signal via Toll-like receptor 4 (TLR-4) 
present on macrophages [30, 31]. Although we did not investigate how S100A8 induced 
canonical Wnt signaling in the present study, this raises a possible important role of 
TLR-4-mediated signaling in the induction of canonical Wnt signaling.
In this study, we showed that the alarmins S100A8/A9 and several members of the canonical 
Wnt signaling pathway have coinciding expression and that the effects of S100A8/A9 
stimulation of cells are partly mediated by activation of the β-catenin-dependent 
canonical Wnt signaling pathway. This is consistent with the findings of a study by Duan 
et al that directly linked S100A8 and S100A9 signaling to increased canonical Wnt signaling [32]. 
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They showed that S100A8 and S100A9 are associated with colorectal cancer progression 
and survival and that stimulation of two colorectal cancer cell lines with recombinant 
S100A8 and S100A9 resulted in increased β-catenin accumulation. Overexpression of 
β-catenin resulted in increased proliferation and cell migration. Finally, they knocked 
down β-catenin, which led to decreased cell-viability and migration after stimulation with 
S100A8 and S100A9 proteins. Although we did not investigate activation of noncanonical 
Wnt signaling by the alarmins S100A8/A9 in this study, it remains of interest to elucidate 
whether S100A8/A9 activate noncanonical Wnt signaling in addition to the canonical 
pathway.
The strongly increased expression of the members of the Wnt signaling pathway and the 
alarmins S100A8/A9 on day 7 and 21 after the induction of collagenase-induced OA seems 
to be associated with the synovial activation found in this model at these time points. In 
contrast, the increased expression of these genes is not directly correlated to other 
features of OA-like degeneration of the articular cartilage and osteophyte formation, 
which have a progressive character. However, synovial inflammation at the early time 
points after induction is thought to be a major contributor to other pathologic features, 
such as cartilage degeneration and osteophyte formation, that appear later in the model. 
It should be noted that we did not study the effects of S100A8/A9-induced canonical Wnt 
signaling on OA pathology in this study, as the time points chosen were too early to detect 
OA pathologies, and BSA and recombinant S100A8 were injected into naive mouse knee 
joints.
Historically, one of the best-known effects of canonical Wnt signaling is an increase in 
bone formation. Canonical Wnt signaling activates osteoblast differentiation while 
inhibiting osteoclast differentiation, shifting the balance to increased bone formation [33, 
34]. Consistent with these findings, a recent study by our group showed that the alarmins 
S100A8/A9 aggravate osteophyte formation after the induction of collagenase-induced 
OA in mice [22]. The present study shows that in this experimental OA model, canonical 
Wnt signaling is reduced in S100A9-deficient mice. Therefore, studying the relative 
importance of activation of the canonical Wnt signaling pathway in S100A8/A9-induced 
new bone formation by shifting the balance between osteoblast and osteoclast differen-
tiation is an enticing opportunity for future studies.
The expression of Il1b, which is considered an important protein in the development of 
OA, was strongly increased on day 7 after the induction of collagenase-induced OA and 
thus might induce the expression of S100A8/A9 and activate canonical Wnt signaling [1, 2]. 
However, because there was a steep decline in IL-1β expression between day 7 and day 21, 
it seems unlikely that this is a major contributor to the effects that we describe in this 
study. 
In the present study, 24 h of in vitro stimulation with S100A8 promoted the expression of 
both WNT16 and WISP1 in macrophages. Therefore, it is highly likely that S100A8 directly 
activates Wnt signaling, although we cannot completely rule out indirect effects via the 
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production of another factor. However, we have previously shown that S100A8/A9 strongly 
influence cellular infiltration in joints. Whereas S100A8 injections into naive mouse knee 
joints strongly induce cell influx in the synovium, decreased synovial inflammation is 
present in S100a9-deficient mouse joints during experimental OA [20, 35]. This will result in 
altered numbers of monocytes and macrophages. Therefore, S100 proteins could 
indirectly affect canonical Wnt signaling via differences in inflammation in addition to the 
direct activation of Wnt signaling on resident cells that we propose here. 
Blocking canonical Wnt signaling by means of overexpressing Dkk1 blocked the induction 
of Mmp3, Il6, and Kc expression after injection of S100A8. However, the induction of other 
proteins that are usually regulated by S100A8/A9, such as Mip1α, was affected to a lesser 
extent by blocking canonical Wnt signaling. These proteins are all well-known targets of 
S100A8/A9 signaling, and their association with OA has been elegantly described 
previously [2, 3, 36, 37]. Taken together, these data indicate that S100A8 exerts its effects 
partly via activation of canonical Wnt signaling, but that in addition S100A8 has β-caten-
in-independent effects.
In conclusion, the present study is the first to show that the alarmins S100A8/A9 induce 
canonical Wnt signaling in mouse knee joints but that increased expression of Wnt 
signaling pathway members does not result in a further increase in S100 protein levels. 
Furthermore, activation of the β-catenin-dependent canonical Wnt signaling pathway is 
partly responsible for the effects observed after injection of S100A8 into naive mouse 
knee joints. Therefore, it would be of interest to study the relative role of activation of 
canonical Wnt signaling as the result of S100A8/A9 stimulation in an OA environment to 
determine if the alarmins S100A8/A9 and canonical Wnt signaling could be therapeutic 
targets in OA.
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Abstract
Proteins from the Wnt signaling pathway are very important for joint development. 
Curiously, osteoarthritis (OA) is thought to be a recapitulation of developmental processes. 
Various members of the Wnt signaling pathway are overexpressed in the synovium during 
experimental OA. Here, we investigated the potency of specific Wnt proteins, when 
expressed in the synovium, to induce OA pathology. We overexpressed Wnt5a, Wnt8a, 
Wnt16, and WISP1 in the synovium using adenoviral vectors. We determined whether 
overexpression resulted in OA pathology by histology, and we measured whether Wnt 
signaling led to increased protease activity in the joint. Synovial overexpression of Wnt8a 
and Wnt16 led to canonical Wnt signaling in the cartilage, whereas overexpression of 
Wnt5a did not. Canonical Wnt signaling increased protease activity and induced cartilage 
damage shortly after overexpression. Specific blocking of the canonical Wnt signaling 
pathway with Dickkopf-1 reduced the Wnt-signaling-induced cartilage damage. By contrast, 
the noncanonical signaling Wnt5a did not cause cartilage lesions. Overexpression of 
WISP1, a downstream protein of canonical Wnt signaling, resulted in increased cartilage 
damage. In conclusion, our data show that canonical Wnts and WISP1, which we found 
overexpressed in the synovium during experimental OA, may conduce to OA pathology.
77
SYNOVIAL OVEREXPRESSION OF WNTS INDUCES CARTILAGE DAMAGE
4
Introduction
The Wnt signaling pathway plays a central role in a plethora of processes, including 
embryonic development, axis patterning, cell proliferation, and cell migration. The 
development of the articular joints, including cartilage, bone, and joints cavities, is highly 
dependent on Wnt signaling [1-3]. Osteoarthritis (OA) is a degenerative joint disease with 
cartilage damage, synovial inflammation, fibrosis, and osteophyte formation. OA probably 
is in part the result of a recapitulation of developmental processes in the joint, making 
Wnt signaling an alluring pathway to study [4-6]. 
In the past, we have found highly increased expression of several Wnts specifically in the 
synovium of various murine experimental OA models, as well as an increase in Wnt-1- 
induced signaling protein 1 (WISP1), a downstream protein of canonical Wnt signaling, 
in both the synovium and the cartilage. In addition, increased expression of WISP1 was 
found in human OA cartilage [7].
Wnt proteins are a family of lipid-modified glycoproteins that can bind to Frizzled (Fzd) 
receptors. Wnt proteins can signal via noncanonical and canonical signaling pathways. 
Although the paradigm is shifting, Wnt5a is historically considered to be a noncanonical 
protein, whereas Wnt8a is considered a canonical Wnt protein. In addition to Wnt-Fzd 
interaction, binding to the coreceptor complex of low-density lipoprotein receptor-relat-
ed protein (LRP) 5/6 is essential for β-catenin-dependent canonical signaling. 
Normally, β-catenin is continuously ubiquitinated by a protein complex and subsequently 
broken down, a process that is inhibited by binding of a Wnt protein to a Fzd receptor and 
LRP5/6 leading to translocation of β-catenin to the nucleus where it converts TCF/LEF to 
an activator of transcription.
Most of the data concerning the role of Wnt signaling in OA is related to the canonical 
pathway. Polymorphisms in the genes encoding various members of the Wnt signaling 
pathway have been linked to OA [8-11]. In addition, various studies with conditional activation 
or inhibition of Wnt signaling in the cartilage show effects on disease activity. [12-14]. 
Active Wnt signaling has been shown to result in increased expression of matrix metallo-
proteinases (MMPs) in various diseases, including many types of tumors [15-17]. Among 
the MMPs that are increased by Wnt signaling are MMP2, MMP3, MMP9, and MT1-MMP, 
and in addition, Wnt signaling increases the expression of the aggrecanases A disintegrin 
and metalloproteinase with thrombospondin motifs (ADAMTS) 4 and 5 [13, 18-21]. 
Breakdown of the matrix surrounding the chondrocytes by protease activity is one of the 
main mechanisms underlying the damage that is found in OA. During arthritic diseases, 
both MMPs and aggrecanases cleave aggrecan, one of the most abundant proteins in the 
cartilage matrix. This leads to the formation of the neoepitopes VDIPEN and NITEGE 
respectively [22-24].
Here, we investigated the capability of members of the Wnt signaling pathway to cause 
cartilage damage in vivo in naive mice. We intraarticularly injected adenoviral vectors 
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containing several selected members of the Wnt signaling pathway into murine knee 
joints to overexpress these proteins, after which the knee joints were examined for OA-like 
pathology by histological analysis and immunohistochemical staining to reveal the 
presence of protease activity.
Materials and methods
Animals
Male C57BL/6 mice (12 weeks old) were purchased from Janvier (Le Genest Saint Isle, 
France). All mice were housed in filtertop cages with woodchip bedding. Mice were fed a 
standard diet, with food and tap water ad libitum. All animal studies were according to the 
Dutch law and approved by the local animal experimentation committee.
Cell lines and culture
Primary synovial fibroblasts were isolated from the synovial tissue of C57Bl/6 mice by 
spontaneous outgrowth for 2 weeks and were cultured in Dulbecco’s Modified Eagle’s 
Medium (DMEM; Invitrogen, Carlsbad, CA) supplemented with 10% fetal calf serum (FCS; 
Hyclone, Logan, UT), sodium pyruvate and 48 μg/mL gentamicin at 37°C.
Construction of adenoviral vectors
To overexpress members of the Wnt signaling pathway we generated adenoviral vectors 
for selected members of the Wnt signaling pathway, using a method described previously 
[25]. We chose Wnt5a as a classical example of a Wnt ligand that signals via noncanonical 
signaling, Wnt16 and WISP1 as found overexpressed during experimental OA, and Wnt8a 
as a classical example of a Wnt ligand that signals via the canonical pathway [26, 27]. 
The complete coding sequences of Wnt5a and Wnt8a were cloned from human 
complementary DNA (cDNA), whereas the complete coding sequences of Wnt16 and 
WISP1 were cloned from murine cDNA. The DKK1 adenovirus was a kind gift of Jill Helms 
(Stanford University, Stanford, CA).
To achieve overexpression in vivo, we intraarticularly injected 1x107 plaque-forming units 
of the adenoviral vectors in a total volume of 6 μl into murine knee joints. An adenoviral 
vector containing luciferase was used as control. To determine which cells are targeted by 
our adenoviral vectors in vivo, we used an adenoviral vector with the same backbone 
containing LacZ and performed an X-Gal staining afterward. In the experiment described 
with the double overexpression of two targets, 1x107 plaque-forming units of each target 
were injected simultaneously in a total volume of 6 μl. To overexpress the target in vitro, we 
transduced primary synovial fibroblast with the adenoviral vectors under serum-free 
condition for 2 h. We used a multiplicity of infection (MOI) of 50 for the in vitro experiments.
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RNA isolation and quantitative real-time polymerase chain reaction
Gene expression was determined using quantitative real-time polymerase chain reaction 
(qRT-PCR).
Tissue samples for RNA isolation were homogenized using the MagNA Lyser Instrument 
(Roche, Mannheim, Germany). Total RNA was isolated using the RNeasy Fibrous Tissue 
Mini Kit (Qiagen, Venlo, the Netherlands) and subsequently reverse transcribed into cDNA. 
qRT-PCR reactions were performed using the Applied Biosystems StepOnePlus real-time 
PCR system (Applied Biosystems, Foster City, CA). Primers were accepted if the deviation 
of the primer’s slope was ≤0.3 when compared with the slope of the GAPDH mRNA as a 
reference. Primer sequences were as follows: murine GAPDH, forward 5’-ATC-TTC-TTT-TGC-
GTC-GCC-AG-3’ and reverse 5’-TTC-CCC-ATG-GTG-TCT-GAG-C-3’; human Wnt5a forward 
5’-AAC-TCG-CCC-ACC-ACA-CAA-G-3’ and reverse 5’-CTC-ATT-GCG-CAC-GCA-GTA-GT-3’; 
human Wnt8a forward 5’-ATA-ACA-GGT-CCC-AAG-GCC-TAT-CT-3’ and reverse 5’-GCA-CTC-
CTC-GAT-GCC-ACT-CT-3’; murine Wnt16 forward 5’-CCA-AGG-AGA-CAG-CAT-TCA-TTT-
ATG-3’ and reverse 5’-CTG-CAT-GAC-CTG-GTG-ACA-GAG-T-3’; murine WISP1 forward 
5’-GCC-CGA-GGT-ACG-CAA-TAG-G-3’ and reverse 5’-GCA-GTT-GGG-TTG-GAA-GGA-CT-3’ 
and murine Axin2 forward 5’-AAC-GAC-AGC-GAG-TTA-TCC-A-3’ and reverse 5’-AGG- 
AGG-GAC-TCC-ATC-TAC-G-3’. qRT-PCR reactions were performed in a total volume of 10 μl, 
containing 3 μl cDNA, 1 μl forward primer, 1 μl reverse primer and 5 μl SYBR Green Master 
Mix (Applied Biosystems). Reactions were presented as -dCt values, calculated by correcting 
the negative threshold cycle (-Ct) of the gene of interest to the -Ct of the reference gene 
GAPDH. qRT-PCR analyses were performed on at least six mice per group.
Western Blot
Western blot analysis was performed to determine protein production by the adenoviruses. 
Total cell lysates were made and subsequently sonicated. Protein concentrations in the 
samples were determined with the BCA protein assay kit (Thermo Scientific, Rockford, IL). 
Equal protein concentrations of the samples were loaded on a SDS-polyacrylamide gel, 
and after separation, proteins were transferred onto nitrocellulose membranes with the 
iBlot system (Invitrogen). Nitrocellulose membranes were incubated with primary 
antibodies against Wnt5a (1:400), Wnt8a (1:1000), and WISP1 (1:1000; all R&D systems, 
Minneapolis, MN) and Wnt16 (1:250; Santa Cruz Biotechnology, Santa Cruz, CA) overnight 
at 4°C. Subsequently, membranes were incubated with appropriate secondary antibodies, 
and proteins were visualized using the Licor Odyssey scanner (Licor Biosciences, Lincoln, 
NE) or the ECL Plus Western blotting detection system (GE Healthcare, Little Chalfont, UK) 
respectively. Presented Western Blots are representative images for multiple experiments.
Histological analysis
Seven days after overexpression, mice were sacrificed and knee joints were fixed for 7 days 
in 4% phosphate-buffered formalin, followed by decalcification in 5% formic acid for 7 
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days. Subsequently, the joints were dehydrated and embedded in paraffin. Coronal tissue 
sections of 7 μm were made, deparaffinized, rehydrated, and stained with Safranin O and 
Fast Green (Brunschwig, Amsterdam, the Netherlands). Eight sections from various depths 
were used, representing the whole knee joints.
Cartilage damage in the tibia-femoral joints was scored using the scoring system 
developed by Pritzker et al, which was modified for mice [28]. Five sections per knee joint 
were scored. Histological analysis was performed for at least 10 mice per group.
Immunohistochemistry
To visualize the aggrecan neoepitopes VDIPEN and NITEGE, the result of aggrecan cleavage 
by MMPs and ADAMTSs, respectively, immunohistochemical staining of total knee joint 
sections was performed using specific antibodies directed against these cleavage sites 
as previously described [29]. Both primary antibodies were a kind gift from John Mort 
(McGill University, Montreal, Canada).
 
Statistical analysis
Statistics were performed using GraphPad Prism version 5.0 (GraphPad Software, San Diego, 
CA). Differences between groups were tested using an unpaired two-tailed t-test. P < 0.05 
was considered significant. Results are expressed as means ± SEM.
Results
Expression of Wnts in vivo in osteoarthritic tissue
We found in microarray data from a previous study that both Wnt16 and WISP1, a 
downstream protein of canonical Wnt signaling, were significantly upregulated in the 
synovium of a collagenase-induced OA and a destabilization of the medial meniscus 
model (DMM) longitudinal expression study [30]. We validated these findings using 
qRT-PCR. In the collagenase-induced OA, we found an upregulation of Wnt16 (fold 
increase at day 7: 257.7x, d21: 20.8x) and WISP1 (fold increase d7:180.8x, d21: 39.0x). In 
addition, we found an upregulation of Wnt16 (fold increase d7:1.1x, d28: 2.9x) and WISP1 
(fold increase d7:3.2x, d28: 16.3x) in the DMM. However, the effect of synovial overexpression 
of the members of the Wnt signaling pathway on OA pathology remained unknown.
Intraarticular injection of adenoviral vectors for Wnt5a, Wnt8a  
and Wnt16 leads to protein production by synovial cells
To determine whether our Wnt adenoviral overexpression system led to increased expression 
levels, we transduced primary murine synovial fibroblasts with adenoviral vectors for 
Wnt5a, considered a noncanonical Wnt ligand; Wnt8a, historically considered to be a model 
for canonical signaling; and Wnt16. Adenoviral overexpression led to strongly increased 
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expression, both on the RNA (Figure 1A) and protein (Figure 1B) levels. Next, we determined 
whether adenoviral overexpression in vivo led to increased expression in the synovium. 
RNA levels of Wnt5a, Wnt8a, and Wnt16 strongly increased in vivo as compared to levels 
after overexpression of the luciferase control virus in the synovium (Figure 1C). Adenoviral 
overexpression of LacZ showed that these adenoviral vectors caused overexpression 
specifically in the synovium, but not in the cartilage (Figure 1D).
Figure 1   Adenoviral targeting results in increased expression of Wnt5a, Wnt8a and 
Wnt16.
A) Quantitative real-time PCR shows that targeting of primary murine synovial fibroblasts with 
adenoviral vectors containing Wnt5a, Wnt8a and Wnt16 results in increased expression of these Wnts 
at the RNA level, 24 h after overexpression. B) Western Blot showed increased protein expression. 
C) Intraarticular injection of adenoviral vectors containing Wnt5a, Wnt8a, and Wnt16 into murine 
knee joints results in increased expression of these members of the Wnt signaling pathway in the 
synovium, 3 days after overexpression. D) In vivo overexpression with the adenoviral vectors resulted 
in increased expression specifically in the synovium, but not in the cartilage (S=synovium, P=patella, 
T=tibia, C=cartilage). Representative Western Blots and a representative image of an X-Gal staining 
are shown. Values are presented as –dCt means ±SEM.
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Overexpression of Wnt8a and Wnt16 results in canonical Wnt signaling
To check whether in our situation synovial overexpression of the Wnt proteins led to 
canonical Wnt signaling in articular cartilage, we determined β-catenin accumulation as a 
telltale sign of canonical Wnt signaling. Wnt8a and Wnt16, but not Wnt5a, resulted in 
increased levels of β-catenin in the cartilage, suggesting synovial production of both 
Wnt8a and Wnt16-induced canonical Wnt signaling in the cartilage, whereas Wnt5a did 
not (Figure 2A). However, accumulation of β-catenin does not necessarily cause active 
canonical Wnt signaling. Therefore, we determined whether the signaling marker of 
canonical Wnt signaling Axin2 was increased. Increased expression of Wnt8a and Wnt16 
but not Wnt5a, resulted in significantly increased expression of Axin2 in the cartilage 
(Figure 2B). These data indicate that the Wnt proteins that were produced in the synovium 
were able to migrate toward the cartilage to allow Wnt signaling.
Canonical Wnt signaling causes erosive superficial OA-like  
cartilage lesions
Next, we determined whether synovial overexpression of members of the Wnt signaling 
pathway resulted in OA pathology. Overexpression of Wnt8a and Wnt16 led to β-caten-
in-dependent Wnt signaling and strongly increased the incidence of erosive lesions in the 
superficial cartilage layer, mainly on the medial tibia near the cruciate ligaments (control 
30%, Wnt5a 33%, Wnt8a 65%, Wnt16 64%). Lesions were formed on the surface or just 
through the most superficial chondrocyte layer and often ran over a considerable length 
through the superficial cartilage layer (Figure 3A). We scored the cartilage damage of the 
tibia-femoral joints (Figure 3B). As suggested by the highly increased number of erosive 
lesions on the medial tibia, the most significant increase in cartilage damage was found in 
this part of the tibia femoral joint. Although histological scoring of the cartilage damage 
in the medial and lateral femur and lateral tibia only gave a trend toward increased 
cartilage damage, the cumulative score of all four cartilage areas in the tibiofemoral joint 
was significantly increased if compared with overexpression of the control virus in the 
same experiments. 
By contrast, noncanonical Wnt signaling, achieved by overexpression of Wnt5a, did not 
result in increased incidence of the OA-like cartilage lesions. Quantification of the cartilage 
damage using the OARSI scoring system optimized for mice did not show increased 
damage after overexpression of Wnt5a (Figure 3). 
Cartilage damage induced by canonical Wnt signaling is associated  
with protease activity
We observed decreased Safranin O staining around the erosive cartilage lesions, suggesting 
that the lesions might be the result of increased protease activity, in turn leading to 
degradation of the matrix surrounding the chondrocytes. Therefore, we determined the 
formation of the NITEGE neoepitope, which is induced by activity of the aggrecanases, 
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Figure 2   Synovial overexpression of Wnt8a and Wnt16, but not Wnt5a, results in the 
accumulation of β-catenin.
A) Immunohistochemical staining for β-catenin, whose accumulation is a telltale sign for canonical 
Wnt signaling, shows that adenoviral overexpression of Wnt8a and Wnt16 results in increased staining 
in the cartilage, 7 days after overexpression. By contrast, overexpression of Wnt5a had no effect. 
B) Quantitative real-time PCR shows that accumulation of β-catenin after overexpression of Wnt8a 
and Wnt16 resulted in increased expression of Axin2, which is a signaling marker for canonical Wnt 
signaling, in the cartilage. By contrast, overexpression of Wnt5a had no effect. Representative images 
of β-catenin staining are shown. Values are presented as –dCt means ±SEM. *P < 0.05 versus control.
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using immunohistochemical staining. We observed increased NITEGE staining adjoining 
the erosive superficial cartilage lesions after overexpression of both Wnt8a and Wnt16 but 
not after overexpression of Wnt5a (Figure 4A). Next to the group of aggrecanases, MMP 
activity can result in decreased Safranin O staining by cleavage of aggrecan. We conducted 
immunohistochemical staining for the MMP-induced VDIPEN neoepitope. We found that 
canonical Wnt signaling resulted in marginally increased VDIPEN staining bordering the 
lesions. As positive controls, we used the growth plates, which showed strong staining 
(data not shown).
Figure 3   Synovial overexpression of Wnts that result in canonical signaling increases 
cartilage damage.
A) Histological staining with Safranin O and Fast Green shows that synovial overexpression of Wnt8a 
and Wnt16, but not Wnt5a, results in superficial erosive cartilage lesions, mainly found at the medial 
tibia near the cruciate ligaments at day 7 after overexpression. B) Scoring of the cartilage damage 
using the Pritzker scoring system, modified for mouse, shows that canonical Wnt signaling induced by 
Wnt8a and Wnt16 significantly increased cartilage damage at the medial tibia and at all four cartilage 
areas in the tibiofemoral joint, whereas noncanonical Wnt signaling by Wnt5a overexpression does 
not increase the cartilage damage. Representative histological images are shown. Cartilage damage 
is presented as mean histological osteoarthritis scores ±SEM. *P < 0.05 and **P < 0.01 versus control.
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In addition to the superficial erosive cartilage lesions (Figure 3), we observed several 
other kinds of pathologies in the cartilage as the result of overexpression of both Wnt8a 
and Wnt16 (Figure 4B). The canonical Wnt signaling resulted in profound proteoglycan 
depletion in the superficial cartilage layer. This depletion was associated with both strong 
NITEGE and VDIPEN staining, indicating both aggrecanase and MMP activity. Tears were 
observed deeper in the cartilage. Staining of consecutive sections for the NITEGE and 
VDIPEN neoepitopes showed that this type of OA-like cartilage damage was mainly 
associated with MMP activity, whereas hardly any NITEGE staining was found (Figure 4).
Blocking canonical Wnt signaling prevents cartilage damage
The data above suggest that the observed cartilage damage was the effect of Wnt 
signaling via the canonical β-catenin-dependent route. Therefore, to ensure that specifically 
signaling via the canonical pathway resulted in cartilage damage, we overexpressed DKK-1 
to block canonical Wnt signaling. DKK-1 overexpression led to decreased severity of the 
lesions in the tibiofemoral joint (Figure 5A). Histological scoring showed significantly 
decreased cartilage damage (Figure 5B). These observations suggested that the effects 
on the cartilage were indeed the result of canonical Wnt signaling.
Figure 3   Continued.
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Figure 4   Osteoarthritis-like cartilage pathologies resulted from protease activity.
A) Immunohistochemical staining for the aggrecanase neoepitope NITEGE and the matrix metallo-
proteinase (MMP) neoepitope VDIPEN shows that the superficial erosive cartilage lesions induced by 
the overexpression of Wnt8a and Wnt16 are associated with strong NITEGE staining, whereas there 
was only a minor increase in VDIPEN. B) In addition to the superficial erosive cartilage lesions, several 
other types of pathologies in the cartilage after overexpression of Wnt8a or Wnt16, resulting in 
canonical signaling, were observed. Staining for NITEGE and VDIPEN shows that profound superficial 
proteoglycan depletion was associated with both aggrecanase and MMP activity. In addition, tears in the 
cartilage were associated mainly with MMP activity as measured by VDIPEN staining. Representative 
images of all stainings are shown after overexpression of Wnt8a or Wnt16.
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WISP1 can be responsible for the effects of canonical Wnt signaling
We overexpressed WISP1 to determine whether its overexpression caused cartilage 
lesions resulting from increased canonical Wnt signaling. Overexpression of WISP1 
increased production of WISP1 at RNA level in vitro in primary murine synovial fibroblasts 
(Figure 6A), at protein level (Figure 6C) and in vivo in the synovium (Figure 6B). We 
observed an increased incidence of the same type of erosive superficial cartilage lesions 
that we observed after overexpression of Wnt8a and Wnt16 (53% after WISP1 
overexpression, compared to 30% after overexpression of the control virus) (Figure 6D). 
Histological scoring showed that the cartilage damage significantly increased both the 
medial tibia and the overall joint score (Figure 6E). These lesions were mainly associated 
with increased aggrecanase activity, determined by NITEGE staining (Figure 6F). However, 
VDIPEN staining did not show an increase.
Figure 4   Continued.
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Figure 5   Inhibition of canonical Wnt signaling by Dickkopf-1 (DKK-1) overexpression 
reduces the cartilage damage.
A) Histological staining with Safranin O and Fast Green shows that synovial overexpression of DKK-1 
reduces the superficial erosive cartilage lesions are induced by canonical Wnt signaling at day 7 
after overexpression. B) Scoring of the cartilage damage using the Pritzker scoring system, modified 
for mouse, shows that inhibition of canonical Wnt signaling by overexpression of the selective 
inhibitor DKK-1 significantly reduced the cartilage damage induced by canonical Wnt signaling in 
the tibiofemoral joint. Representative histological images are shown. Cartilage damage is presented 
as mean histological osteoarthritis scores ±SEM. *P < 0.05 versus control.
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Figure 6   WISP1, a downstream protein of canonical Wnt signaling, might be partially 
responsible for the osteoarthritis-like cartilage pathology.
A - C) WISP1 was successfully overexpressed with an adenoviral vector both in vitro in murine synovial 
fibroblasts (A and C) and in vivo in synovial tissue (B). D and E) An increased incidence of superficial 
erosive cartilage lesions at the medial tibia after overexpression of WISP1 (D), led to significantly 
increased cartilage damage (E). F) Comparable with Wnt8a and Wnt16 overexpression, the lesions 
were associated with increased NITEGE staining, whereas VDIPEN staining was only increased to 
a minor extent. Gene expression is presented as –dCt means ±SEM. Representative Western Blots 
and images are shown. Cartilage damage is presented as the mean histological osteoarthritis scores 
±SEM. *P < 0.05 and **P < 0.01 versus control.
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Discussion
Here, we show for the first time that synovial overexpression of Wnt proteins leading to 
canonical signaling results in increased protease activity and OA-like cartilage damage.
Wnt signaling has been linked to OA incidence via the β-catenin-dependent canonical 
signaling pathway. We have earlier shown that the expression of various members of the 
Wnt signaling pathway increases in two experimental OA mouse models [7]. Therefore, in 
this study, we determined the effects of overexpression of selected members of the Wnt 
signaling pathway in vivo. 
We used Wnt8a as a classical example of a Wnt ligand that signals via the canonical 
 β-catenin-dependent pathway [27]. Overexpression of Wnt8a and Wnt16 led to increased 
β-catenin protein levels in the articular cartilage thereby indicating signaling via the 
canonical pathway. Overexpression of Wnt5a, on the contrary, did not result in β-catenin 
accumulation. Historically, Wnt signaling pathways were divided in the β-catenin-dependent 
Figure 6   Continued.
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canonical Wnt signaling pathway and various β-catenin-independent noncanonical 
pathways. Wnt5a was considered to be a noncanonical Wnt protein that solely signaled 
via noncanonical Wnt signaling. However, currently, the activation of the signaling 
pathways is considered to be mainly dependent on the cellular context and the 
arrangement of the Wnt receptors, rather than on a sequence or structural basis in the 
Wnt proteins. The idea of canonical and noncanonical Wnt proteins is waning, although 
most proteins preferentially activate either the β-catenin-dependent or -independent 
pathway [31]. Our study shows that Wnt5a in the joint microenvironment does not result 
in canonical Wnt signaling.
Increased expression in the synovium of Wnt8a and Wnt16, both signaling via the 
canonical pathway, led to superficial erosive cartilage lesions and increased cartilage 
damage, as early as 7 days after overexpression. This was observed both in young mice (12 
weeks old) and older mice (6 months old, data not shown). This is consistent with findings 
by Zhu et al, showing that the activation of β-catenin in articular chondrocytes results in 
increased cartilage erosion [13]. However, we did not find significant cartilage loss in our 
model. This could be due to the relatively short time of overexpression of the Wnts. We 
observed cartilage lesions 7 days after overexpression of the adenoviral vectors, whereas 
Zhu et al reported these months after the conditional activation of β-catenin in the 
chondrocytes. However, whereas Zhu et al conditionally activated β-catenin directly in 
the chondrocytes, here we show that an increased expression of Wnt proteins in the 
synovium is able to induce canonical Wnt signaling and subsequent cartilage damage in 
the cartilage. However, it cannot be ruled out that the effects in the synovium as the result 
of synovial overexpression of canonical Wnts contribute to the effects seen in the cartilage. 
This underlines the idea that the synovium is an active player in the induction of OA 
pathology. Moreover, we tested whether the observed cartilage pathology was due to 
the induction of WISP1, a downstream protein of canonical Wnt signaling, reported to be 
increased in both the cartilage and the synovium [7]. We observed an increased incidence 
of cartilage lesions that were comparable to overexpression of Wnt8a and Wnt16. In 
addition, this resulted in significantly higher cartilage damage, suggesting that WISP1 
might be the downstream mediator of canonical Wnt signaling responsible for the 
cartilage damage.
Wnt signaling has been linked to the balance of bone formation and resorption and has 
been linked to fibrosis in kidney, liver, lungs, and skin; both phenomena are examples of 
typical OA pathologies [32-35]. Luyten and colleagues showed increased bone mass on 
FrzB knockout in mice [12], whereas Zhu et al reported increased osteophyte formation 
after conditional activation of β-catenin in the cartilage [13]. On the other hand, tumor 
necrosis factor-α-induced DKK-1 expression and subsequent inhibition of Wnt signaling 
leads to decreased bone apposition [36], whereas Oh et al have shown that increased 
expression of DKK-1 in the cartilage reduces the osteophyte size [37]. However, we did not 
find osteophyte formation by overexpression of Wnts or WISP1 in the synovium. 
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Transforming growth factor-β (TGF-β) is one of the dominant factors in synovial fibrosis 
[38, 39]. There is complex crosstalk between the Wnt and the TGF-β signaling pathways, as 
nicely reviewed by Guo et al [40]. Wnt signaling plays an important role in the pathogenesis 
of many fibrotic disorders, at least partially via interplay with the TGF- β signaling pathway, 
was reviewed by Guo et al in 2012 [41]. However, overexpression of Wnt or WISP1 proteins 
in the synovium did not result in increased fibrosis in our experiments. The absence of 
both new bone formation and fibrosis could possibly be explained by the fact that OA is 
a composite disease with extra factors that are missing in this study.
Finally, IL-1 has been implicated in OA. Rowan et al have shown that overexpression of IL-1 
in the knee joint using an adenovirus leads to increased inflammation in the synovial 
lining and depletion of both proteoglycans and type II collagen in the cartilage [42]. In our 
study, adenoviral overexpression of members of the Wnt signaling pathway did not result 
in severe proteoglycan depletion throughout the cartilage, although we found focal 
depletion as the result of MMP and aggrecanase-activity in the superficial cartilage layer, 
suggesting that canonical Wnt signaling did not conduct its effects via IL-1. 
In conclusion, we have shown for the first time that excessive production of members of 
the Wnt signaling pathway in the synovium that signal via the canonical Wnt signaling 
pathway results in OA-like cartilage lesions shortly after overexpression. Moreover, we 
show that WISP1 might be a pivotal downstream mediator of canonical Wnt signaling in 
this process.
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CHAPTER 5
Abstract
Objectives. Balanced Wnt signaling has been shown to be crucial during both development 
and homeostasis of joint tissues. However, increased activation of canonical Wnt signaling 
has been associated with the development of osteoarthritis. In this study, we investigated 
the potency of inhibition of canonical Wnt signaling by overexpression of Dickkopf 1 
(DKK1) to reduce pathology in experimental animal models of osteoarthritis. Methods. 
An inducible DKK1 transgenic mouse was generated by backcrossing rtTA transgenic 
mice with tetO-Dkk1 transgenic mice. DKK1 was overexpressed in mice by feeding them 
food with doxycycline. Collagenase-induced osteoarthritis (CIOA) or destabilization of 
the medial meniscus (DMM) experimental animal models of osteoarthritis were induced 
in mice with or without doxycycline supplementation to induce DKK1 expression. Gene 
expression was determined with qRT-PCR. Joint pathology was assessed using histology. 
Results. Doxycycline treatment strongly increased the expression of DKK1 in both the 
cartilage and synovium. Due to the inducibility, our DKK1 transgenic mice did not show a 
basal phenotype in both cartilage and subchondral bone at the age of induction of the 
osteoarthritis models. Moreover, supplementation of doxycycline did not affect the 
severity of the experimental osteoarthritis models. Finally, whereas overexpression of 
DKK1 did not affect the synovial inflammation, degeneration of the articular cartilage in 
both the CIOA and DMM model was significantly decreased. Conclusions. Our findings 
support the importance of canonical Wnt signaling in the development of osteoarthritis. 
Moreover, this study shows that inhibition of canonical Wnt signaling by DKK1 might 
prove an efficient way to limit osteoarthritis-related cartilage degeneration.
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Introduction
Osteoarthritis (OA) is the most common debilitating joint disease in the aging population. 
OA patients often suffer from severe dysfunction of the affected joints [1, 2]. The main 
hallmark of OA is the degeneration of the articular cartilage, which is often accompanied 
by other pathologies, such as inflammation and fibrosis in the synovium, ectopic bone 
formation and sclerosis of the subchondral bone. Today, it is generally accepted that not 
only the cartilage, but all tissues in the joint are actively involved in OA pathology, in which 
a particularly important role is accredited to the synovial tissue [3-5]. Synovial activation 
and/or inflammation is found in around 50% of the patients, and this is thought to be 
important for the later development of the disease pathology [6, 7]. However, the detailed 
molecular mechanisms that underlie the OA pathology remain to be elucidated. As a 
result, no disease-modifying therapies exist up until now.
Previously, we described strong upregulation of various Wnt ligands in the synovial tissue, 
but not in the cartilage in experimental OA [8]. Wnt signaling has been implicated in OA 
pathology mainly via activation of the β-catenin-dependent canonical signaling pathway 
[9]. Therefore, it is interesting that we observed increased expression of the Wnt-induced 
target Wnt-1-induced signaling protein 1 (Wisp1) in both the synovium and cartilage, 
indicating active canonical Wnt signaling in both tissues [8]. 
Wnt proteins are lipid-modified glycoproteins that can bind to Frizzled (FZD) receptors. 
Wnt ligands can signal via both canonical and noncanonical signaling routes, where the 
canonical Wnt signaling pathway is the most well-studied. In order to activate the 
canonical Wnt signaling pathway, binding of the Wnt ligand to the co-receptor complex 
of low-density lipoprotein receptor-related protein (LRP) 5/6 is essential, next to the 
Wnt-FZD interaction that is needed for activation of all signaling routes. Binding to both 
FZD and LRP5/6 results intracellularly in accumulation of free β-catenin in the cytoplasm 
that translocates into the nucleus to cause transcription of target genes. Wnt signaling is 
strictly regulated by a set of inhibitors, among which the members of the Dickkopf (DKK) 
family are considered important factors to specifically antagonize canonical Wnt signaling 
by binding to LRP5/6, which results in their internalization [10].
We previously studied the consequences of increased synovial expression of Wnt ligands 
and showed that induction of canonical Wnt signaling in the joint by overexpression of 
specific Wnts increased the number and severity of early OA-like cartilage lesions [11]. In 
addition, we demonstrated that we could block these effects by overexpression of DKK1. 
The implicated role of Wnt signaling in OA was further strengthened by previous studies, 
which demonstrated that Wnt signaling via the canonical route induced hypertrophy-like 
differentiation of chondrocytes [9, 12, 13]. Moreover, canonical Wnt signaling has been 
shown to increase the expression of various matrix metalloproteinases (MMPs), which can 
break down the cartilage matrix [9, 14].
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In the present study, we studied the importance of canonical Wnt signaling in OA 
development. To this end, we induced two animal models of experimental OA in mice 
that overexpressed DKK, a selective inhibitor of canonical Wnt, in an inducible manner 
and investigated whether this resulted in decreased cartilage degeneration.
Materials and methods
Generation of inducible DKK1 transgenic mice and experimental  
OA models
B6.Cg-Gt(ROSA)26Sortm1(rtTA*M2)Jae/J, which show a widespread expression of the optimized 
form of reverse tetracycline-controlled transactivator (rtTA) protein, were obtained from 
The Jackson Laboratory. tetO-Dkk1 mice were a kind gift of Sarah Miller (University of 
Pennsylvania, Philadelphia, PA). These mouse strains were used to generate inducible 
rtTA-Dkk1 mice that were homozygous for rtTA and heterozygous for Dkk1. Mice were kept 
in filtertop cages with woodchip bedding and cage enrichment under standard pathogen-  
free conditions and fed a standard diet and tap water ad libitum. In experiments including 
doxycycline (dox) to overexpress Dkk1, the standard diet (off dox) was replaced by a diet 
containing 575 mg/kg doxycycline hyclate (Sigma) (on dox), which was refreshed once a 
week. 
Induction of experimental OA
Collagenase-induced OA (CIOA) was induced by 2 intraarticular injections of 1 unit bacterial 
collagenase VII (Sigma-Aldrich) as described previously [15]. In addition, the destabilization of 
the medial meniscus (DMM) was induced as described previously [16]. CIOA was induced 
in female mice, whereas DMM was induced in male mice of 12 weeks old that were fed 
either a standard diet or a dox-enriched diet, starting from 7 days before induction of the 
model. The study protocol for all animal experiments was approved by the local animal 
experimentation committee, Nijmegen, the Netherlands.
Histological analysis
Osteoarthritis pathology was allowed to develop for 42 days (CIOA) or 56 days (DMM), 
after which mice were sacrificed. Knee joints were fixed in 4% phosphate-buffered 
formalin for 7 days, followed by decalcification in 5% formic acid for 7 days. Subsequently, 
joints were dehydrated and embedded in paraffin. Coronal sections of 7 µm were made. 
Sections from various depths, representing the entire knee joints, were mounted, 
deparaffinized, rehydrated and stained with either hematoxylin and eosin or Safranin-O 
and Fast Green (Brunschwig). Cartilage damage in the tibiofemoral joints was scored in a 
blinded manner for 5 sections per joint using the scoring system developed by Pritzker et 
al [17], which was modified for mice. Sections from the naïve knee joints of mice of 12 
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weeks old that either had the tetO-Dkk1 transgene and the rtTA transgene or the rtTA 
transgene alone were used to determine whether a basal phenotype in the bone and 
cartilage tissue was present. Cartilage degeneration was scored in a blinded manner 
using the Pritzker scoring system, modified for mice. 
The subchondral bone tissue was investigated in a blinded manner using sections stained 
with Safranin-O/Fast Green with the Leica Application Suite software (Leica Microsystems) 
for 5 sections per joint. The calcified surface area staining blue was corrected for the total 
area of the subchondral bone, where the calcified place of attachment of the cruciate 
ligaments was excluded. Representative images of stainings are shown.
RNA isolation and quantitative real-time polymerase chain reaction
Gene expression was determined using quantitative real-time polymerase chain reaction 
(qRT-PCR). Cartilage tissue and synovial biopsies were homogenized in Trizol and RLT 
buffer respectively, using the MagNA Lyser Instrument (Roche). Total RNA was isolated 
from the cartilage tissue according to the manufacturer’s protocol. Total RNA from the 
synovial biopsies was isolated using the RNeasy Fibrous Tissue Mini Kit (Qiagen) with a 
Proteinase K step according to the manufacturer’s protocol. 
RNA isolation and quantitative real-time polymerase chain reaction
Gene expression was determined using quantitative real-time polymerase chain reaction 
(qRT-PCR). Tissue samples were homogenized using the MagNA Lyser Instrument (Roche) 
in either Trizol or RLT buffer. Total RNA was isolated using the manufacturer’s protocol for 
Trizol RNA isolation (Sigma) or using the RNeasy Fibrous Tissue Mini Kit (Qiagen) with a 
Proteinase K step according to the manufacturer’s protocol. After determination of the 
RNA concentration with the Nanodrop spectrophotometer, the RNA was reverse transcribed 
into complementary DNA (cDNA). qRT-PCR reaction were performed using specific 
primers and the SYBR Green Master Mix in the Applied Biosystems StepOnePlus real-time 
PCR system in a total volume of 10 µL. Reactions were presented as minus delta threshold 
cycle Ct (-ΔCt) values, calculated by correcting the negative threshold cycle (-Ct) of the 
gene of interest to the -Ct of the reference gene GAPDH.
Statistical analysis
Statistics were performed using GraphPad Prism version 5.0 (GraphPad Software). 
Differences between groups were tested using a Student’s t-test. P < 0.05 was considered 
significant. Results are expressed as means ± SEM, indicated by the error bars. 
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Results
Increased Dkk1 expression in rtTA-Dkk1 mice upon dox exposure
First, we determined whether exposure to dox via the diet resulted in increased expression 
of Dkk1 in our transgenic mice. Therefore, rtTA-Dkk1 mice were fed dox or no dox for 7 days, 
after which both the synovial tissue and the cartilage were isolated for mRNA detection of 
Dkk1. This showed that mice that were fed a diet containing dox, had significantly increased 
expression of Dkk1 both in the synovium and cartilage (30.2 and 8.1 fold increase compared 
to off dox controls, calculated as 2ΔΔCt) (Figure 1).
Inducible Dkk1 transgenic mice do not have a basal phenotype
Next, we investigated whether the presence of the Dkk1 transgene in our mice did affect 
the basal phenotype of the mice. Safranin-O and Fast Green staining of tibiofemoral joints 
of 12 weeks old Dkk1 transgenic mice and their controls, the age on which CIOA or DMM 
were induced, did not show clear differences between both groups (Figure 2A). Next, we 
used more detailed scoring systems to determine whether the presence of the tetO-Dkk1 
transgene affected the basal phenotype. Figure 2B shows that the cartilage damage was 
not altered in both male and female mice at both the medial and lateral side of the tibia 
and femur. Moreover, in the same sections, we determined the relative area of the bone 
tissue as part of the entire surface of the subchondral bone. However, we did not observe 
Figure 1   Induction of Dkk1 expression upon exposure to doxycycline in rtTA-Dkk1 
transgenic mice.
Mice homozygous for the rtTA transgene and heterozygous for the tetO-Dkk1 transgene were fed 
doxycycline (dox) or a regular diet (off dox) for 7 days. Mice were sacrificed and synovium and 
articular cartilage of the tibiofemoral joints were isolated. Increased expression levels of Dkk1 were 
found in both the articular cartilage and synovial tissue after feeding the mice a dox-enriched diet 
for 7 days, as determined by quantitative real-time polymerase chain reaction (n=8 mice per group). 
Bars show the mean ± SEM. *** = P < 0.001, versus off dox control mice.
Synovium
o dox on dox
-22
-20
-18
-16
-14
-12
-10
-8
m
RN
A 
ex
pr
es
si
on
 (-
∆C
t)
Cartilage
o dox on dox
-8
-6
-4
-2
m
RN
A 
ex
pr
es
si
on
 (-
∆C
t)
*** ***
103
DKK1 OVEREXPRESSION AMELIORATES EXPERIMENTAL OSTEOARTHRITIS
5
Figure 2   rtTA-Dkk1 mice do not have a basal phenotype.
Both male and female rtTA-Dkk1 and rtTA mice of 12 weeks old, the age at which experimental mouse 
models of OA were induced, were sacrificed and studied to determine whether the Dkk1 transgene 
induced a basal phenotype. Photomicrographs (original magnification x 100) of representative 
Safranin-O/Fast Green stained sections are shown, which show no visible differences in both the 
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differences in the relative fraction of the bone between Dkk1 positive mice and their 
controls. These data indicate that our mice did not have a cartilage or bone phenotype 
prior to induction of the experimental OA models (Figure 2C).
Inhibition of canonical Wnt signaling reduces cartilage degeneration  
in experimental models of OA
Next, we set out to determine whether inhibition of canonical Wnt signaling by means of 
DKK1 overexpression decreased the cartilage degeneration in induced experimental OA 
models. First, we determined whether the addition of doxycycline to the food affected 
the severity of cartilage degeneration after induction of CIOA. Therefore, we induced 
CIOA in mice that only had the rtTA transgene, but not the tetO-Dkk1 transgene. Induction 
of CIOA in female mice resulted in mild cartilage damage. However, we observed highly 
comparable cartilage degeneration in mice that were fed a normal diet and mice that 
were fed a dox-enriched diet, showing that doxycycline did not affect the degeneration 
(Figure 3A). Next, we induced CIOA in mice that were positive for both rtTA and Dkk1. 
Although only a mild degeneration of the articular cartilage was observed, this was 
significantly reduced at the medial side of the joint in mice that overexpressed DKK1, 42 
days after induction of the model (Figure 3B). Because synovial activation has been 
shown to be actively involved in this model, we arbitrarily scored synovial thickening at 
day 7 after induction of the CIOA. However, comparable synovial thickening was observed 
in mice that were fed a dox-enriched diet and mice with a standard diet (Figure 3C).
Next, to validate our findings, we induced the DMM model, which is less dependent on 
synovial inflammation for the development of the pathology. Induction of DMM resulted 
in a more severe degeneration of the articular cartilage. As expected, the cartilage 
degeneration at the lateral side of the tibia and femur was not affected and lower 
compared to the medial side of the joint (data not shown). In line with our findings in the 
CIOA, we observed no significant differences in cartilage degeneration between mice 
that were fed a normal diet or a dox-enriched diet when the DMM was induced in mice 
that only had the rtTA transgene (Figure 4A). Underlining our findings in the CIOA model, 
we observed significantly decreased degeneration of the articular cartilage at the medial 
side of the tibia and medial side of the femur in mice overexpressing DKK1, 56 days after 
induction of the DMM model (Figure 4B).
cartilage and bone tissue (A). Scoring of the cartilage degeneration did reveal comparable cartilage 
damage between mice that had the rtTA transgene alone and mice that carried both the rtTA and 
Dkk1 transgenes in both male and female mice (B). Moreover, scoring of the relative calcified area as 
part of the total area of the subchondral bone did not result in differences between rtTA and rtTA-
Dkk1 mice, indicating that no basal phenotype in both the cartilage and subchondral bone is present 
at the time of induction of experimental OA (C). Bars show the mean ± SEM.
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Figure 3   Inhibition of canonical Wnt signaling by overexpression of Dkk1 reduces 
cartilage degeneration in collagenase-induced osteoarthritis.
Possible effects of doxycycline (dox) enrichment of the diet, in order to overexpress Dkk1, on the 
induction of the collagenase-induced osteoarthritis experimental model were tested. No differences 
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in cartilage degeneration were observed in rtTA mice that were fed a dox-enriched (on dox) or 
standard (off dox) diet, 42 days after induction of the model (A). Induction of CIOA in rtTA-Dkk1 mice 
that were fed a dox-enriched diet resulted in significantly decreased degeneration of the articular 
cartilage, 42 days after induction of the model (B). Although synovial activation is closely involved 
in the CIOA model, no difference in synovial thickness between on dox and off dox mice was 
observed (C). Representative micrographs are shown (original magnification x 100). Bars show the 
mean ± SEM. * = P < 0.05, versus off dox controls.
Figure 4   Overexpression of Dkk1 reduces cartilage degeneration after destabilization  
of the medial meniscus.
Findings from the collagenase-induced osteoarthritis model were validated in the destabilization 
of the medial meniscus (DMM) mouse model of osteoarthritis. rtTA mice that were fed a standard 
diet (off dox) or a diet enriched with doxycycline (on dox) showed comparable degeneration of the 
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Discussion
In this study, we show that inducible overexpression of DKK1 inhibits the degeneration of 
the articular cartilage in two experimental models of OA. 
In an earlier study, we showed that increased expression of various Wnt ligands was found 
in the synovium, whereas increased expression of the Wnt-induced protein Wnt-1-induced 
signaling protein 1 (WISP1) was observed both in the synovium and cartilage after induction 
of two experimental animal models of OA [8].
Wnt signaling has been linked to the development of OA mainly via the activation of 
the β-catenin-dependent canonical Wnt signaling pathway. Conditional activation of 
β-catenin in articular chondrocytes has been shown to result in increased expression of 
various MMPs and severe cartilage erosions [9]. Moreover, it has been shown that activation 
of canonical Wnt signaling results in the hypertrophy-like differentiation of articular 
chondro cytes [9, 12]. These findings gave rise to the question whether inhibition of 
canonical Wnt signaling could serve as a tool to reduce the cartilage degeneration in OA. 
The Dickkopf family member DKK1 has been shown to effectively inhibit canonical Wnt 
signaling by binding to LRP5/6, thereby inhibiting the possibility to interact with the Wnt/
FZD complex [18]. Serum levels of DKK1 have been shown to predict progression of OA 
and an inverse correlation between serum DKK1 levels and severity of knee OA has been 
described [19, 20].
We previously described that synovial overexpression of Wnt ligands that led to canonical 
Wnt signaling in the joint, resulted in increased incidence and severity of early OA-like 
cartilage lesions. However, co-overexpression with DKK1 resulted in cartilage degeneration 
that was comparable with the control virus [11]. Nonetheless, these experiments were 
performed in naive C57Bl/6 mice, which do not mimic an OA environment. Because OA is 
considered a complex multifactorial disease, in the present study, we are the first to 
overexpress DKK1 during two animal models of experimental OA using an inducible 
system to ensure increased DKK1 levels only during the course of these models. We 
observed decreased cartilage degeneration in both models; however, we cannot 
conclude that the mechanism underlying the decrease in cartilage degeneration is 
comparable. Whereas synovial activation is closely involved in the induction of OA 
pathology in the CIOA, we did not observe differences in synovial activation between 
mice that were fed a standard diet or a dox-enriched diet. However, a crucial role for 
canonical Wnt signaling in immunity has not been described previously.
articular cartilage, indicating that doxycycline did not affect the induction of the DMM model (A). 
Overexpression of Dkk1 in rtTA-Dkk1 mice that were on dox significantly decreased the cartilage 
degeneration in the tibiofemoral joint compared to their off dox controls, 56 days after induction of 
the model. Representative photomicrographs are shown (original magnification x 100). Bars show 
the mean ± SEM. ** = P < 0.01; *** = P < 0.001, versus off dox controls.
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Previously, constitutive Dkk1 transgenic mice were used to study the role of canonical Wnt 
signaling in OA pathology. However, because of the central importance of canonical Wnt 
signaling during developmental processes, it is highly likely that the non-inducible Dkk1 
transgenic mice have a basal phenotype as the result of increased DKK1 levels during 
embryogenesis. Funck-Brentano et al showed that constitutive overexpression of DKK1 in 
the bone led to decreased cartilage degeneration and decreased osteophyte formation 
after induction of a partial meniscectomy model. However, the DKK1-overexpressing mice 
showed a profoundly reduced bone volume/total volume in the subchondral bone. 
Changes in the subchondral bone have been described throughout the course of OA 
development and have been shown to be actively involved in the pathological processes 
[21-23]. In contrast, the Dkk1 transgenic mice that were used in this study did not show a 
phenotype before induction of the OA models, ruling out the influence of a basal 
phenotype on the further induction of OA pathology.
Another study by Oh et al showed that overexpression of Dkk1 under the Col2a1 promoter, 
resulting in overexpression in articular chondrocytes, significantly reduced the cartilage 
degeneration, osteophyte formation and sclerosis of the subchondral bone plate after 
induction of the DMM model. However, canonical Wnt signaling plays a central role in the 
development and homeostasis of the articular cartilage. Therefore, due to the constitutive 
overexpression of DKK1 in chondrocytes, one cannot conclude that the effects observed 
are solely the effect of inhibition of canonical Wnt signaling during the experimental OA 
model. 
Nonetheless, although these studies show a beneficial effect of blocking canonical Wnt 
signaling during experimental OA, care should be taken to prevent “overblocking” of this 
pathway. Wnt signaling has been shown to play a crucial role in the development and 
homeostasis of the tissues in the joint. Conditional knockdown of β-catenin in the articular 
cartilage has been shown to result in equally detrimental effects on the cartilage integrity, 
showing strongly increased chondrocyte apoptosis [24].
Taken together, in the current study we have shown that inhibition of canonical Wnt 
signaling by means of temporal overexpression of DKK1 reduces the cartilage degeneration 
in animal models of experimental OA. This indicates that inhibition of canonical Wnt 
signaling during OA might prove beneficial for the progression of the disease pathology.
Acknowledgments
The authors would like to thank Annet Sloetjes, Birgitte Walgreen and Monique Helsen for 
their excellent technical assistance. Moreover, we thank Sarah Miller for providing 
tetO-Dkk1 transgenic mice.
109
DKK1 OVEREXPRESSION AMELIORATES EXPERIMENTAL OSTEOARTHRITIS
5
References
1 Goldring SR, Goldring MB. Clinical aspects, pathology and pathophysiology of osteoarthritis. Journal of 
 musculoskeletal & neuronal interactions 2006;6(4):376-8.
2 Felson DT. Clinical practice. Osteoarthritis of the knee. The New England journal of medicine 2006;354(8):841-8.
3 Samuels J, Krasnokutsky S, Abramson SB. Osteoarthritis: a tale of three tissues. Bulletin of the NYU hospital for 
joint diseases 2008;66(3):244-50.
4 Scanzello CR, Goldring SR. The role of synovitis in osteoarthritis pathogenesis. Bone 2012;51(2):249-57.
5 Berenbaum F. Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthritis 
Cartilage 2013;21(1):16-21.
6 Ayral X, Pickering EH, Woodworth TG, Mackillop N, Dougados M. Synovitis: a potential predictive factor of 
structural progression of medial tibiofemoral knee osteoarthritis -- results of a 1 year longitudinal arthroscopic 
study in 422 patients. Osteoarthritis Cartilage 2005;13(5):361-7.
7 Kortekaas MC, Kwok WY, Reijnierse M, Stijnen T, Kloppenburg M. Brief Report: Association of Inflammation 
With Development of Erosions in Patients With Hand Osteoarthritis: A Prospective Ultrasonography Study. 
Arthritis & rheumatology 2016;68(2):392-7.
8 Blom AB, Brockbank SM, van Lent PL, et al. Involvement of the Wnt signaling pathway in experimental and 
human osteoarthritis: prominent role of Wnt-induced signaling protein 1. Arthritis Rheum 2009;60(2):501-12.
9 Zhu M, Tang D, Wu Q, et al. Activation of beta-catenin signaling in articular chondrocytes leads to osteoarth-
ritis-like phenotype in adult beta-catenin conditional activation mice. J Bone Miner Res 2009;24(1):12-21.
10 Clevers H, Nusse R. Wnt/beta-catenin signaling and disease. Cell 2012;149(6):1192-205.
11 van den Bosch MH, Blom AB, Sloetjes AW, et al. Induction of Canonical Wnt Signaling by Synovial Over-
expression of Selected Wnts Leads to Protease Activity and Early Osteoarthritis-Like Cartilage Damage. The 
American journal of pathology 2015;185(7):1970-80.
12 Dong YF, Soung do Y, Schwarz EM, O‘Keefe RJ, Drissi H. Wnt induction of chondrocyte hypertrophy through 
the Runx2 transcription factor. Journal of cellular physiology 2006;208(1):77-86.
13 Guo X, Mak KK, Taketo MM, Yang Y. The Wnt/beta-catenin pathway interacts differentially with PTHrP signaling 
to control chondrocyte hypertrophy and final maturation. PloS one 2009;4(6):e6067.
14 Tamamura Y, Otani T, Kanatani N, et al. Developmental regulation of Wnt/beta-catenin signals is required for 
growth plate assembly, cartilage integrity, and endochondral ossification. The Journal of biological chemistry 
2005;280(19):19185-95.
15 van der Kraan PM, Vitters EL, van Beuningen HM, van de Putte LB, van den Berg WB. Degenerative knee joint 
lesions in mice after a single intra-articular collagenase injection. A new model of osteoarthritis. Journal of 
experimental pathology 1990;71(1):19-31.
16 Glasson SS, Blanchet TJ, Morris EA. The surgical destabilization of the medial meniscus (DMM) model of 
osteoarthritis in the 129/SvEv mouse. Osteoarthritis Cartilage 2007;15(9):1061-9.
17 Pritzker KP, Gay S, Jimenez SA, et al. Osteoarthritis cartilage histopathology: grading and staging. Osteoarthritis 
Cartilage 2006;14(1):13-29.
18 Nusse R. Wnt signaling. Cold Spring Harbor perspectives in biology 2012;4(5).
19 Lane NE, Nevitt MC, Lui LY, de Leon P, Corr M, Study of Osteoporotic Fractures Research G. Wnt signaling 
antagonists are potential prognostic biomarkers for the progression of radiographic hip osteoarthritis in 
elderly Caucasian women. Arthritis Rheum 2007;56(10):3319-25.
20 Honsawek S, Tanavalee A, Yuktanandana P, Ngarmukos S, Saetan N, Tantavisut S. Dickkopf-1 (Dkk-1) in plasma 
and synovial fluid is inversely correlated with radiographic severity of knee osteoarthritis patients. BMC mu-
sculoskeletal disorders 2010;11:257.
21 Suri S, Walsh DA. Osteochondral alterations in osteoarthritis. Bone 2012;51(2):204-11.
22 Karsdal MA, Bay-Jensen AC, Lories RJ, et al. The coupling of bone and cartilage turnover in osteoarthritis: 
opportunities for bone antiresorptives and anabolics as potential treatments? Annals of the rheumatic diseases 
2014;73(2):336-48.
23 Loeser RF, Goldring SR, Scanzello CR, Goldring MB. Osteoarthritis: a disease of the joint as an organ. Arthritis 
Rheum 2012;64(6):1697-707.
24 Zhu M, Chen M, Zuscik M, et al. Inhibition of beta-catenin signaling in articular chondrocytes results in articular 
cartilage destruction. Arthritis Rheum 2008;58(7):2053-64.

Canonical Wnt signaling skews  
TGF-β signaling in chondrocytes towards 
signaling via ALK1 and Smad1/5/8
Martijn H. van den Bosch, Arjen B. Blom, Peter L. van Lent, 
Henk M. van Beuningen, Esmeralda N. Blaney Davidson, 
Peter M. van der Kraan, Wim B. van den Berg
Cellular signalling (2014) 26(5): 951-958
6
112
CHAPTER 6
Abstract
Background. Both Wnt signaling and TGF-β signaling have been implicated in the 
regulation of the phenotype of many cell types including chondrocytes, the only cell type 
present in the articular cartilage. A changed chondrocyte phenotype, resulting in 
chondrocyte hypertrophy, is one of the main hallmarks of osteoarthritis. TGF-β signaling 
via activin-like kinase (ALK)5, resulting in Smad2/3 phosphorylation, inhibits chondrocyte 
hypertrophy. In contrast, TGF-β signaling via ALK1, leading to Smad1/5/8 phosphorylation, 
has been shown to induce chondrocyte hypertrophy. In this study, we investigated the 
capability of Wnt3a and WISP1, a protein downstream in canonical Wnt signaling, to skew 
TGF-β signaling in chondrocytes from the protective Smad2/3 towards the Smad1/5/8 
pathway. Results. Stimulation with Wnt3a, either alone or in combination with its 
downstream protein WISP1, decreased TGF-β-induced C-terminal phosphorylation of 
Smad2/3. In addition, both Wnt3a and WISP1 increased Smad1/5/8 phosphorylation at 
the C-terminal domain in both murine and human chondrocytes. DKK-1, a selective 
inhibitor of canonical Wnt signaling, abolished these effects. TGF-β signaling via Smad2/3, 
measured by the functional CAGA12-Luc reporter construct activity, was decreased by 
stimulation with Wnt3a in accordance with the decrease in Smad2/3 phosphorylation 
found on Western blot. Furthermore, in vivo overexpression of the canonical Wnt8a decreased 
Smad2/3 phosphorylation and increased Smad1/5/8 phosphorylation. Conclusions. Our data 
show that canonical Wnt signaling is able to skew TGF-β signaling towards dominant 
signaling via the ALK1/Smad1/5/8 pathway, which reportedly leads to chondrocyte 
hypertrophy. In this way canonical Wnts and WISP1, which we found to be increased during 
experimental osteoarthritis, may contribute to osteoarthritis pathology.
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Introduction
In healthy articular cartilage, the balance between anabolic and catabolic chondrocyte activity 
maintains cartilage homeostasis. However, in osteoarthritis patients this balance is disturbed, 
resulting in cartilage breakdown. During this process, chondrocytes undergo a phenotypic 
change characterized by the expression of hypertrophic markers and undergo a process with 
similarities to terminal differentiation, normally preceding endochondral ossification.
Genetic studies point out that abnormal Wnt signaling contributes to osteoarthritis 
pathology. Polymorphisms in the genes encoding the soluble inhibitor of Wnt signaling 
FrzB and low-density lipoprotein receptor-related protein (LRP) 5, a co-receptor for 
canonical Wnt signaling, have been associated with osteoarthritis [1-4]. In addition, Zhu et 
al. showed that conditional activation of β-catenin in articular chondrocytes resulted in an 
osteoarthritis-like phenotype in mice, whereas inhibition of β-catenin signaling resulted in 
cartilage destruction by increased chondrocyte apoptosis [5, 6]. Taken together, these 
data give strong indications for the involvement of the Wnt signaling pathway in the 
development of osteoarthritis. 
Normal Wnt signaling is critical for the regulation of a variety of processes, including body 
patterning and the embryonic development of bone, cartilage and joint cavities [7-9]. 
Disturbed Wnt signaling has been demonstrated to be highly involved in tumorigenesis 
[10, 11]. The best studied Wnt signaling pathway is the canonical pathway, in which Wnt 
proteins, a family of secreted glycoproteins, bind to one of the transmembrane receptors 
referred to as frizzled (Fzd) and the co-receptors LRP5/LRP6. Binding results in increased 
β-catenin levels by inhibition of glycogen synthase kinase (GSK)-3β. β-catenin translocates 
to the nucleus where it forms a complex with TCF/LEF, this complex becoming an activator 
of many target genes. To control this complex Wnt signaling network, several inhibitors 
exist, including the Dickkopf (DKK) family members. These bind to the Wnt co-receptors 
LRP-5/6 and Kremen, resulting in the internalization of LRP-5/6, thereby specifically 
inhibiting the canonical Wnt signaling pathway. In a previous study, our lab has shown 
highly increased expression of several Wnts and a downstream mediator of canonical Wnt 
signaling Wnt-1-induced secreted protein 1(WISP1) in murine knee joints in two 
experimental osteoarthritis models. WISP1 expression was highly increased in osteoarthritis 
cartilage and might be a mediator of canonical Wnt signaling [12]. 
The TGF-β signaling pathway is receiving much attention for its role in maintaining the 
chondrocyte phenotype and its involvement in osteoarthritis. This pathway has been 
shown to be involved in all differentiation stages of the chondrocyte and is of the utmost 
importance for the maintenance and protection of healthy cartilage by maintaining 
cartilage homeostasis, as reviewed by van der Kraan et al. [13]. In healthy cartilage, TGF-β 
signals predominantly by binding to the activin-like kinase (ALK)5 receptor and subsequent 
C-terminal Smad2/3 phosphorylation. This signaling route blocks terminal differentiation 
and chondrocyte hypertrophy and stimulates production of matrix components [14-16]. 
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In addition, TGF-β has also been shown to signal via binding to the ALK1 receptor, which 
was previously thought to be involved in BMP signaling solely, and subsequent C-terminal 
phosphorylation of Smad1/5/8. This pathway is known to induce hypertrophy and 
terminal differentiation in chondrocytes [17]. 
Interestingly, interplay between the Wnt signaling and TGF-β signaling has been extensively 
demonstrated [18-20]. However, effects of a possible interplay on the balance between 
TGF-β-induced ALK5 and ALK1 signaling in chondrocytes remain to be elucidated.
We hypothesize that canonical Wnts and WISP1 cause a shift in TGF-β signaling from 
dominant signaling via the protective ALK5 and Smad2/3 pathway towards the ALK1 and 
Smad1/5/8 pathway.
Methods
Cell lines and culture
The murine chondrocyte cell line P2 was obtained as described previously [21]. In short, 
chondrocytes were isolated from mouse C57Bl/6 patellae by digestion with Collagenase 
B and subsequently infected with a retrovirus containing both the SV40 large T antigen 
and a neomycin-resistance gene. Afterwards, cultures were subjected to selection 
medium containing G418 and clones were made by limiting dilution. The human 
chondrocyte cell line G6 was made as described previously [22]. Briefly, human adult 
articular chondrocytes, derived from femoral head (Tebu-bio, Heerhugowaard, the 
Netherlands) were transduced with a retroviral construct encoding for a temperature-de-
pendent SV40 large T antigen and neomycin resistance. G6 chondrocytes were grown at 
32°C while experiments were conducted at 37°C. Afterwards, cells were transduced with a 
retroviral construct encoding for both human telomerase reverse transcriptase (hTERT), to 
prevent telomere shortening, and hygromycin B resistance and were subsequently 
selected for resistance against both antibiotics. Both retroviral constructs were a kind gift 
of Dr. M. O’Hare, Ludwig Institute for Cancer Research, London, UK [23]. Clones were made 
by limiting dilution. We tested that both cell lines express ALK1 and ALK5. P2 chondrocytes 
were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM; Invitrogen, Carlsbad, CA) 
supplemented with 10% fetal calf serum (FCS; Hyclone, Logan, UT), sodium pyruvate and 
100 U/mL penicillin and 100 μg/mL streptomycin at 37°C. Human G6 chondrocytes were 
cultured in Lonza Mesenchymal Stem Cell Growth Medium (MSCGM; Lonza, Basel, 
Switzerland) 1:1 mixed with DMEM/F-12 (Ham) (Invitrogen) supplemented with 5% FCS, 
sodium pyruvate and 100 U/mL penicillin and 100 μg/mL streptomycin. G6 chondrocytes 
were grown at 32°C and experiments were conducted at 37°C during experiments. Cells 
were stimulated with recombinant TGF-β1 (Biolegend, San Diego, CA), recombinant 
Wnt3a (R&D Systems Minneapolis, MN) as a model for canonical Wnts or recombinant 
WISP1 (Peprotech, Rocky Hill, NJ) under serum-free conditions.
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Western blot
Western blot analysis was done to determine C-terminal phosphorylation levels of 
Smad2/3 and Smad1/5/8. After stimulation of the cells, lysates were made in 20 mM 
Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM Na2EDTA, 1 mM EGTA, 1% Triton X-100, 2.5 mM 
sodium pyrophosphate, 1 mM β-glycerophosphate, and 1 mM Na3VO4, supplemented 
with complete protease inhibitor cocktail (Roche, Mannheim, Germany) and subsequently 
sonicated to obtain total cell lysates. Protein concentrations were determined using the 
BCA protein assay kit (Thermo Scientific, Rockford, IL) and 10 μg of the protein sample was 
loaded. Samples were separated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
and afterwards, proteins were transferred onto nitrocellulose membranes using the iBlot 
system (both Invitrogen). Membranes were incubated with antibodies against Smad2P 
(1:1000) and Smad1/5/8P (1:1000) overnight at 4°C. Protein loading was counterchecked by 
the use of a β-actin antibody (all Cell Signaling Technologies, Danvers, MA). Subsequently, 
membranes were incubated with a HRP-conjugated anti-rabbit (1:1500) (Dako, Glostrup, 
Denmark) secondary antibody for all primary antibodies and proteins were visualized 
using the ECL Plus Western blotting detection system (GE Healthcare, Little Chalfont, UK). 
Images of representative Western blots are shown. Image analysis for the quantification of 
immunopositive blots was performed with ImageJ 1.47 (National Institutes of Health) by 
multiplying the size and the intensity of the bands, normalizing data to β-actin as loading 
control and referring to TGF-β stimulated samples as positive control.
CAGA12-Luc assay
To determine if differences in Smad2/3 phosphorylation led to downstream biological 
effects, we used the CAGA12-Luc reporter construct, which starts producing luciferase 
when TGF-β signaling induces binding of a complex containing Smad3/Smad4 to the 
CAGA box, normally present in the Smad2/3 downstream gene plasminogen activator 
inhibitor 1 (PAI-1). The CAGA12-Luc construct was a kind gift from Dr. P. ten Dijke (Leiden 
University, Leiden, the Netherlands). In short, the CAGA12-Luc reporter construct was 
made using the pGL3 basic plasmid. The MLP promoter was PCR-amplified and placed 
between the BglII and the HindIII site. Subsequently, the CAGA sequence, containing 
12 copies of the CAGA box was cloned into the XhoI site and was cloned into an 
adenovirus [24].
RNA isolation and quantitative real-time polymerase chain reaction
Gene expression was determined using quantitative real-time polymerase chain reaction 
(qRT-PCR). At first, total RNA of cells was isolated using Trizol reagent (Invitrogen) and 
treated with DNAse to remove genomic DNA. Subsequently, samples were reverse 
transcribed into complementary DNA (cDNA) using Moloney murine leukemia virus 
reverse transcriptase, oligo(dT) primers and dNTPs (Invitrogen). qRT-PCR reactions were 
done using the Applied Biosystems StepOnePlus real-time PCR system (Applied Biosystems, 
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Foster City, CA). The qRT-PCR amplification protocol was 10 min at 95°C, followed by 
40 cycles of 15 s at 95°C and 1 min at 60°C, followed by data collection. Melting curves 
were run in all PCR reactions to confirm product specificity. Primers were accepted if the 
deviation of the primer’s slope of the standard curve was ≤0.3 when compared with the 
slope of the standard curve of the reference gene GAPDH. Primer sequences for GAPDH 
and the genes of interest were as follows: GAPDH, forward 5’-GGC-AAA-TTC-AAC-GGC-
ACA-3’ and reverse 5’-GTT-AGT-GGG-GTC-TCG-CTC-CTG-3’; ALK1 forward 5’-AAG-CCT-TCC-
AAG-CTG-GTG-AA-3’ and reverse 5’-GCA-GAA-TGG-TCT-CTT-GCA-GTG-3’; ALK5 forward 
5’-CAT-CAG-GGT-CTG-GAT-CAG-GTT-3’ and reverse 5’-GTA-ACA-CAA-TGG-TCC-TGG-CAA-3’. 
qRT-PCR reactions were performed in a total volume of 10 μl, containing 3 μl cDNA, 1 μl 
forward primer, 1 μl reverse primer and 5 μl SYBR Green Master Mix (Applied Biosystems). 
Samples were presented as ΔΔCt values, calculated by correcting the threshold cycle (Ct) 
of the gene of interest to the Ct of the reference gene GAPDH and comparing it with that 
of non-stimulated controls.
Construction and intraarticular injection of adenoviral vectors
In order to overexpress proteins in vivo we generated adenoviral vectors, using a method 
described previously [25]. In short, the coding sequence of human Wnt8a was cloned with 
primers containing restriction sites for cloning them into adenoviral vectors, that were 
E1A, B and E3 deleted and were produced as described by Chartier et al [26]. In order 
to achieve overexpression in vivo, we intraarticularly injected 1x107 plaque-forming units 
of the adenoviral vectors into six murine knee joints. An adenoviral vector containing 
luciferase was used as control.
Statistical analysis
Statistics were performed using Graphpad Prism version 5.0 (Graphpad Software Inc., San 
Diego, CA). Differences between groups were tested using the Student’s t-test. P-values 
less than 0.05 were considered significant. Results are expressed as mean ± SEM.
Results
Wnt3a does not change expression levels of ALK1 and ALK5  
in murine P2 chondrocytes
A possible mechanism how Wnt3a may alter the TGF-β signaling pathway is via modulation 
of the balance between the TGF-β receptors ALK1 and ALK5. Because members of the 
Wnt signaling pathway are overexpressed during experimental osteoarthritis in murine 
knee joints, we started to investigate this in a murine chondrocyte cell line. However, as is 
shown in Figure 1, Wnt3a pre-stimulation did not alter ALK expression as compared with 
TGF-β alone after incubation for 24 h. In addition, no differences were found after 30 min 
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and 6 h of TGF-β stimulation. Another way how Wnt signaling may affect TGF-β signaling 
is on phosphorylation levels of Smad proteins, downstream of the ALK receptors.
Wnt3a and WISP1 reduce TGF-β-induced phosphorylation of Smad2/3  
in murine chondrocytes
Therefore, we studied whether Wnt3a and WISP1, a downstream protein of canonical Wnt 
signaling, may reduce TGF-β signaling via the protective Smad2/3 pathway in 
chondrocytes. It is known that TGF-β stimulation results in Smad2/3 phosphorylation but 
kinetics may vary between different cell types. Figure 2A shows that TGF-β1 stimulation 
of murine P2 chondrocytes activates both the protective Smad2/3 and the chondro-
cyte-hypertrophy-inducing Smad1/5/8 pathway by inducing rapid phosphorylation of 
both protein complexes with a peak after 1 h, after which phosphorylation levels declined. 
To assure enough window for either increased or decreased TGF-β-induced Smad phos-
phorylation, we chose 30 min of TGF-β stimulation, because phosphorylation was 
submaximal at this incubation time. Figure 2B (upper panel) and 2C shows that TGF-β 
strongly increased the phosphorylation of Smad2/3. If we pre-incubated the cells with 
Wnt3a, a decrease in TGF-β-induced Smad2/3 phosphorylation was observed. We have 
shown that WISP1, a downstream mediator of canonical Wnt signaling, was present in the 
knee joint during experimental osteoarthritis. This protein is a possible mediator of the 
Wnt3a effects. Pre-stimulation of P2 chondrocytes with both Wnt3a and WISP1 led to a 
more profound decrease of Smad2/3 phosphorylation than did Wnt3a alone. However, 
pre-incubation with WISP1 alone did not result in decreased Smad2/3 phosphorylation.
Figure 1   Wnt3a does not alter the expression of the TGF-β receptors ALK1 and ALK5.
Quantitative real-time PCR analysis shows that Wnt3a does not alter the expression of the TGF-β 
receptors ALK1 and ALK5 after 24 h of stimulation in murine P2 chondrocytes. Cells were pre-
stimulated with 300 ng/mL Wnt3a for 90 min, followed by stimulation with 1 ng/mL TGF-β1 for 24 h. 
Values are presented as ddCt mean values ± SEM.
ALK5
Wnt3a TGF-β TGF-β + Wnt3a
-2
-1
0
1
2
3
m
RN
A 
ex
pr
es
si
on
 (d
dC
t)
ALK1
Wnt3a TGF-β TGF-β + Wnt3a
-2
-1
0
1
2
3
m
RN
A
 e
xp
re
ss
io
n 
(d
dC
t)
118
CHAPTER 6
Wnt3a and WISP1 increase TGF-β-induced phosphorylation  
of Smad1/5/8 in murine chondrocytes
It has been postulated that terminal differentiation of chondrocytes can be mediated by 
binding of TGF-β to ALK1, which results in signaling via phosphorylation of Smad1/5/8 in 
chondrocytes. Therefore, we questioned whether pre-incubation with Wnt3a and/or 
WISP1 could increase TGF-β1-induced Smad1/5/8 phosphorylation, next to decreasing 
Smad2/3 phosphorylation. As can be seen in Figure 2B (lower panel) and Figure 2C, 
addition of TGF-β increased Smad1/5/8 phosphorylation. Pre-incubation with Wnt3a led 
to increased TGF-β-induced Smad1/5/8 phosphorylation, which was further increased 
after pre-stimulation with the combination of Wnt3a and WISP1. Pre-incubation with 
WISP1 alone led to increased Smad1/5/8 phosphorylation, comparable with pre-stimula-
tion with Wnt3a alone.
Wnt3a and WISP1 skew Smad-dependent TGF-β signaling  
in human chondrocytes
Next, we translated these findings to human G6 chondrocytes. Figure 3A shows that 
TGF-β1 stimulation of human G6 chondrocytes led to phosphorylation of Smad2/3 and 
Smad1/5/8 showing comparable kinetics as the P2 murine chondrocytes. Therefore, we 
chose to use 30 min of TGF-β stimulation in experiments. Pre-incubation of G6 cells with 
Wnt3a resulted in decreased Smad2/3 phosphorylation levels, whereas an increase was 
found in the level of Smad1/5/8 phosphorylation. If we pre-stimulated the cells with the 
combination of Wnt3a and WISP1, we found a reduction in Smad2/3 phosphorylation and 
an increase in Smad1/5/8 phosphorylation that was more profound than the regulations 
by either of the proteins alone. To test if Wnt3a may conduct its effects via the downstream 
protein WISP1, we pre-stimulated G6 chondrocytes with WISP1. Whereas WISP1 did not 
decrease the TGF-β-induced Smad2/3 phosphorylation, we found an increase in 
Smad1/5/8 phosphorylation levels. (Figure 3B and Figure 3C).
Wnt3a and WISP1 skew functional TGF-β signaling
Changes in upstream Smad phosphorylation do not necessarily lead to alterations in the 
downstream signaling. Therefore, we tested functional downstream signaling of Smad2/3, 
using the CAGA12-Luc reporter construct in G6 chondrocytes. Figure 4 shows that in 
agreement with the increased phosphorylation of Smad2/3, TGF-β highly increased the 
luciferase activity. Substantiating the Western blot experiments, Wnt3a significantly 
decreased functional TGF-β signaling via Smad2/3 as measured by the luciferase activity. 
However, WISP1 alone did not decrease TGF-β-induced luciferase activity and the 
combination of Wnt3a with WISP1 did not lead to an additional decrease of the CAGA12-Luc 
reporter activity.
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Figure 2   Wnt3a with or without WISP1 skews TGF-β signaling towards ALK1/Smad1/5/8 
in murine chondrocytes.
A) Western Blot analysis of murine P2 chondrocytes shows that TGF-β signals via both ALK5 and ALK1, 
 leading to rapid C-terminal phosphorylation of Smad2/3 and Smad1/5/8 respectively. B) Pre-
incubation with Wnt3a, followed by 30 min stimulation with TGF-β results in decreased levels of 
phosphorylated Smad2/3, but increased levels of phosphorylated Smad1/5/8. Wnt3a together with 
WISP1, a downstream protein of canonical Wnt signaling that was overexpressed in experimental 
osteoarthritis, resulted in decreased Smad2/3 phosphorylation and increased Smad1/5/8 
phosphorylation, both more profound than by either of the proteins alone. Pre-incubation with 
WISP1 alone did not result in decreased TGF-β-induced Smad2/3 phosphorylation, whereas 
Smad1/5/8 phosphorylation was increased. C) Western blots were quantified and bands were 
corrected for β-actin as loading control and TGF-β alone as reference sample. Values are presented 
as the mean ± SD of three quantified and independent experiments. Cells were pre-stimulated with 
300 ng/mL Wnt3a and/or 500 ng/mL WISP1 for 90 min, followed by stimulation with 5 ng/mL TGF-β1. 
Representative Western Blots are shown of three independent experiments.
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Figure 3   Wnt3a, whether or not in combination with WISP1 skews Smad-dependent 
TGF-β signaling in human chondrocytes.
A) Western Blot analysis of a time series of TGF-β stimulation in human G6 chondrocytes shows that 
TGF-β signals via both ALK5 and ALK1, thereby displaying rapid phosphorylation of Smad2/3 and 
Smad1/5/8 respectively. B) Pre-incubation with Wnt3a, followed by stimulation with TGF-β results 
in decreased levels of phosphorylated Smad2/3, but increased levels of phosphorylated Smad1/5/8. 
Pre-stimulation with the combination of WISP1 and Wnt3a, resulted in decreased Smad2/3 
phosphorylation and increased Smad1/5/8 phosphorylation, both more profound than by either 
of the proteins alone. However, pre-stimulation with WISP1 alone did not decrease phosphorylation 
levels of Smad2/3, whereas Smad1/5/8 phosphorylation was increased. C) Western Blots were 
quantified and bands were corrected for β-actin as loading control and TGF-β alone as reference 
sample. Values are presented as the mean ± SD of three quantified and independent experiments. 
Cells were pre-stimulated with 300 ng/mL Wnt3a and/or 500 ng/mL WISP1 for 90 min, followed by 
stimulation with 5 ng/mL TGF-β1. Representative Western Blots are shown of three independent 
experiments.
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Wnt3a skews TGF-β signaling via the canonical pathway
Next, the question arose whether the skewing of the TGF-β signaling pathway by Wnt3a 
was conducted via the canonical Wnt signaling pathway. Therefore, we stimulated G6 
chondrocytes with Wnt3a and the combination of Wnt3a and WISP1, followed by TGF-β 
stimulation, all in the presence of DKK-1, a selective inhibitor of Wnt/β-catenin signaling. 
Figure 5 shows that phosphorylation of Smad2/3 was not decreased by Wnt3a and the 
combination of Wnt3a and WISP1 in the presence of DKK-1. In addition, Smad1/5/8 was 
not increased under these conditions, showing that DKK-1 inhibits these effects of Wnt3a.
Figure 4   Wnt3a and WISP1 modulate functional TGF-β signaling.
Functional TGF-β signaling was tested with use of the CAGA12-Luc reporter construct, which 
produces luciferase after binding of Smad3/Smad4 to the CAGA-sequence, normally present in the 
PAI-1 promoter downstream of ALK5/Smad2/3 signaling. Human G6 chondrocytes were transduced 
with the adenoviral vector containing CAGA12-Luc. Afterwards, cells were pre-stimulated with 
Wnt3a and/or WISP1 for 90 min, followed by TGF-β stimulation for 16 h. Addition of TGF-β strongly 
increases luciferase activity. However, pre-stimulation with either Wnt3a alone or the combination 
of Wnt3a and WISP1 significantly decreases luciferase activity. Cells were pre-stimulated with 300 
ng/mL Wnt3a and/or 500 ng/mL WISP1 for 90 min, followed by stimulation with 0.5 ng/mL TGF-β1. 
Values are presented as relative luciferase activity ± SEM.
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In vivo overexpression of Wnt8a results in skewed Smad phosphorylation
Next, in order to underline our in vitro findings, we overexpressed the canonical Wnt8a in 
vivo with the use of an adenoviral vector. In agreement with our in vitro findings, 
overexpression of Wnt8a led to decreased phosphorylation of Smad2/3 in chondrocytes, 
whereas it increased the phosphorylation of Smad1/5/8 compared with the control virus 
containing luciferase (Figure 6).
Figure 5   Wnt3a skews TGF-β signaling via the canonical Wnt signaling pathway.
A) Western Blot analysis shows that pre-stimulation of human G6 chondrocytes with Wnt3a in 
the presence of DKK-1, a selective inhibitor for the canonical Wnt signaling pathway, followed by 
TGF-β stimulation did not decrease Smad2/3 phosphorylation and did not increase Smad1/5/8 
phosphorylation. B) Western Blots were quantified and bands were corrected for β-actin as loading 
control and TGF-β alone as reference sample. Values are presented as the mean ± SD of three 
quantified and independent experiments. Cells were pre-stimulated with 300 ng/mL Wnt3a and/or 
500 ng/mL WISP1 in the presence of 900 ng/mL DKK-1 for 90 min, followed by stimulation with 5 ng/
mL TGF-β1. Representative Western Blots are shown of two independent experiments.
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Discussion
In the present study, we show for the first time that Wnt3a, whether or not in combination 
with its downstream protein WISP1, is able to skew TGF-β signaling in both murine and 
human chondrocytes. Whereas Wnt3a reduces TGF-β-induced phosphorylation levels of 
Smad2/3 proteins, both Wnt3a and its downstream protein WISP1 increase the phosphor-
ylation of Smad1/5/8 proteins. In addition, we found that on a functional level, Wnt3a 
decreases the TGF-β-induced luciferase production of the CAGA12-Luc reporter construct, 
which is highly specific for the Smad2/3 signaling pathway. We show that Wnt3a 
modulates the TGF-β signaling via the canonical Wnt signaling pathway. Finally, in vivo 
overexpression of the canonical Wnt8a decreases the Smad2/3 phosphorylation and 
increases the Smad1/5/8 phosphorylation in vivo.
Historically the ALK5 receptor was considered the only TGF-β type I receptor in chondrocytes. 
TGF-β signaling via ALK5 is followed by C-terminal phosphorylation, and thus activation, 
of Smad2 or 3. TGF-β signaling via the Smad2/3 pathway has been shown to be essential 
for the inhibition of terminal differentiation of chondrocytes [14]. Mice lacking Smad3 
were prone to develop degenerative joint disease that showed a high similarity to human 
osteoarthritis pathology. In addition, Smad3 deficiency resulted in increased expression of 
hypertrophic markers for chondrocytes, such as collagen X [16]. Moreover, overexpression 
of Smad2 and 3 in Smad3 deficient chondrocytes increased the inhibitory effect of TGF-β 
on chondrocyte maturation, as measured by expression level of collagen X and alkaline 
phosphatase activity [27]. These findings show that TGF-β signaling via Smad2/3 seems to 
be important in blocking chondrocyte terminal differentiation. In this light, our observation 
that Wnt3a in vitro and Wnt8a in vivo decreased TGF-β signaling via Smad2/3 indicates that 
canonical Wnt signaling could be deleterious for chondrocytes by reducing the block on 
chondrocyte terminal differentiation. This is of importance because in the past we have 
Figure 6   In vivo overexpression of Wnt8a results in skewing of Smad signaling towards 
Smad1/5/8.
We stained phosphorylated Smad2/3 and Smad1/5/8 with specific antibodies. Representative 
pictures show that adenoviral overexpression of Wnt8a results in decreased phosphorylation of 
Smad2/3 and increased phosphorylation of Smad1/5/8 in chondrocytes.
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shown that both Wnts and WISP1, a downstream protein of canonical Wnt signaling, were 
upregulated in the joint during experimental osteoarthritis. 
In addition, recently it has been shown that TGF-β can signal via the alternative receptor 
ALK1 in various cell types, including chondrocytes [17]. TGF-β signaling via ALK1 is followed 
by phosphorylation of Smad1, 5 or 8 at the C-terminus. Signaling via this pathway is 
associated with terminal differentiation and expression of terminal differentiation markers 
in articular chondrocytes [28, 29]. Our lab has found that signaling via ALK1 is associated 
with the expression of the marker for chondrocyte hypertrophy MMP13. Overexpression 
of constitutively active ALK1 resulted in increased expression of MMP13 in chondrocytes, 
whereas knockdown of ALK1 by a short hairpin RNA (shRNA) led to decreased MMP13 
expression. In addition, knockdown of ALK5 with a shRNA caused increased levels of 
MMP13 [17]. These effects are highly dependent on the transcription factor Runx2. Smad 
signaling controls the function of Runx2. Binding of Smad1 to Runx2 results in increased 
Runx2 activity, resulting in chondrocyte terminal differentiation [30]. Contrastingly, 
signaling via Smad3 blocks the function of Runx2 and thereby chondrocyte hypertrophy 
and terminal differentiation [31]. Blocking this pathway in vitro with the use of Smad6 
results in decreased expression of the hypertrophy markers type X collagen and alkaline 
phosphatase activity [32]. In addition, inhibition of signaling via the Smad1/5/8 pathway as 
present in Smad6 transgenic mice results in delayed chondrocyte hypertrophy [33]. In the 
present study, we show that both Wnt3a and the downstream protein WISP1 are able to 
increase TGF-β signaling via Smad1/5/8 in both murine and human chondrocytes in vitro. 
Furthermore, in vivo overexpression of the canonical Wnt8a resulted in increased Smad1/5/8 
phosphorylation in chondrocytes. In the light of the previous findings concerning Smad1/5/8 
signaling in chondrocytes, this strongly suggests that canonical Wnts and WISP1, both 
present in the joint during experimental osteoarthritis, could result in chondrocyte 
hypertrophy and terminal differentiation, thereby contributing to osteoarthritis pathology.
Inkson et al. have shown that WISP1 inhibits TGF-β-induced Smad2 phosphorylation in 
human bone marrow stromal cells [34]. However, we did not find that WISP1 could reduce 
TGF-β-induced phosphorylation of Smad2/3 in chondrocytes. In contrast, we show for 
the first time that Wnt3a reduces TGF-β-induced Smad2/3 phosphorylation in 
chondrocytes. In addition, WISP1 increased TGF-β-induced Smad1/5/8 signaling. Hence, 
WISP1 alone is still able to skew the TGF-β signaling towards dominant signaling via ALK1 
and downstream via Smad1/5/8.
In their paper, Fuentealba et al. have shown that Wnt3a stabilizes Smad1/5/8 phosphorylation 
after stimulation with BMP7 and FGF2 in L cells. They show that Wnt3a stabilizes the 
phosphorylated Smad1/5/8 protein by reducing GSK3-induced phosphorylation of the 
Smad1 linker region, thereby reducing its degradation, resulting in increased levels of 
phosphorylated Smad1/5/8 protein [35]. In contrast to these findings, we did not see 
prolonged phosphorylation of Smad1/5/8 in experiments with prolonged TGF-β stimulation 
(data not shown), but rather increased phosphorylation levels. In addition, we show for 
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the first time that WISP1 alone or the combined incubation with Wnt3a and WISP1 results 
in increased TGF-β signaling via Smad1/5/8 in chondrocytes. 
In the human G6 chondrocytes, the presence of Wnt3a alone or the combination of 
Wnt3a and WISP1 led to increased phosphorylation of Smad2/3 in the absence of TGF-β. 
However, in the presence of TGF-β, a situation that is representative for the physiological 
situation, Smad2/3 phosphorylation was decreased under these conditions.
Interestingly, we have found that stimulation of both murine and human chondrocytes 
with the combination of Wnt3a and WISP1 resulted in decreased Smad2/3 phosphorylation 
and increased phosphorylation of Smad1/5/8, both more profound than after stimulation 
with either Wnt3a or WISP1 alone. This is a significant finding, because both canonical 
Wnts and WISP1 are overexpressed in the joint in experimental osteoarthritis. However, we 
were not able to show additionally decreased Smad2/3 signaling using the CAGA12-Luc 
reporter construct. Because WISP1 alone did not decrease Smad2/3 phosphorylation, but 
Wnt3a combined with WISP1 resulted in a more profound decrease in phosphorylation 
than Wnt3a did alone, it seems that WISP1 potentiates the effect of Wnt3a. A possible 
explanation may be that WISP1 acts as a carrier, thereby enhancing the function of Wnt3a. 
However, more research is needed to elucidate this synergistic mechanism. It is possible 
that in the in vitro situation, this potentiating effect is lost over time. Longer TGF-β 
stimulation was needed in the case of the CAGA12-Luc reporter construct in order to 
produce luciferase protein as compared with the Western blot experiments. This could 
explain why no additional decrease was found in this functional assay. By contrast, another 
possibility is that the additional skewing of TGF-β signaling by combined stimulation with 
Wnt3a and WISP1 on phosphorylation level does not skew signaling on a functional level.
It has been shown by Nalesso et al. that Wnt3a can signal both via the canonical 
Wnt/β-catenin route and via the noncanonical Ca2+/CaMKII route in chondrocytes [36]. 
In order to determine whether Wnt3a skews the TGF-β signaling via the canonical 
Wnt/β-catenin pathway, we stimulated G6 chondrocytes with Wnt3a and/or WISP1 in the 
presence of DKK-1, a selective inhibitor for canonical Wnt signaling. The results showed 
that Wnt3a modulated the TGF-β-induced Smad phosphorylation via the canonical Wnt 
signaling pathway, because the shift in TGF-β-induced Smad phosphorylation as was 
found in the absence of DKK-1 was not present if DKK-1 was added to the cultures. The 
canonical Wnt signaling pathway has been implicated in osteoarthritis pathology in the 
past. Therefore, the elevated levels of both Wnt proteins and their downstream protein 
WISP1 in the knee joint during experimental osteoarthritis, can possibly contribute to the 
osteoarthritis pathology by skewing TGF-β signaling in chondrocytes. This entails that 
therapies aiming at the inhibition of canonical Wnt signaling may be beneficial for the 
pathology during the process of osteoarthritis.
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Conclusions
Our study shows for the first time that canonical Wnt signaling can skew TGF-β signaling 
in chondrocytes from the preserving ALK5 and Smad2/3 route towards the ALK1 and 
Smad1/5/8 pathway, which is known to result in chondrocyte hypertrophy and terminal 
differentiation ultimately. Although WISP1, a downstream protein of canonical Wnt 
signaling, did not have any effect on Smad2/3 signaling, it might partially conduct the 
effects of Wnt3a on TGF-β signaling by increasing Smad1/5/8 signaling.
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Abstract
Objectives. Increased Wnt signaling in chondrocytes is associated with osteoarthritis 
development. Here, we determined whether Wnt signaling in the synovial tissue could 
further contribute through the production of MMPs. Furthermore, we determined the 
relation of synovial expression of Frizzled (FZD) receptors and the Wnt inhibitor FRZB to 
MMP expression and disease progression in early osteoarthritis patients (CHECK cohort). 
Methods. WNT8A and WNT16 were overexpressed in mice using adenoviral vectors. 
MMP expression was determined by qRT-PCR or Luminex. Expression of Wnt members in 
synovium from early osteoarthritis patients was linked to MMP expression and disease 
progression. MMP production in human synovium was determined after stimulation of 
Wnt signaling or inhibition with FRZB or DKK1. Results. WNT8A/WNT16 overexpression 
induced MMP-expression in vivo. The expression of MMPs relevant for osteoarthritis in 
synovium from CHECK participants significantly correlated with FZD1, FZD10, and FRZB. 
Moreover, we observed increased FZD1 and decreased FRZB expression in CHECK patients 
with disease progression compared to non-progressors. WNT3A stimulation of human 
osteoarthritis synovium induced the production of various MMPs, whereas inhibition of 
Wnt signaling with FRZB or DKK1 reduced the MMPs production. Conclusions. Wnt 
signaling in the synovium may potently induce progression of osteoarthritis via increased 
production of MMPs. 
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Introduction
Osteoarthritis (OA) is one of the most common debilitating diseases worldwide. However, 
no curative treatment is available. It is now accepted that OA involves all joint tissues [1]. 
Synovial activation is present in over 50% of the OA patients and is involved in cartilage 
degeneration [2, 3].
We previously described strongly increased synovial expression of members of the Wnt 
signaling pathway during experimental OA models [4]. Wnt proteins are lipid-modified 
glycoproteins that bind to Frizzled (FZD) receptors. Binding to both a FZD receptor and 
the co-receptor low-density lipoprotein receptor-related protein (LRP)5/6 activates the 
β-catenin-dependent canonical Wnt signaling pathway, whereas binding to FZD alone 
results in noncanonical Wnt signaling [5].
Various studies have linked aberrant Wnt signaling to the development of OA [6, 7]. 
A polymorphism in the Wnt inhibitor FRZB that decreases its Wnt inhibitory activity is 
associated with a higher incidence of OA [8]. In line, absence of Frzb increases the disease 
activity during experimental OA [9]. A possible mechanism might be an elevated production of 
matrix metalloproteinases (MMPs) induced by active Wnt signaling, as has been described 
in various diseases [10, 11]. 
Whereas most previous studies focused on the relation between Wnt signaling in the 
cartilage and the development of OA, in this concise study we investigated whether 
active Wnt signaling in the synovial tissue resulted in increased expression of MMPs. 
Furthermore, we studied the relation between the expression of members of the Wnt 
signaling pathway and disease progression in the Cohort Hip And Cohort Knee (CHECK) 
study of early symptomatic OA patients.
Methods
Early OA patients
Synovial biopsies were taken arthroscopically from a subgroup of participants with knee 
pain that were enrolled in the CHECK study, initiated to follow early symptomatic OA 
patients. Standardized radiographs were taken to determine joint space width narrowing 
and osteophyte size using knee images digital analysis (KIDA) [12]. At baseline, participants 
had pain/stiffness of the knee or hip, were aged 45-65 years and did not consult their 
physician for these symptoms during 6 months before entry. Participants with other 
pathologic conditions that could explain the symptoms were excluded. We determined 
whether the CHECK participants showed progression in joint space width narrowing and 
osteophyte size between the baseline and five-year follow-up measurement and 
participants were accordingly classified as either progressor or non-progressor. Progression 
was defined as a decrease in joint space width of ≥ 1mm and an increase in osteophyte 
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size of ≥ 4x. This resulted in two groups with roughly comparable numbers of patients. 
Patients signed a written informed consent. All study protocols involving human tissues 
were approved by the local ethics committee (CMO Arnhem – Nijmegen; approval 
number 2004-009).
Established OA patients and cell culture
Anonymized synovial tissue specimens were obtained from end-stage OA patients 
undergoing joint replacement, and were stimulated in quadruple with 300 ng/mL WNT3A 
(R&D systems), one of the few recombinant canonical Wnt signaling inducers with 
sufficient bioactivity, or 10 ng/mL IL-1 (R&D systems). Alternatively, biopsies were incubated 
with 100 ng/mL FRZB (R&D systems), 500 ng/mL DKK1 (Peprotech) or IL-1RA (SOBI). All 
cultures were performed in Roswell Park Memorial Institute (RPMI) 1640 medium, 
supplemented with 10% fetal calf serum (FCS), sodium pyruvate, 100 units/ml penicillin, 
and 100 μg/ml streptomycin for 24 hours. 
Animals and adenoviral vectors
Adenoviral vectors for human Wnt8a and murine Wnt16 were made as previously 
described [13]. 1x107 plaque-forming units were injected into naïve knee joints of male 
C57BL/6J mice (Janvier), aged 12 weeks. Mice were housed in filtertop cages, and water 
and food were provided ad libitum. As control, we used an adenoviral vector for luciferase. 
Animal studies were approved by the local Animal Experimentation Committee (RU-DEC 
2011-226).
RNA isolation and quantitative real-time polymerase chain reaction
Gene expression was determined using quantitative real-time PCR (qRT-PCR). Total RNA 
was isolated using Trizol Reagent (Invitrogen), according to the manufacturer’s protocol 
after homogenizing with the MagNA Lyser Instrument (Roche). qRT-PCR was performed 
with specific primers and the SYBR Green Master mix using StepOnePlus real-time PCR 
system (Applied Biosystems). Expression levels are presented as -ΔCt values, normalized to 
the reference gene GAPDH.
Protein measurement using Luminex technology
Protein levels in culture supernatants were determined using the Luminex multianalyte 
technology on the Bio-Plex system in combination with multiplex kits (Millipore) and 
adjusted for tissue weight.
Statistical analysis
Statistics were performed using Graphpad Prism version 5 (Graphpad Software). For every 
analysis, data were checked for normality using the  D’Agostino-Pearson test. Differences 
between groups were tested using a Student’s t-test or one-sample t-test. P < 0.05 was 
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considered significant. Correlations were tested with Pearson’s correlation and considered 
significant if the P value was <0.05.
Results
Increased expression of MMPs after in vivo overexpression of Wnts  
in the synovial tissue
We previously showed that targeting the synovium with adenoviral vectors for Wnt8a, a 
classical model to activate canonical Wnt signaling, and Wnt16, which we found strongly 
increased in the joint during experimental OA, resulted in a strong overexpression in the 
synovium, activation of canonical Wnt signaling in the joint and induced cartilage damage 
[14]. Because this cartilage damage was associated with neoepitope formation as the 
result of cartilage-degrading enzymes, we determined whether the overexpression of the 
Wnt ligands resulted in increased synovial expression of MMPs. We observed significantly 
increased expression of Mmp2/3/9/13 three days after overexpression of WNT8A, whereas 
the expression of Mmp3/9 was increased after overexpression of WNT16 (Figure 1). 
Correlation between relevant MMPs in human OA and members from 
the Wnt signaling pathway
We used synovial biopsies from participants of the CHECK study to determine whether 
baseline mRNA levels of relevant MMPs for OA development correlated with the expression 
of a set of members of the Wnt signaling pathways that were selected because they were 
differentially expressed between disease progressors and non-progressors in a micro-array 
analysis of these biopsies. We observed that the expression of MMP1, MMP2, MMP3, and 
MMP13 inversely correlated with the Wnt inhibitor FRZB and positively with the Wnt 
receptors FZD1 and FZD10, but not FZD8. In addition, FZD1 positively and FRZB inversely 
correlated with AXIN2, as indicator of active canonical Wnt signaling. In contrast, MMP9 did 
not correlate with any of these members of the Wnt signaling pathway (Figure 2A). 
Increased expression of FZD receptors, but decreased expression  
of the Wnt inhibitor FRZB in patients with early OA that showed disease 
progression
Subsequently, we investigated the relation between the expression of these members of 
the Wnt signaling pathway and progression of OA. We observed significantly increased 
expression of the Wnt receptor FZD1 and significantly decreased expression of the Wnt 
inhibitor FRZB in the progressors, as compared to the non-progressors (Figure 2B), in line 
with our correlation data. 
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Increased MMP production in human end-stage synovial tissue  
as the result of Wnt signaling
Next, we determined whether stimulation of end-stage OA synovium with WNT3A, 
increased the production of MMPs. We observed significantly increased concentrations of 
MMP1 and MMP9 proteins, whereas MMP2 and MMP3 showed a trend towards increased 
production (Figure 3A). To test the hypothesis that endogenous Wnt signaling in OA 
synovium drives MMP production, we incubated OA synovium with FRZB (inhibiting all 
Figure 1   Synovial overexpression of Wnts results in increased expression of MMPs.
WNT8A, a classical example of a Wnt ligand that activates the canonical Wnt signaling pathway, 
and WNT16, which we found strongly upregulated in the joint during experimental osteoarthritis 
[4], were overexpressed in the synovium by intraarticular injection of 1x107 plaque forming units 
of adenoviral vectors containing Wnt8a or Wnt16 (n=6). This resulted in significantly increased 
expression of Mmp2/3/9/13 in the synovial tissue, 3 days after overexpression of WNT8A and Mmp3 
and Mmp9 after synovial overexpression of WNT16, as determined by quantitative real-time PCR. Bars 
show the mean ± SEM. * = P < 0.05; ** = P < 0.01, versus the control virus.
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signaling members; FZD1 is positively, whereas FRZB is inversely associated 
with disease progression in a cohort of early symptomatic OA patients.
Gene expression analysis in synovia from patients enrolled in the CHECK study shows that the 
expression of MMP1, MMP2, MMP3, and MMP13 correlates positively with the expression of the Wnt 
receptors FZD1 and FZD10, but not with FZD8. In addition, the expression of these MMPs correlates 
inversely with the expression of the Wnt inhibitor FRZB, whereas AXIN2 significantly correlated with 
FRZB and FZD1 (A). Moreover, the expression of the Wnt receptor FZD1 at baseline, was significantly 
increased in synovial tissue from CHECK participants that showed progression of osteoarthritis 
(n=4), compared to non-progressors (n=5). We defined disease progression as an increase in joint 
space width narrowing of ≥ 1 mm and an increase in osteophyte size of ≥ 4x between baseline 
and the five-year follow-up measurement. Furthermore, the expression of the Wnt inhibitor FRZB 
was significantly decreased in participants with disease progression, as compared to patients that 
did not show progression of OA (B). The MMPs in (A) were chosen because of the relevance for 
development of osteoarthritis (OA). The Wnt signaling members in (A) and (B) were selected from 
micro-array analysis from the same synovia where the expression of these markers was different 
between progressors and non-progressors of OA. Dots in (A) represent individual donors. Bars in (B) 
show the mean ± SEM. * = P < 0.05, versus non-progressors.
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Wnt pathways). We observed significantly decreased MMP2 and MMP3 production 
(Figure 3B). To determine if this decreased MMP production was the result of inhibited 
canonical Wnt signaling, we blocked human OA synovium with DKK1, specifically 
inhibiting β-catenin/canonical signaling. This led to decreased protein production of 
MMP1 and MMP3, but not MMP2 and MMP9 (Figure 3C).
Figure 2   Continued.
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Discussion
Here, we show for the first time that activated Wnt signaling in OA synovial tissue results 
in increased MMP production, which might contribute to tissue damage. Furthermore, we 
show that synovial expression of various Wnt receptors and the Wnt inhibitor FRZB 
correlate with MMP expression and that increased FZD1 and decreased FRZB expression is 
associated with disease progression in a cohort of early symptomatic OA patients.
Figure 3   Increased synovial Wnt signaling induces the production of matrix-degrading 
MMPs.
Human end-stage osteoarthritis synovial biopsies were stimulated with 300 ng/mL recombinant 
human WNT3A for 24 h. MMP1 and MMP9 protein levels were significantly increased in the 
supernatant, whereas a trend towards induced production of MMP2 and MMP3 was observed (A). 
Because our hypothesis was that increased Wnt signaling, and thus increased production of MMPs, 
is present in OA synovial tissue, end-stage OA synovial biopsies were incubated with 100 ng/mL 
recombinant human FRZB (thereby inhibiting all Wnt signaling) (B) and 500 ng/mL recombinant 
human DKK1 (specifically inhibiting canonical Wnt signaling) (C). 24 h after the start of the 
experiment, we observed significantly decreased MMP2 and MMP3 production after incubation with 
FRZB, whereas inhibition of canonical Wnt signaling with DKK1 resulted in significantly decreased 
production of MMP1 and MMP3 proteins. Bars show the mean ± SEM. * = P < 0.05; ** = P < 0.01, 
versus non-stimulated samples.
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Until now, research on the relation between Wnt signaling and OA mainly focused on the 
cartilage [6, 7, 9]. In this study, we add to this knowledge by studying synovial Wnt signaling 
in an OA context. We previously showed that induction of canonical Wnt signaling by 
synovial overexpression of WNT8A and WNT16 results in OA-like cartilage lesions, associated 
with protease neoepitopes [14]. Here, we show that overexpression of WNT8A and WNT16 
increases the synovial expression of MMPs able to enhance cartilage matrix breakdown. 
The different extent of MMP regulation by WNT8A and WNT16 overexpression might 
be the result of either differences in signaling by the individual Wnts or the differences 
in efficiency to overexpress these Wnt ligands that might arise when using adenoviral 
vectors.  
Our data show that synovial Wnt signaling increases the production of various MMPs that 
are relevant for OA development, in line with a study that shows increased MMP expression 
in RA fibroblasts upon Wnt1 stimulation [15]. The discrepancy in regulated MMPs observed 
after stimulation or inhibition of Wnt signaling might derive from the use of end-stage 
OA synovium, where the expression of various MMPs, such as MMP3, likely is strongly 
increased.
Whereas Wnt signaling in multiple joint tissues has been studied in an OA context, this 
study using synovial tissue from the CHECK study is the first that links synovial expression of 
FZD1 and FRZB to disease progression. This cohort study provides unique opportunities to 
study disease progression, starting from the initial phases of disease. Our findings support 
other studies that show continuous β-catenin signaling in fibroblast-like synoviocytes 
from rheumatoid arthritis (RA) patients [15, 16]. Moreover, we show that the expression of 
various MMPs in the synovium of early symptomatic OA patients correlates to Wnt 
signaling members, which showed an altered expression in micro-array analysis of these 
synovia. Nonetheless, the number of synovium donors is limited, although the nature of 
the samples, collected at the initial phases of OA, is highly unique. Therefore, further 
studies with comparable designs would greatly improve insight into the early events that 
promote OA development. 
In conclusion, in the current study we show for the first time that Wnt signaling, at least 
partially via the canonical signaling pathway, in synovial tissue induces the expression of 
various MMPs that are relevant for OA development. Furthermore, we show that increased 
synovial expression of the FZD1 receptor and decreased expression of the Wnt inhibitor 
FRZB are associated with disease progression in early human symptomatic OA.
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Abstract
Objective: Increased Wisp1 expression was previously reported in experimental and 
human osteoarthritis. Here, we determined the relation between WISP1 expression and 
osteoarthritis-progression in early osteoarthritis patients. Furthermore, we determined how 
WISP1 is involved with osteoarthritis pathology with aging and experimental osteoarthritis 
in Wisp1-/- and WT mice. Methods: The relation between synovial WISP1 expression and 
osteoarthritis-progression was determined in early symptomatic osteoarthritis patients. 
WT and Wisp1-/- mice were aged or experimental osteoarthritis was induced with intra-
articular collagenase injection, destabilization of the medial meniscus or anterior cruciate 
ligament transection. Joint pathology was assessed using histology and microCT. 
Protease expression was determined with qRT-PCR and activity was determined by 
immuno histochemical staining of the aggrecan neoepitope NITEGE. Results: Increased 
WISP1 expression at baseline was observed in early osteoarthritis patients with disease 
progression between baseline and the five-year follow-up measurement compared to 
non-progressors. Stimulation of human osteoarthritis synovium with WISP1 increased the 
expression of various proteases. Aging of Wisp1-/- and WT mice did not result in altered 
spontaneous cartilage degeneration. However, we observed significantly decreased 
cartilage damage in Wisp1-/- mice after induction of experimental osteoarthritis models. 
While the degree of ectopic bone formation was comparable between WT and Wisp1-/- 
mice, increased cortical thickness and reduced trabecular spacing was observed in Wisp1-/- 
mice. In addition, we observed decreased MMP3/9 and ADAMTS4/5 expression in Wisp1-/- 
mice, which was accompanied by decreased levels of NITEGE. Conclusion: WISP1 plays 
an important role in the development of post-traumatic experimental osteoarthritis. 
Moreover, WISP1 is associated with disease progression of human osteoarthritis.
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Introduction
Osteoarthritis (OA) is the most common joint disease in the aging population, with 
patients often suffering from severe pain and immobility of the affected joints (1, 2). 
Although degeneration of the articular cartilage is the main hallmark of OA, the paradigm 
that the disease only involves the cartilage has shifted. It is now generally accepted that 
other tissues in the joint, such as the subchondral bone and the synovium, play important 
roles in OA pathogenesis (3-5). However, the exact molecular mechanisms that lead to the 
induction and progression of OA have yet to be elucidated.
We have previously shown that the expression of various Wnt ligands is strongly increased 
in the synovium in experimental OA (6). Wnt signaling was linked to OA mainly via 
activation of the β-catenin-dependent canonical pathway (7-9). One of the most enticing 
members of the Wnt signaling pathway we observed that was increased was Wnt-1-induced 
signaling protein 1 (Wisp1). This protein, which is induced by β-catenin-dependent 
canonical Wnt signaling, was not only increased in the synovium in experimental OA 
models, but also in cartilage. Additionally, we observed increased WISP1 expression in the 
cartilage of OA patients (6). The possible role for WISP1 in OA was further reinforced by our 
finding that synovial overexpression of WISP1 in naive knee joints results in the induction 
of OA-like cartilage lesions (10).
WISP1/CCN4 is the fourth member of the CCN (connective tissue growth factor, Cyr61, 
NOV) family, sharing conserved functional protein domains with the other family 
members, which appear to have overlapping functions, including cell differentiation and 
proliferation, and the regulation of signal transduction (11). WISP1 was first discovered as a 
target gene of canonical Wnt signaling in human colon cancer (12). Later studies confirmed 
its role in several types of cancers and suggested that its function includes the induction 
of protease expression in various cell types (6, 13-15). 
Up until now, most studies that examined WISP1 focused on bone; high levels of WISP1 
are expressed during skeletal development and during fracture healing (16). However, 
over the years, WISP1 has gained increasing attention in the field of OA research because 
a single nucleotide polymorphism in WISP1 has been linked to OA in the spine (17). 
However, much remains to be elucidated about the in vivo role of WISP1 in the 
etiopathology of OA. To deepen our understanding of the role that WISP1 plays in OA, we 
determined whether there is a relation between WISP1 expression and the progression of 
OA pathology in a human cohort study with early symptomatic OA. Additionally, we 
generated a mouse strain deficient in Wisp1 (Wisp1-/-) to determine whether the 
spontaneous OA-like cartilage degeneration upon aging was affected by the absence of 
Wisp1. Next, to further pinpoint the role for WISP1 in OA, we induced various well-estab-
lished experimental OA mouse models in Wisp1-/- mice and their Wisp1+/+ (WT) controls 
and determined cartilage degeneration.
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Materials and methods
Patients with early OA from the CHECK study
Biopsy samples were taken arthroscopically from knee joints of patients with knee pain, 
enrolled in the Cohort Heup En Cohort Knie (Cohort Hip and Cohort Knee; CHECK) study. 
Biopsy samples were taken from various areas of the synovium, both medially and laterally 
from the patella to minimize bias related to sampling of inflamed tissue rather than global 
sampling. In addition, standardized radiographs were taken to determine joint space 
width narrowing and osteophyte size using the novel knee images digital analysis (KIDA) 
method [18]. CHECK is a prospective cohort study of 1,002 individuals with early 
symptomatic OA of the knee or hip, initiated by the Dutch Arthritis Foundation to follow 
early symptomatic OA patients in time. On entry into the CHECK study, all participants had 
pain or stiffness of the knee or hip, and were aged 45-65 years. They had not yet consulted 
their physician for these symptoms, or the first consultation occurred within 6 months 
before cohort entry. Participants with any other pathologic condition that could explain 
the symptoms were excluded (e.g., other rheumatic diseases, previous hip or knee joint 
replacement, congenital dysplasia, osteochondritis dissecans, intra articular fractures, 
septic arthritis, Perthes disease, ligament or meniscus damage, plica syndrome, Baker’s 
cyst). Patients signed a written informed consent before entering the study. From a subset 
of these patients synovial tissue samples were taken during an arthroscopic procedure. A 
separate informed consent was signed by this subset of patients. To examine expression 
patterns in human OA, synovial tissue samples were analyzed using quantitative real-time 
PCR (qRT-PCR). 
Established OA patients
Anonymized human synovium was obtained from end-stage OA patients during joint 
replacement surgery of either the knee or hip. Synovial punches were taken and were 
cultured in RPMI medium (Gibco Invitrogen), supplemented with 10% fetal calf serum, 
sodium pyruvate and 100 U/mL penicillin and 100 μg/mL streptomycin at 37°C. Synovial 
tissue was stimulated with 500 ng/mL recombinant human (rh)WISP1 (Peprotech) or 10 
ng/mL IL-1 as positive control for 24 h. 
Generation of Wisp1-/- mice and experimental OA models
Wisp1-/- mice were generated as described previously (19). In short, a PGK neo cassette was 
inserted into exon 2 of the Wisp1 gene, causing a frame-shift mutation in the coding 
sequence for the WISP1 protein. Subsequently, clones that were specifically targeted by 
the construct were used for blastocyst injections. Mice were backcrossed to a C57Bl/6 
background for at least 5 generations. Experimental OA models were induced in 12 weeks 
old male Wisp1-/- mice and their WT controls. First, the collagenase-induced OA (CIOA) 
model was induced by two intraarticular injections with 1U bacterial collagenase (Sigma-
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Aldrich) as previously described (20). Furthermore, both a destabilization of the medial 
meniscus (DMM) and anterior cruciate ligament transection (ACLT) surgical instability 
models were induced, as previously described by Glasson et al. (21). Seven days after CIOA 
induction of experimental OA, mice were sacrificed and synovial biopsies were taken 
before proceeding to RNA isolation. In addition, other joints were harvested at 42 days 
(CIOA) or 56 days (DMM and ACLT) after induction of experimental OA and fixed for 2 days 
with Z-fix (Anatech). For the aging study mice were sacrificed at 3, 6, and 12 months of age. 
All mice were housed in cages with Tech Fresh bedding and cage enrichment. Mice were 
fed a standard diet, with food and filtered tap water ad libitum. All experiments involving 
animals described in this study were approved by the Animal Care and Use Committee at 
the NIH, NIDCR (#13-700) and were performed according to the related codes of practice.
Micro-computed Tomography (μCT)
Fixed knee joints were transferred to 70% ethanol and scanned with 10 µm isotropic 
voxels using a µCT50 scanner (Scanco Medical). Morphometric analysis was performed on 
the subchondral bone of the tibia between the cartilage and the growth plate. The outer 
margins of the subchondral bone and the margins between the trabecular and cortical 
bone were manually traced and both compartments were analyzed using automated 
scripts to extract the trabecular bone from the total subchondral bone, resulting in 
separate cortical and trabecular areas of interest. 
RNA isolation and quantitative real-time polymerase chain reaction
Gene expression was determined using quantitative real-time PCR (qRT-PCR). Tissue 
samples for RNA isolation were homogenized in RLT buffer using the MagNA Lyser 
Instrument (Roche). Total RNA was isolated using the RNeasy Fibrous Tissue Mini Kit 
(Qiagen) with a Proteinase K step according to the manufacturer’s protocol. The RNA 
concentration was determined using a Nanodrop spectrophotometer and subsequently 
reverse transcribed into cDNA. qRT-PCR was performed using specific primers and the 
SYBR Green Master Mix in the Applied Biosystems StepOnePlus real-time PCR system 
(Applied Biosystems). qRT-PCR reactions were performed in a total volume of 10 μL, 
containing 3 μL cDNA, 1 μL forward primer (2 µM), 1 μL reverse primer (2 µM) and 5 μL 
SYBR Green Master Mix (Applied Biosystems). Reactions were presented as minus delta 
threshold cycle Ct (-ΔCt) values, calculated by correcting the negative threshold cycle (-Ct) 
of the gene of interest to the -Ct of the reference gene GAPDH. qRT-PCR analysis was 
performed on a minimum of six mice per group.
Histological analysis
Fixed joints were decalcified in 270 mM EDTA for 14 days. Coronal sections of 7 μm made 
from various depths were used, representing the whole knee joints, which were 
deparaffinized, rehydrated and stained with Safranin-O and Fast Green (Brunschwig). 
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Cartilage damage in the tibiofemoral joints was scored in a blinded way using a more 
detailed version of the OARSI scoring system (22). Briefly, this OA score represents the 
combined assessment of the OA grade (the severity of the OA pathology observed; 0-6, 
where 0 represent no damage and 6 represents bone loss/remodeling/serious deformation 
of the subchondral bone) and OA stage (showing the extent of OA as percentage of total 
surface that shows any degree of degeneration; 0-5, where 0 represents no OA activity 
observed and 5 represent >75% of the total surface area). Five sections per knee joint were 
scored. Histological analysis for cartilage degeneration was performed for at least ten 
mice per group. The size of ectopic bone formation was scored in a blinded fashion using 
the Leica Application Suite software (Leica Microsystems), where osteophytes were 
manually encircled. The surface area in three sections per knee joint was determined.
Immunohistochemistry
To visualize protease activity in the joint, immunohistochemical staining for the aggrecan 
neoepitope NITEGE was performed as previously described [23]. In short, sections were 
incubated with a primary antibody raised against the NITEGE neoepitope (1:1000) 
(Aggrecan Neo; Acris) overnight. IgG isotype controls were included to verify antibody 
specificity. Next, sections were incubated with a biotin-labeled secondary antibody 
(DAKO), followed by incubation with a biotin-streptavidin detection kit (Vector Laboratories) 
and peroxidase binding was visualized using diaminobenzidine. Sections were counter-
stained with haematoxylin. Staining was scored in a blinded way using the Leica Application 
Suite software (Leica Microsystems) for three sections per joint. The surface area staining 
positive was corrected for the total area that was measured. Representative images of 
immunohistochemical stainings are shown.
Protein measurement using Luminex technology
To determine protein levels of MMP1, MMP2, MMP3 and MMP9 in the supernatant of the 
human end-stage synovial tissue cultures, Luminex multianalyte technology on the 
Bio-Plex system was performed in combination with multiplex MMP kits (Milliplex kits; 
Millipore). The sensitivity of the kit was <5 pg/mL.
 
Statistical analysis
Statistics were performed using GraphPad Prism version 5.0 (GraphPad Software). Differences 
between groups were tested using a Student’s t-test or paired t-test. P < 0.05 was considered 
significant. Results are expressed as means ± SEM, indicated by the error bars. 
Study approval
All experiments involving animals described in this study were approved by the Animal 
Care and Use Committee at the NIH, NIDCR (#13-700) and were performed according to 
the related codes of practice. The experiments involving humans were approved by the 
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Local Ethics Committee (CMO Arnhem – Nijmegen; approval number 2004-009), and 
written informed consent was obtained from all patients.
Results
Increased WISP1 expression in early OA patients with disease progression
First, we determined the relation between WISP1 expression in the synovial biopsies, 
obtained from a subgroup of the early symptomatic OA patients enrolled in the CHECK 
study, and damage at baseline, which was determined with the Kellgren Lawrence scoring 
system. We observed that WISP1 mRNA levels were not different between patients with no 
damage and patients that showed damage at baseline (Figure 1A). Next, we classified the 
CHECK patients as progressors or non-progressors, and defined progression of OA as a 
decrease in joint space width of ≥ 1mm and an increase in osteophyte size of ≥ 4x between 
baseline and the five-year follow-up measurement. We investigated whether WISP1 
expression levels were increased at baseline in patients that showed disease progression. 
Interestingly, we observed an association between WISP1 expression and progression of 
OA, where significantly increased WISP1 expression was found in the synovial tissue of 
patients that showed disease progression (2.83 fold increase, calculated as 2ΔΔCt) (Figure 1B).
Figure 1   WISP1 expression is increased in early symptomatic OA patients that show 
disease progression.
Expression levels of WISP1 in synovial tissue from early symptomatic OA patients was not significantly 
different between patients (n=12 donors) that had no damage and patients with damage, as 
determined by quantitative real-time PCR (A). WISP1 expression, determined by quantitative real-
time PCR, was significantly higher at baseline in CHECK participants that showed progression of 
OA (n=4 donors), compared to non-progressors (n=5 donors). We defined progression of OA as 
an increase in joint space width narrowing of ≥ 1 mm and an increase in osteophyte size of ≥ 4x 
between baseline and the five-year follow-up measurement. (B). Horizontal and vertical bars show 
the mean ± SEM. * = P < 0.05, versus non-progressors.
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Stimulation of human OA synovial specimen with WISP1 results 
in increased protease production
Next, to determine the mechanism of how WISP1 might be involved in OA pathology, we 
stimulated human end-stage synovial tissue with rhWISP1 and determined whether this 
resulted in increased protease expression. We observed increased mRNA expression of 
matrix metalloproteinase (MMP)3, MMP9, MMP13, and a disintegrin and metalloproteinase 
with thrombospondin motifs (ADAMTS)4 (2.5, 4.1, 5.8 and 2.0 fold increase respectively, 
calculated as 2ΔΔCt) (Figure 2A). Next, we determined the protein levels of excreted MMPs 
in the culture supernatants. This showed significantly increased expression of MMP1 and 
MMP9 (2.2 and 2.1 fold increase). In line with the results we obtained by mRNA expression, 
MMP2 levels were not significantly increased, whereas MMP3 upregulation showed a high 
variation (Figure 2B).
Spontaneous cartilage degeneration upon aging is not affected by WISP1
In the next set of experiments, we sought to determine the in vivo role of WISP1 in OA 
pathology. To this end, WT and Wisp1-/- mice were naturally aged up to 12 months and the 
spontaneous cartilage damage was assessed at 3 months, 6 months and 12 months of 
age. We observed an overall increase in cartilage damage with age; however, no significant 
differences in cartilage damage were detected between WT and Wisp1-/- mice at all ages 
(Supplementary Figure 1A). Expression of Wisp1 was fully depleted in Wisp1-/- mice 
(Supplementary Figure 1B). Because obesity is an important risk factor for OA, we 
determined the weight of the mice at 3 months of age. However, we could not detect 
weight differences between WT and Wisp1-/- mice (Supplementary Figure 1C).
Reduced cartilage degeneration in Wisp1-/- mice after induction 
of experimental OA
Next, we investigated the role of WISP1 in animal models of experimental OA. 
Representative photomicrographs showing the cartilage degeneration after induction of 
the CIOA, DMM or ACLT animal models of experimental OA in WT or Wisp1-/- mice are 
presented in Figure 3. We first induced CIOA in 3 month-old WT and Wisp1-/- mice. As 
presented in Figure 3A, 42 days after induction of the model, moderate cartilage 
degeneration was observed, which was significantly decreased in Wisp1-/- mice compared 
with their WT controls (44% reduction in the mean damage for the medial side). This 
indicates that WISP1 is actively involved in the disease progression of OA. Next, in order to 
substantiate our findings, we induced either DMM or ACLT experimental models in WT 
and Wisp1-/- mice. In agreement with what we observed in the CIOA model, the cartilage 
degeneration was significantly reduced in mice lacking Wisp1, 56 days after induction of 
both the DMM (29% reduction in the mean damage for the medial side) (Figure 3B) and 
the ACLT (22% reduction in the mean cartilage damage at the lateral side) (Figure 3C). 
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Figure 2   Increased protease expression in human end-stage OA synovium after 
stimulation with WISP1.
mRNA expression levels of MMP3, MMP9, MMP13 and ADAMTS4 in end-stage human OA synovial 
tissue (n=6 donors) were significantly increased after stimulation with 500 ng/mL recombinant 
human WISP1 for 24h compared to non-stimulated (NS) controls (A). Protein levels of MMP1 and 
MMP9 in the culture supernatant, as determined by Luminex multiplex analysis, were significantly 
increased after stimulation of end-stage OA synovium with WISP1 (n=6 donors) (B). Bars show the 
mean ± SEM. * = P < 0.05; ** = P < 0.01, versus NS samples.
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Figure 3   Reduced cartilage degeneration during experimental OA models in  
Wisp1-/- mice.
Representative photomicrographs (original magnification x 100) are shown from Safranin-O/Fast 
Green-stained sections of knee joints, after induction of collagenase-induced OA (CIOA; n=10 mice 
per group), destabilization of the medial meniscus (DMM; n=14 mice per group) or anterior cruciate 
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Increased cortical thickness and reduced trabecular spacing, 
but no differences in ectopic bone formation in Wisp1-/- after induction 
of experimental OA
Because OA is considered a whole joint disease, we determined whether differences in 
osteophyte formation and changes in the subchondral bone were observed between 
Wisp1-/- and WT mice. No clear differences in bony tissues were observed using histology 
and X-ray analysis after induction of CIOA whereas the induction of the ACLT model 
caused severe cartilage destruction that resulted in bone-on-bone contact and severe 
bone turnover. X-ray analysis after induction of the DMM showed possible differences in 
the bony compartment (Figure 4A). Therefore, we determined the osteophyte size and 
used µCT analysis to quantify morphometric changes in the subchondral bone in more 
detail. However, no differences in the formation of osteophytes on the medial side of the 
tibia and femur were observed between WT and Wisp1-/- mice (Figure 4B). µCT analysis 
revealed no differences in bone volume/total volume and bone mineral density of the 
entire subchondral bone compartment between WT and Wisp1-/- mice (Figure 4C). After 
conducting more detailed analyses on the cortical and subchondral bone, we observed 
an increased cortical thickness in Wisp1-/- joints (Figure 4D). Moreover, whereas the 
trabecular number, the trabecular thickness and the shape of the trabeculae was not 
different in the trabecular compartment of WT and Wisp1-/- mice, we observed a reduced 
trabecular spacing in the Wisp1-/- mice (Figure 4E).
Reduced expression of matrix-degrading enzymes in Wisp1-/- mice
To determine whether the differences in cartilage degeneration between the WT and 
Wisp1-/- mice could have arisen from differential expression of proteases, we isolated 
synovial biopsies 7 days after induction of CIOA, the model with the most prominent 
synovial involvement, and determined the expression of various proteases. We observed 
significantly decreased expression of both Mmp3 and Mmp9 (78.3% and 84.5% reduction, 
compared to the WT controls) (Figure 5A) as well as of the aggrecanases Adamts4 and 
Adamts5 (81.5% and 44.4% reduction, compared to the WT controls) (Figure 5B) in mice 
lacking Wisp1. Expression of the protease inhibitor Timp1 was significantly decreased in the 
Wisp1-/- mice (87.5% decreased, compared to WT controls), but interestingly levels of Timp3, 
which is an important inhibitor of ADAMTS4/5, were not affected (Figure 5C). Expression 
levels of these factors showed no differences between WT and Wisp1-/- mice in the 
ligament transection (ACLT; n=11 mice per group) in WT (Wisp1+/+) and Wisp1-/- mice. Arrowheads 
point to areas with cartilage degeneration. At 42 days after induction of CIOA, significantly decreased 
cartilage degeneration was observed at the medial side of the tibia, medial side of the femur and if 
the mean was calculated of these cartilage areas (A). Induction of the DMM experimental OA model 
(B) and the ACLT model (C) resulted in significantly decreased cartilage damage in Wisp1-/- mice at 
56 days after induction. Bars show the mean ± SEM. * = P < 0.05, versus WT controls.
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Figure 4   Increased cortical thickness and reduced trabecular spacing but no differences 
in ectopic bone formation in Wisp1-/-.
X-ray analysis of the subchondral bone after induction of the DMM model suggested differences in 
the bone compartment between wild type (Wisp1+/+) and Wisp1-/- mice (A). However, a more detailed 
investigation of the surface area using histology showed comparable sizes of ectopic bone formation 
on the medial side of the femur and tibia in wild type and Wisp1-/- mice (B). Moreover, whereas 
microCT analysis showed no differences in bone volume/total volume and bone mineral density 
of the entire subchondral bone (C), the Wisp1-/- mice showed an increased cortical thickness (D) 
and reduced trabecular spacing (E), compared to wild type mice. Representative three-dimensional 
reconstructions of the subchondral bone of the tibia are shown (F). Bars show the mean ± SEM. * = 
P < 0.05; ** = P < 0.01, versus wild type controls.
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contralateral control joints, except for a slightly reduced expression of Mmp3 and Timp1 in 
the Wisp1-/- mice (data not shown).
Decreased protease activity in the cartilage of Wisp1-/- mice after 
induction of experimental OA
To study whether the demonstrated differences in protease expression on the mRNA level 
results in altered cartilage degradation, we stained our sections for the neoepitope NITEGE, 
Figure 5   Decreased expression of MMPs and ADAMTSs during experimental OA in mice 
lacking WISP1.
Collagenase-induced OA was induced in WT (Wisp1+/+) and Wisp1-/- mice and 7 days after induction 
of the model, total RNA was isolated from synovial tissue biopsies (n=6 per group). Reduced 
expression of Mmp3 and Mmp9 (A), and Adamts4 and Adamts5 (B) was observed in Wisp1-/- mice 
compared to WT controls, as determined by quantitative real-time PCR. Additionally, the expression 
of Timp1 was decreased in Wisp1-/- mice. The expression of Timp3, which is known to be a potent 
inhibitor of ADAMTS4 and ADAMTS5 was not different between WT and Wisp1-/- mice (C). Bars show 
the mean ± SEM. * = P < 0.05, versus WT controls.
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formed by enzymatic cleavage of aggrecan. We observed decreased staining of NITEGE in 
the Wisp1-/- mice (representative images are shown in Figure 6A). Quantification using 
image analysis software showed significantly decreased staining in the mice lacking Wisp1 
(60% reduction in the mean staining for the medial side) (Figure 6B), indicating decreased 
protease activity
Figure 6   Reduced protease activity is observed in the cartilage of Wisp1-/- mice.
Protease activity in the cartilage during the collagenase-induced OA model was determined 
by immunohistochemical staining for the aggrecan neoepitope NITEGE (n=10 mice per group). 
Representative micrographs (original magnification x 400) of NITEGE-stained sections and the 
isotype IgG control are shown (A), which suggest that the amount of protease activity is decreased in 
mice lacking Wisp1 expression compared to WT (Wisp1+/+) controls, in both damaged and relatively 
unaffected parts of the cartilage. Quantitative scoring of the positively stained area confirmed that 
the protease activity was significantly decreased in Wisp1-/- under these circumstances, as determined 
by quantitatively scoring the positively stained area for three sections per joint (B). Bars show the 
mean ± SEM. * = P < 0.05, versus WT controls.
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Discussion
Here, we show for the first time that WISP1, a protein induced by canonical Wnt signaling, 
correlates with progression of OA pathology in a human cohort study of early symptomatic 
patients. Furthermore, we demonstrate that cartilage degradation in experimental animal 
models of OA is reduced in the absence of WISP1. Finally, we indicate that these effects 
might be caused by reduced protease expression and activity in mice lacking Wisp1.
In a previous study, we showed that various ligands that stimulate the Wnt signaling 
pathway were strongly increased in the synovium of two experimental OA models (6). 
Furthermore, we observed that the Wnt-induced protein WISP1 was significantly increased 
in these models. In contrast to the Wnt ligands, which only showed enhanced expression 
in the synovium, Wisp1 expression was increased in both the synovium and the cartilage. 
In addition to the experimental OA models, we observed that WISP1 expression in human 
cartilage was increased. Whereas WISP1 expression is normally present in the bone and 
only the superficial layer of the cartilage, human OA cartilage showed increased expression 
not only in the superficial layer but also in the deeper zones of the cartilage. This is in line 
with a study by Geyer et al, which shows increased expression of, amongst others, WISP1 
in affected OA cartilage (24). In this study we add to this knowledge by showing that the 
expression of WISP1 is increased in OA patients that showed disease progression over time.
These findings gave rise to the question: is there a role for WISP1 in the etiopathology of 
OA? We showed earlier that overexpression of Wisp1 in the synovium of naïve mice 
resulted in increased incidence and severity of early OA-like cartilage lesions 7 days after 
overexpression (10). However, in this previous study we investigated the role of Wisp1 only 
in naïve mice, whereas OA is a complex and multifactorial disease. Therefore, in the present 
study, we deepened our understanding of the role of Wisp1 in vivo by inducing 
experimental OA models in Wisp1-/- mice and compared them to WT controls. Our finding 
that WISP1 is associated with OA pathology parallels a study by Urano et al that showed 
that a single nucleotide polymorphism in the 3’-UTR of the WISP1 gene is associated with 
spinal OA (17). However, the cartilage areas where we observed decreased degeneration 
were not the same in all models. This might be due to different characteristics of, and 
pathways involved in the various models. Moreover, we found differences in cartilage 
damage between wild type and Wisp1-/- mice only after induction of experimental animal 
models of OA, whereas spontaneous degeneration as the result of aging was not affected 
up until 12 months of age. This is consistent with our finding that WISP1 expression at 
baseline was not different between CHECK participants with and without damage and 
suggests that WISP1 is involved in the progression of OA, rather than the initiation of the 
disease.
Surprisingly, in contrast to the reduction in cartilage damage we observed, most bone 
parameters we determined were not altered in the Wisp1-/- mice compared to their wild 
type controls. However, we observed an unexpected increase in the cortical thickness and 
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decreased trabecular spacing in Wisp1-/- mice, although this did not result in an increased 
total amount of bone tissue or mineral density. Previous studies have linked WISP1 with 
bone formation, by stimulation of osteoblast and inhibition of osteoclast differentiation 
(19). However, how exactly the severity of cartilage degradation and changes in the 
subchondral bone influence each other during the course of OA, remains a matter of 
debate and the apparent uncoupling of cartilage and bone parameters needs further 
mechanistic investigation.  
We show that the absence of Wisp1 results in decreased protease expression and activity. 
Previously, we and others have shown the potency of WISP1 to induce MMP expression (6, 
13, 14). We observed that stimulation of both murine and human synovial cells and 
chondrocytes resulted in increased expression of Mmp3 and Mmp9 (6). Other studies 
showed that WISP1 stimulated the production of MMP2 and MMP9 (13, 14).
Furthermore, this study associates synovial expression of WISP1 with disease progression, 
but not with damage at baseline, using biopsies from patients enrolled in the CHECK 
study. This CHECK cohort study provides a unique opportunity to study disease 
development, starting from the really early phases when participants visited their 
physician with complaints of hip and/or knee pain, although the number of participants 
that donated synovial biopsies is limited and the five-year follow-up data was not available 
for all participants. Therefore, additional studies with comparable designs would strongly 
further our insight into the early events that promote OA development.
Historically, WISP1 was considered to be a downstream protein target of canonical Wnt 
signaling. However, Kawaki et al. showed that addition of WISP1 to osteoblast cultures 
increased the accumulation of β-catenin (25). This shows that WISP1 also positively 
regulates upstream canonical Wnt signaling. Later, this finding was confirmed in another 
study that showed that WISP1 autoregulates its expression in a β-catenin-dependent 
manner (26). In the past, canonical Wnt signaling has been linked to OA pathology by our 
group and others (7, 9, 10). Although we did not assess this possibility in the present study, 
previous findings indicate that Wisp1-/- cells have reduced β-catenin levels (19). This 
feedback loop on canonical Wnt signaling therefore could possibly further aggravate OA 
once WISP1 production is increased.
Whereas Wnt signaling has been broadly implicated in the etiopathology of OA, both the 
canonical and noncanonical Wnt signaling pathways are extremely complex and are 
tightly regulated by a set of ligands, receptors, and inhibitors (27). In addition to this 
complex nature, Wnt signaling has been shown to be of central importance in many 
biological processes, ranging from early embryonic development to the maintenance of 
cell homeostasis later on in life. Furthermore, profound cross-talk between the Wnt 
signaling pathway and other pathways, such as the FGF-, TGF-β and Hedgehog signaling 
has been proven to be crucial for the functioning of these pathways (28-30). Therefore, 
upstream targeting of the canonical Wnt signaling pathway could be complex, likely 
causing multiple undesired side-effects. Specific targeting of Wnt-induced targets 
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proteins of the canonical Wnt signaling pathway therefore could provide an appealing 
alternative. In this light, this study supports the notion that WISP1 is an attractive target for 
OA therapy. Thus, targeting WISP1 may more specifically regulate the pathological events 
that take place during OA without interfering with normal processes.
Taken together, in the current study we have shown for the first time that the canonical 
Wnt-induced protein WISP1 plays an important role in the development of experimental 
osteoarthritis. In addition, we have shown that synovial expression of WISP1 may prove a 
useful target to predict cartilage damage and osteophyte progression during human OA.
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Supplementary Figure 1   Spontaneous cartilage damage upon aging is not affected 
by the absence of WISP1.
Wisp1-/- mice were generated and aged up to 12 months together with wild type (Wisp1+/+) controls. 
Cartilage degeneration was assessed after 3 months, 6 months and 12 months. No differences were 
observed between wild type and Wisp1-/- mice (n=5 mice per group), whereas cartilage damage 
increased with age. Photomicrographs (original magnification x 100) of representative Safranin-O/
Fast Green stained sections of 3 months old wild type and Wisp1-/- mice (A). Wisp1 expression was 
abolished in Wisp1-/- mice (n=6 mice per group), as determined by quantitative real-time PCR (B). 
The weight of wild type and Wisp1-/- mice was not different at 3 months of age, which was the age 
when experimental OA models were induced (n>20 mice per group) (C). Bars show the mean ± SEM.
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Supplementary Figure 2   Decreased β-catenin levels in Wisp1-/- mice.
Expression levels of Ctnnb1, the gene encoding β-catenin, were determined in the synovial tissue 
after induction of collagenase-induced OA, which is the model with the clearest involvement of the 
synovium in the induction of joint pathology. Quantitative real-time PCR showed decreased Ctnnb1 
expression levels in Wisp1-/- mice compared to wild type control mice (Wisp1+/+) (A). Moreover 
reduced protein accumulation of β-catenin was observed in both the cartilage and synovium in 
Wisp1-/- mice after induction of experimental OA (B). Representative photomicrographs of β-catenin 
staining are shown. Bars show the mean ± SEM. * = P < 0.05, versus wild type controls.
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Summary and concluding remarks
The Wnt signaling pathway plays a pivotal role in the development of many tissues during 
embryogenesis and is equally important in tissue homeostasis afterwards. Therefore, it is 
not surprising that deranged signaling is implicated in a multitude of diseases, among 
which many types of cancer [1]. The aim of this thesis was to enhance our knowledge 
about the role of Wnt signaling in OA, a complex disease for which the cause remains 
elusive, although it is more likely that OA is a central outcome of a multitude of processes. 
Up until now, no disease-modifying therapy to treat OA has been established and 
therefore more research on possible underlying mechanisms is indispensable. Among the 
many routes to increase our knowledge about OA, studying the effects of activation of 
signaling pathways is a popular approach. 
Wnt signaling is of the utmost importance in the development and homeostasis of the 
joint. Previous studies have shown that genetic defects in the Wnt inhibitor FRZB result in 
increased OA and that overactivation of canonical Wnt signaling in chondrocytes induces 
breakdown of the cartilage matrix (reviewed in Chapter 1). To further unravel the 
processes that underlie OA, we investigated the role of Wnt expression in the synovial 
tissue and the Wnt-induced protein WISP1 in both the synovium and cartilage.  
Wnt signaling in OA is induced by the alarmins S100A8/A9
Although we learned from a previous study conducted in our lab that various Wnt ligands 
and WISP1 were strongly upregulated in the synovial tissue during experimental OA, the 
cause for this increased expression remained unclear [2]. In Chapter 2 and Chapter 3 we 
demonstrated that the alarmins S100A8 and S100A9 showed coinciding expression with 
Wnt16 and WISP1, the two main members of the Wnt signaling pathway that we observed 
to be increased during experimental OA. Moreover, we observed that the alarmins S100A8 
and S100A9 induced the expression of Wnt16 and WISP1 in the synovium, mainly in M1 
macrophages. Translating these findings to a functional readout, we demonstrated 
accumulation of β-catenin in both the synovial tissue and cartilage. These findings are 
substantiated by a previous study that showed that S100A8 and S100A9 induce canonical 
Wnt signaling [3]. Previously, our lab investigated the involvement of S100A8/A9 signaling 
in the various processes that take place in the joint. It was described that S100A8/A9 result 
in increased production of MMPs and promotes osteophyte formation [4-6]. These data 
make it likely that at least part of the S100A8/A9 effects are mediated by activation of 
canonical Wnt signaling. Interestingly, Wnt and WISP1 signaling are well-known for their 
capacity to induce MMP production and both play a central role in bone formation where 
they promote osteoblastogenesis, while inhibiting osteoclastogenesis [2, 7-12]. However, 
whereas the alarmins S100A8 and S100A9 are very potent inducers of innate immune 
reactions, members from the Wnt signaling pathway have a far less well-established role 
in activating the innate immune system. Therefore, the exact contribution of activation of 
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Wnt signaling to the effects of S100A8/A9 that are observed in the joint during OA remains 
to be investigated. Vice versa, it seems likely that S100A8 and S100A9 are not the sole 
factors that induce Wnt members during experimental OA, because the extent of 
upregulation of Wnt16 and WISP1 induction during these models was much more 
profound than we observed after stimulation of synovium or cells with S100A8/A9 or 
injecting recombinant S100A8 into a naïve mouse knee joint. Additionally, Wnt signaling 
during OA was not completely absent in S100A9-/- mice. 
Increased synovial expression of Wnts resulting in canonical Wnt 
signaling results in increased cartilage damage
Although we previously described increased expression of Wnt members during OA, the 
consequences for the integrity of the joint remained to be elucidated. In contrast to a 
previous study [13], we found increased expression of the Wnt ligands, mainly Wnt16, 
specifically in the synovium [2]. Our results described in Chapter 4, show that adenoviral 
overexpression of Wnt8a (a classical model for a canonical Wnt ligand), and Wnt16 (the 
strongest upregulated Wnt in our experimental OA models) into naïve knee joints 
activated the canonical Wnt signaling pathway and increased both the number and 
severity of early OA-like superficial cartilage erosions. This was opposed to overexpression 
of Wnt5a (a classical model for noncanonical Wnt signaling), which failed to activate 
canonical Wnt signaling and did not result in cartilage lesions. These findings show that 
synovial expression of Wnts can contribute to the progressive cartilage damage that is 
found during OA. Moreover, they are in agreement with previous studies which mainly 
described activation of the canonical β-catenin-dependent pathway as the inducer of 
cartilage degeneration [8, 14]. Finally, they substantiate the increasing recognition of the 
synovium as important player in the induction of joint pathology during OA [15, 16].
Inhibition of canonical Wnt signaling decreases cartilage degeneration 
during OA
After having mapped the consequences of synovial overexpression of Wnts on the 
cartilage integrity, our next approach was to inhibit canonical Wnt signaling under OA 
conditions (Chapter 5). To this end, we induced experimental OA in mice that 
overexpressed DKK1 in an inducible manner. We showed that inhibition of canonical Wnt 
signaling resulted in decreased cartilage degeneration. This is in line with both our 
previous findings and other studies, in which experimental OA was induced in DKK1 
overexpressing mice [14, 17]. Nevertheless, we are the first to use an inducible approach. 
Because of the central role that canonical Wnt signaling plays in the development of both 
bone and cartilage, it is predictable that a non-inducible overexpression of this protein 
results in a severe phenotype before induction of the experimental OA models, which 
highly likely influences the course of pathology development [17]. 
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In short, Chapter 1-5 show that increased Wnt signaling is not merely present in the joint 
during OA, but in fact that this increased signaling, mainly via activation of the β-catenin-
dependent canonical route plays an important role in the induction of OA pathology. In 
the following chapters, we sought to determine possible mechanisms that could underlie 
these effects on the joint integrity.
Wnt/WISP1 signaling skews TGF-β signaling towards signaling  
via Smad1/5/8
As a first step, we showed that Wnt3a, which we used as a model system for canonical Wnt 
signaling, and/or WISP1 skewed TGF-β-induced Smad phosphorylation from Smad2/3 
towards Smad1/5/8 phosphorylation (Chapter 6). The TGF-β signaling pathway has been 
shown to be of key importance for maintaining chondrocyte homeostasis. TGF-β signaling 
via Smad2/3 has been shown to provide a brake on hypertrophic differentiation of 
chondrocytes, whereas the Smad1/5/8 pathway is historically known to mediate BMP 
signaling and has been associated with the induction of chondrocyte hypertrophy. 
Interestingly, it was previously described that canonical Wnt signaling could induce hy-
pertrophy-like differentiation of chondrocytes [8, 18, 19] and that profound crosstalk 
between the Wnt and TGF-β signaling pathways has been found (reviewed in Chapter 1). 
Our findings are in line with previous studies that showed decreased phosphorylation of 
Smad2/3 [20] and increased Smad1/5/8 phosphorylation [20, 21] under the influence of 
either Wnt or WISP1. Although we did not observe real chondrocyte hypertrophy, most 
probably due to the use of quickly proliferating cell lines, these data might provide a 
mechanism as of how increased canonical Wnt signaling in the OA joint can contribute to 
the degeneration of the articular cartilage.
Increased Wnt signaling in the synovial tissue induces MMP production
In Chapter 4, we already showed that increased expression of various Wnt ligands in the 
synovium resulted in increased OA-like cartilage lesions. However, the consequences of 
the increased expression of Wnt members in the synovial tissue itself remained to be 
elucidated. In Chapter 7, we build on this knowledge by showing that overexpression of 
Wnt8a and Wnt16 in naïve mice resulted in increased expression of various MMPs in the 
synovial tissue. Furthermore, we demonstrated using synovial biopsies from the CHECK 
cohort study of early symptomatic OA patients that various MMPs that are relevant for OA 
significantly correlate positively with the FZD1 and FZD10 receptors for Wnt ligands and 
inversely with the Wnt inhibitor FRZB. Moreover, progressors of OA showed increased 
FZD1 and decreased FRZB expression compared to non-progressors at inclusion in the 
cohort. Finally, we demonstrated that stimulation of human end-stage OA synovium with 
Wnt3a increased the expression of various MMPs that are relevant for OA, whereas 
inhibition of Wnt signaling with FRZB or DKK1 decreased their expression. MMPs are 
thought to be involved in the destruction of the joint and therefore, our results suggest 
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that the increased Wnt signaling that is present in the synovium actively contributes to 
the catabolic processes that are present during OA.
WISP1 as central mediator of Wnt signaling in OA-related pathology 
Finally, in Chapter 8, we zoomed in on the possible role of WISP1 during OA. WISP1 was 
previously described as a protein that is induced by canonical Wnt signaling [22]. Because 
Wnt signaling was mainly associated with OA via activation of the β-catenin-dependent 
canonical signaling route [8], this previous finding combined with our finding that WISP1 
was strongly upregulated in both the synovial tissue and cartilage during two models of 
experimental OA [2], made WISP1 an attractive target to study in more detail. 
We observed that the aging-induced spontaneous cartilage damage in WISP1-deficient 
mice was not different from wild type mice. In contrast, the cartilage degeneration found 
after induction of three different experimental murine models of OA was significantly 
decreased in mice lacking WISP1. This underlines that WISP1 is an important mediator of 
Wnt signaling in the joint under OA conditions. Furthermore, these data suggest that 
WISP1 is more relevant to the aggravation of existing OA pathology than in the initiating 
processes. The decrease in joint destruction in WISP1-deficient mice was accompanied by 
a decreased expression of proteases in the synovium from both the MMP and ADAMTS 
family. Although the effects of WISP1 on the integrity of the cartilage have not been 
studied previously, a stimulating role of WISP1 on the production of various MMPs has 
been described [2, 23] in line with our findings. In addition, a SNP in the WISP1 gene was 
previously associated with spinal OA [24]. 
Concluding remarks
The results delineated in this thesis have improved our understanding of the involvement 
of the Wnt signaling pathway in OA. We have demonstrated that increased Wnt expression 
in the synovial tissue, which we initially observed during two experimental animal models 
of OA, aggravates the joint destruction that takes place during this disease. The importance 
of synovial activation and inflammation is increasingly affirmed by studies that show 
presence of these phenomena in a considerable subgroup of OA patients and indicate 
that this is associated with increased progression of the disease [15, 16, 25]. Our data on 
synovial expression of Wnt ligands and their effects in the joint substantiate this view. 
Targeting synovial activation in OA therefore presents as an important aim to strive for in 
the development of disease-modifying therapies.
In this thesis, we zoomed in on various possibilities for targeting Wnt signaling during OA. 
First, we determined whether overexpression of the Wnt inhibitor DKK1 might serve as 
potential therapy. Although we observed significantly decreased cartilage damage in 
mice overexpressing DKK1, care should be taken with this approach. Long-term blocking 
of canonical Wnt signaling might give serious side effects, as this pathway is closely 
involved in stem cell maintenance and differentiation. Therefore, it is likely that a complete 
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block of canonical Wnt signaling gives rise to problems in tissues with a high cell turnover. 
Indeed, mouse models with constitutive overexpression of DKK1 result in a disorganized 
intestinal mucosa and strongly decreased bone volume [17, 26]. In contrast to these 
studies, pharmacological inhibition of canonical Wnt signaling is tolerated better, probably 
due to less efficient blocking of the signaling pathway. Moreover, we determined whether 
targeting the crosstalk between the Wnt and TGF-β signaling pathways might be a feasible 
approach. Although offering many opportunities to intervene, due to the complex nature 
of both the separate pathways and the profound crosstalk that takes place on many levels, 
it is difficult to determine the net outcome of therapeutic interventions. In addition, both 
pathways play central roles in a wealth of physiological processes. Therefore, we have to 
conclude that targeting this crosstalk is not feasible until enough is known about the 
consequences of interference. Finally, we studied and identified WISP1 as a promising 
target that is able to mediate the effects of canonical Wnt signaling within the joint. 
Although WISP1 is less well-studied in the context of OA and therefore further explorative 
steps should be undertaken to study the possibility of WISP1 as therapeutic target for OA, 
we here provided solid ground to opt for these studies. However, not much is known 
about the exact functioning of the matricellular WISP1 protein, which makes it hard to 
design pharmacological inhibitors. 
Despite the knowledge about the involvement of Wnt signaling in OA that this thesis adds 
to the general understanding of this disease, much of the exact processes that are initiated 
by Wnt signaling in the osteoarthritic joint remains unknown and needs further 
investigation. In this thesis, we mainly focused on the effects of Wnt signaling in the joint 
on the degeneration of the articular cartilage. Although this is considered the main 
characteristic of OA, it is not the sole pathology. Other types of pathology that are found 
during OA are fibrosis, sclerosis of the subchondral bone and ectopic bone formation. 
Based on previous literature, Wnt signaling is hypothesized to influence these processes in 
the OA joint in addition to the cartilage erosions. 
Activation of canonical Wnt signaling was described in multiple forms of organ fibrosis, 
including pulmonary [27, 28], liver [29, 30] and renal fibrosis [31, 32]. Moreover, TGF-β-induced 
skin fibrosis during experimental animal models of systemic sclerosis was shown to be 
mediated by canonical Wnt signaling [33, 34]. Furthermore, the Wnt-induced CCN family 
members WISP1, which we here present as an important mediator of canonical Wnt 
signaling in the OA joint, has been implicated with liver [35] and pulmonary [36] fibrosis. 
In addition, previous research has attributed crucial roles for canonical Wnt signaling in 
bone formation by mechanisms including stem cell renewal, proliferation of pre-osteo-
blasts, stimulation of osteoblastogenesis and inhibition of osteoclastogenesis, as reviewed 
by Krishnan et al [37]. Accordingly, the Wnt-induced WISP1 protein has been accredited a 
stimulating function on osteogenesis [12, 20], while inhibiting osteoclastogenesis [12]. 
Interestingly, a single nucleotide polymorphism in the gene encoding WISP1 is associated 
with endplate sclerosis of the spine during OA [24].
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Together, these findings point towards canonical Wnt signaling as an attractive therapeutic 
target for OA therapy. However, in order to make Wnt inhibition a main lead, further 
studies regarding the involvement of canonical Wnt and WISP1 signaling in OA-related 
pathologies and regarding safety problems that could arise from this inhibition should be 
conducted.
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Een kijkje in de keuken van artrose
In deze tijd dat mensen steeds ouder worden in de Westerse wereld, is er een groeiend 
probleem van veel voorkomende ouderdomsziektes. Dit veroorzaakt zowel maatschap-
pelijke als financiële problemen, naast de persoonlijke belemmeringen die de meerderheid 
van individuen met een ouderdomsziekte ondervindt. Eén van de meest voorkomende 
ouderdomsziektes is artrose (afgekort OA, van het Engelse woord “osteoarthritis”). De 
meerderheid van mensen boven de 50 jaar heeft een zekere mate van OA die kan worden 
vastgesteld door een reumatoloog. Het belangrijkste kenmerk van OA is de afbraak van 
het kraakbeen in gewrichten zoals in de vingers, schouder, ruggenwervel, heup of knie. 
Door zijn unieke eigenschappen speelt het kraakbeen (bestaand uit kraakbeencellen die 
een speciale matrix maakt die om de cellen heen ligt) een cruciale rol bij het dempen van 
schokkende bewegingen in het gewricht en zorgt ervoor dat beide gedeeltes van het 
gewricht (bijvoorbeeld het bovenbeen en het onderbeen in het kniegewricht) soepel en 
praktisch zonder wrijving over elkaar kunnen glijden. Door de afbraak van het kraakbeen 
vervallen deze eigenschappen, wat ervoor zorgt dat er direct bot op bot contact ontstaat, 
wat kan leiden tot gewrichtspijn en snellere slijtage van deze botten. 
Naast deze kraakbeenschade vinden er tijdens artrose ook andere processen plaats in het 
gewricht, zoals botnieuwvormingen op plekken waar normaal geen bot hoort te zitten 
(osteofyten; vaak goed te zien in de vingers van mensen met handartrose) en verdikking 
van de botlaag direct onder het kraakbeen (sclerose). Verder is er in de meerderheid van 
de OA patiënten ontsteking en verbindweefseling van het gewrichtskapsel (het synovium) 
zichtbaar waarbij er een overschot van matrix rondom de cellen komt te liggen. Vroeger 
dacht men dat deze fenomenen slechts een gevolg waren van de ziekte, maar heden ten 
dage is het algemene idee dat deze verschijnselen een actieve rol spelen bij het ontstaan 
en de voortgang van de ziekte. 
Wat de precieze oorzaak is van OA is nog niet bekend. Tevens is er nog geen behandeling 
die de ziekte echt afremt of stopt. De behandeling bestaat voornamelijk uit het onder- 
drukken van de pijn met pijnstillers, gecombineerd met levensstijladviezen. Als de OA 
uiteindelijk te erg wordt, krijgt de patiënt vaak operatief een nieuw gewricht.
Ontsteking in het gewrichtskapsel tijdens OA
Waar andere reumatische aandoeningen, zoals reumatoïde artritis, van oudsher worden 
bestempeld als ontstekingsziektes, was dit lange tijd minder duidelijk het geval voor OA. 
Het algemene beeld bestond dat OA voornamelijk een mechanische ziekte was, waarbij 
het kraakbeen door verkeerd gebruik of overgewicht sneller sleet dan gebruikelijk. 
Er komt echter steeds meer bewijs dat ontsteking weldegelijk ook bij OA een belangrijke 
rol speelt bij het ontstaan en verergeren van de gewrichtsschade. Ontsteking in het OA 
gewricht zit voornamelijk in het synovium (de binnenbekleding van de gewrichtsholte). 
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Hoewel de mate van ontsteking minder ernstig is dan bij reumatoïde artritis, is in meer 
dan 50% van de OA patiënten een duidelijk verhoogd aantal ontstekingscellen zichtbaar 
in het synovium. De twee voornaamste celtypes die aanwezig zijn in het synovium zijn de 
macrofagen en fibroblasten. Macrofagen zijn erg belangrijk bij de ontwikkeling van OA. 
Ze scheiden ontstekingsstoffen uit waarop andere cellen in het gewricht reageren en 
maken enzymen die rechtstreeks het kraakbeen af kunnen breken. Het specifiek verwijderen 
van macrofagen uit een gewricht zorgt ervoor dat de OA minder ernstig verloopt. Fibro- 
blasten kunnen ook ontstekingsstoffen en kraakbeenafbrekende enzymen uitscheiden 
en zijn daarnaast betrokken bij de verbindweefseling van het synovium. Twee stoffen die 
tijdens artrose door het synovium in grote hoeveelheden worden uitgescheiden zijn de 
zogenaamde S100A8 en S100A9 eiwitten en enkele leden van de Wnt (meestal uitgesproken 
als “wind”) signaling familie van eiwitten.
S100A8 en S100A9 eiwitten tijdens artrose
S100A8 en S100A9 eiwitten worden tijdens OA in grote hoeveelheden geproduceerd door 
cellen zoals macrofagen in het synovium. Deze stoffen activeren het immuunsysteem en 
zijn geassocieerd met een groot aantal ontstekingsziektes. Tijdens OA zijn deze eiwitten 
betrokken bij het ontstaan van ontsteking in het synovium en het is aangetoond dat ze 
rechtstreeks negatieve effecten hebben op kraakbeencellen in het gewricht. Tevens heeft 
ons lab beschreven dat er minder kraakbeenschade en verminderde botnieuwvorming is 
wanneer deze stoffen afwezig zijn tijdens experimentele modellen die OA nabootsen. 
Wnt signaling tijdens OA
Wnt signaling in de cel is voornamelijk bekend vanwege de belangrijke rol die deze 
signalerings route speelt tijdens de ontwikkeling van embryo’s. Hier bepaalt deze route 
mede welke route stamcellen nemen in hun verdere ontwikkeling tot allerlei celtypes en 
verder zorgt Wnt signaling voor patroonvorming tijdens de ontwikkeling, waardoor 
bepaald wordt wat voor en achter, links en rechts wordt in het lichaam. Op deze manier 
worden organen, maar ook ledematen en gewrichten aangelegd. Na de geboorte is Wnt 
signaling belangrijk voor veel weefsels in het lichaam om deze in een gezonde staat te 
houden. Is er te weinig Wnt signaling, dan veranderen de weefsels op een ongunstige 
manier, maar teveel Wnt signaling is betrokken bij veel ziektes zoals verbindweefseling 
(fibrose) van onder meer lever, longen en nieren. Verder is er veel bewijs dat Wnt signaling 
verschillende soorten tumoren verergert en ook zorgt voor uitzaaiingen door het 
stimuleren van celdeling en de productie van enzymen waardoor cellen kunnen gaan 
verplaatsen naar andere gebieden in het lichaam (migreren). 
In relatie tot OA is er bekend dat kunstmatige activering van Wnt signaling in kraakbeen-
cellen zorgt voor kenmerken van OA, zoals afbraak van het kraakbeen. Ook hier is echter 
duidelijk geworden dat het volledig blokkeren van Wnt signaling in het kraakbeen niet 
goed is, omdat in dit geval de kraakbeencellen dood gingen wat uiteindelijk ook leidt tot 
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afbraak van het kraakbeenweefsel. Dit geeft aan dat gebalanceerde Wnt signaling van 
uiterste noodzaak is voor het behoud van gezond weefsel. Verder is gevonden dat een 
mutatie in een gen dat codeert voor een remmer van Wnt eiwitten (waarbij de mutatie 
leidt tot verminderde remming van Wnt eiwitten) geassocieerd is met verhoogde kans op 
en ernst van artrose. Ten slotte is aangetoond dat een kunstmatig tot stand gebrachte 
hoge productie van een andere Wnt remmer zorgt voor verminderde gewrichtsschade in 
experimentele modellen voor artrose. Dit alles geeft duidelijke indicaties dat verhoogde 
Wnt signaling kan leiden tot OA. Om deze reden is het interessant dat ons lab in het 
verleden heeft aangetoond dat verschillende leden van de familie van Wnt eiwitten 
tijdens OA verhoogd zijn in het synovium, wat mogelijk invloed kan hebben op de verdere 
ontwikkeling van de ziekte in het aangedane gewricht.
Doel van dit proefschrift
In de experimenten die beschreven staan in dit proefschrift hebben we onderzoek 
gedaan naar de rol van de verhoogde productie van Wnt eiwitten in het synovium op de 
weefsels in het gewricht en wat deze verhoogde productie veroorzaakte. Hiervoor 
hebben we gebruik gemaakt van weefselmateriaal van artrose patiënten en verschillende 
experimentele muismodellen voor OA. Tevens hebben we materiaal van een cohortstudie 
(een studie met een groot aantal patiënten met dezelfde kenmerken) van vroege OA 
patiënten gebruikt om hun weefsel te inventariseren. Met behulp van al dit materiaal 
hebben we geanalyseerd of verhoogde productie van Wnt eiwitten leidt tot meer afbraak 
van het gewrichtskraakbeen en hebben we onderzocht of dit kwam door meer productie 
van ontstekingsstoffen en enzymen die het kraakbeen af kunnen breken.
Onze bevindingen zoals beschreven in dit proefschrift
In hoofdstuk 1 zijn we begonnen met een samenvatting van de huidige kennis over 
artrose en de processen die een rol spelen in deze ziekte. Vervolgens hebben we in meer 
detail de Wnt signaling geïntroduceerd en hoe deze signaleringsroute betrokken kan zijn 
bij het ontstaan en verergeren van OA. In hoofdstuk 2 en 3 hebben we de link gelegd 
tussen de S100A8/S100A9 eiwitten en de leden van de Wnt signaling familie. Het viel ons 
op dat deze eiwitten tijdens artrose modellen op dezelfde momenten tot expressie 
komen en vroegen ons af of er een oorzakelijk verband tussen beide te vinden was. Met 
experimenten hebben we aangetoond dat S100A8 en S100A9 eiwitten het synovium 
stimuleren tot de productie van ontstekingsstoffen en enzymen die het kraakbeen af 
kunnen breken. Dit is de functie waar deze eiwitten het meest bekend om staan. Tevens 
leidde stimulatie van macrofagen, maar niet van fibroblasten, tot de productie van Wnt16 
(een Wnt familielid dat we in eerdere studies het sterkst verhoogd vonden tijdens artrose) 
en WISP1 (een eiwit dat in de cel wordt geproduceerd als er actieve Wnt signaling 
plaatsvindt in deze cel). Injectie van S100A8 eiwit in een gezond kniegewricht activeerde 
Wnt signaling en we vonden verminderde activering van Wnt signaling na het tot stand 
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brengen van experimentele OA in muizen die het S100A9 eiwit missen. Deze experimenten 
tonen aan dat de S100A8 en S100A9 eiwitten Wnt signaling kunnen activeren in een 
gewricht. Door vervolgens eerst S100A8 in te spuiten en tegelijkertijd Wnt signaling te 
remmen konden we aantonen dat een gedeelte van de S100A8 effecten verliep via de 
activering van Wnt signaling. Echter was de mate van activering minder dan we normaal 
zien tijdens artrose, wat aangeeft dat er tijdens OA waarschijnlijk nog andere mechanismen 
aanwezig zijn die zorgen voor de activering van Wnt signaling. Daarnaast hebben de S100 
eiwitten ook effecten die onafhankelijk van Wnt eiwitten zijn. 
Vervolgens beschrijven we in hoofdstuk 4 wat de gevolgen zijn van het kunstmatig 
verhogen van de productie van Wnt eiwitten in het synovium met behulp van een virus, 
om de situatie van de verhoogde expressie in het synoviale weefsel na te bootsen. 
Overexpressie van twee Wnt eiwitten die leiden tot activering van de zogenaamde 
canonical Wnt signaling route (er zijn in de cel meerdere routes die geactiveerd kunnen 
worden door Wnt eiwitten) resulteerde in meer en ernstigere vroege kraakbeenschade 
(kraakbeenlesies). Dit was in tegenstelling tot overexpressie van een Wnt eiwit dat tot 
noncanonical Wnt signaling leidt en geen effect had op het gewricht. Overexpressie van 
WISP1, waarvan de productie in de cel wordt geïnduceerd specifiek door canonical Wnt 
signaling, had soortgelijke effecten. De lesies waren omringd door een heel specifiek 
motief dat achterblijft in de kraakbeenmatrix na activiteit van bepaalde kraakbeen-
afbrekende enzymen, wat duidt op de verhoogde productie van deze enzymen onder 
invloed van Wnts. Deze experimenten zijn echter uitgevoerd in een gewricht zonder 
OA. Dit gaf ons de mogelijkheid om heel specifiek de effecten van overexpressie van deze 
Wnt eiwitten te onderzoeken, hoewel het wel om een oversimplificatie van een OA 
gewricht gaat waar veel factoren tegelijk aanwezig zijn wat tot andere eindeffecten 
kan leiden. 
Om de rol van Wnt signaling tijdens OA beter te bestuderen hebben we een muizenstam 
gemaakt die een Wnt remmer gaat produceren als deze muis voedsel krijgt waaraan het 
stofje doxycycline is toegevoegd. In hoofdstuk 5 laten we zien dat muizen waarin Wnt 
signaling op deze manier is geremd tijdens OA modellen minder schade ontwikkelen. Dit 
toont aan dat Wnt signaling verhoogd is tijdens OA modellen en dat deze verhoogde 
productie ook daadwerkelijk een rol speelt in een OA omgeving. 
In de hoofdstukken 6, 7 en 8 hebben we vervolgens gezocht naar mechanismes die hier 
de oorzaak van kunnen zijn. Hoofdstuk 6 toont aan dat canonical Wnt signaling invloed 
heeft op de TGF-β signaalroute. Deze route is betrokken bij veel van de processen waar 
ook Wnt signaling een rol speelt en eerdere onderzoeken hebben al aangetoond dat 
beide signaalroutes elkaars uitwerking kunnen beïnvloeden. In kraakbeencellen kan 
TGF-β signaleren via twee routes. De Smad2/3 route is erg belangrijk om het kraakbeen in 
een goede conditie te houden, waar voor de Smad1/5/8 route is aangetoond dat dit zorgt 
voor “doorontwikkeling” van de kraakbeen cellen, wat uiteindelijke leidt tot kraakbeenaf-
braak. In dit hoofdstuk tonen we aan dat in kraakbeencellen het TGF-β signaling signaal 
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wordt verschoven van de Smad2/3 route richting de schadelijke Smad1/5/8 route onder 
invloed van canonical Wnt signaling en WISP1. 
In hoofdstuk 7 richten we ons vervolgens weer op het synovium. Waar we eerder 
verhoogde productie van Wnts voornamelijk in dit weefsel beschreven, hadden we echter 
de effecten hiervan op het synoviaal weefsel nog niet onderzocht. We tonen aan dat 
overexpressie van Wnts in het synovium, waarvan in hoofdstuk 4 beschreven is dat dit 
leidt tot een motief in het kraakbeen dat duidt op enzymactiviteit, inderdaad de productie 
van deze enzymen in het synovium verhoogt. Bovendien wordt de productie van deze 
enzymen verminderd als we remmers van Wnt signaling toevoegen aan synoviaal weefsel 
dat verkregen is van OA patiënten nadat deze een gewrichtsvervangende operatie 
ondergaan hadden. Dit is erg interessant richting mogelijke therapie. Verder laten we in dit 
hoofdstuk zien dat deelnemers aan de CHECK (Cohort Heup En Cohort Knie) cohortstudie 
die ziekteprogressie hadden over een tijdsbestek van 5 jaar, een hogere expressie van een 
sensor voor Wnt eiwitten op de cel hadden in hun synovium aan het begin van de studie. 
Tevens hadden de patiënten met progressie juist minder expressie van een remmer voor 
Wnt signaling. Dit toont aan dat niet alleen in muizen maar ook in mensen Wnt signaling 
in het synovium betrokken lijkt te zijn bij de verergering van OA. 
Ten slotte zoomen we in hoofdstuk 8 in op de werking van het WISP1 eiwit, dat in de cel 
geproduceerd wordt als er actieve canonical Wnt signaling plaatsvindt. We tonen aan dat 
in dezelfde cohortstudie als in hoofdstuk 7, WISP1 expressie verhoogd is in patiënten die 
ziekteprogressie laten zien over een tijdsbestek van vijf jaar. Daarnaast resulteerde 
stimulatie van humaan synoviaal weefsel met WISP1 in verhoogde productie van kraak-
beenafbrekende enzymen. Vervolgens hebben we onderzocht wat WISP1 voor invloed 
had op het beloop van experimentele OA. Hiervoor hebben we een muizenstam gebruikt 
die geen WISP1 produceert. Dit resulteerde in verminderde gewrichtsschade in 3 
verschillende experimentele OA modellen. Tevens vonden we dat muizen die geen WISP1 
hebben minder kraakbeenafbrekende enzymen maken in het synovium tijdens 
experimentele OA. Dit resulteerde tevens in verminderde aanwezigheid van het motief 
voor de activiteit van deze enzymen, dat achterblijft in het kraakbeen. 
 
Eindconclusie
In dit proefschrift hebben we aangetoond dat verhoogde productie van eiwitten van de 
Wnt familie een belangrijke rol speelt bij het ontstaan van OA. Tevens hebben we WISP1 
geïdentificeerd als een eiwit dat wordt gemaakt als gevolg van canonical Wnt signaling en 
dat een centrale rol kan spelen in de effecten die Wnt signaling heeft in het OA gewricht. 
In dit proefschrift focussen we voornamelijk op de afbraak van het kraakbeen in de 
gewrichten, maar naar aanleiding van eerdere studies in andere ziektes is het waarschijnlijk 
dat Wnt signaling ook een rol kan spelen in de verbindweefseling van het gewricht en in 
de botnieuwvormingen in het OA gewricht. Om dit verder uit te zoeken zijn echter andere 
studies noodzakelijk.
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Dankwoord
En dan, beste lezers, zijn jullie nu aangekomen bij het laatste onderdeel van mijn proefschrift, 
waar ik naar goed gebruik mensen hartelijk wil bedanken voor hun bijdrage, in welke 
vorm dan ook, aan dit proefschrift. Hieruit blijkt wel weer dat er een flinke lijst aan mensen 
nodig is om een proefschrift mogelijk te maken. Aanvankelijk dacht ik dat dit wel het 
makkelijkste gedeelte van dit boekje zou zijn om te schrijven, maar het valt toch behoorlijk 
tegen. Helaas kan ik niet iedereen uitgebreid bedanken, maar ook als ik alleen je naam 
noem: super bedankt!
Daar gaan we!
Peter van Lent, allereerst gaat mijn dank uit naar jou, als leider van de werkgroep waar 
 ik de meeste tijd heb doorgebracht. Je bent een bioloog/onderzoeker in hart en nieren. 
Twee zinnen zijn voor jou genoeg om tien nieuwe mogelijkheden te zien, wat je 
gecombineerd met een flinke dosis enthousiasme denk ik een goede groepsleider en 
onderzoeker maakt. Af en toe moeten je collega’s even wat bijremmen, maar één ding 
is zeker: aan nieuwe ideeën was er nooit een gebrek. Verder dank voor je vertrouwen, 
waardoor we ook in de toekomst hopelijk nog flink wat samen kunnen gaan werken.
Peter van der Kraan, als tweede groepsleider en later als labhoofd, heb jij altijd je kritische 
blik op mijn werk laten vallen, waarvoor dank. Je commentaar bij bijvoorbeeld manuscripten 
was meestal bondig, soms een tikkeltje absurdistisch, maar zeker raak. Daarnaast is het 
altijd goed om jou als wandelende encyclopedie erbij te hebben aan de koffietafel, voor 
het geval we iets niet weten. Ook wil ik je bedanken voor de introductie op de verschillende 
congressen waar we zijn geweest. 
Wim, dank je dat ik op jouw afdeling mijn promotie mocht doen. Ik heb het altijd prima 
naar mijn zin gehad binnen deze geoliede machine, waarvoor jij grotendeels verantwoor-
delijk bent. Dank ook voor je altijd (denk ik) oprechte interesse en je zeer directe maar 
pakkende manier van communiceren. De “could you please go back to slide 1” en “so 
what?” opmerkingen waren vaak even wennen voor beginnende mensen op het lab, 
maar ik heb er zeer zeker heel veel aan gehad. Ik wens je het allerbeste toe en veel plezier 
als reizende pensionado!  
Arjen, als mijn dagelijkse begeleider en natuurlijk schrijver van het project waarop ik 
aangenomen ben wil ik je bedanken. Het was goed om met je samen te werken. Als 
gedegen onderzoeker ben je een vaste waarde in werkgroep 4, maar ook zeker voor de 
rest van het lab. Ten slotte ken ik weinig mensen met een dergelijk droge humor als jij 
hebt. Werkbesprekingen en koffiepauzes zijn net even leuker met jouw opmerkingen 
en onderschriften, tekeningen en fruit-kunst erbij.
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Marian, the time in your lab (as the only male person, which I understood is the max at a 
time) was great! Your positivity for possibilities in science is very contagious. I learned a lot 
about (subchondral) bone biology and I hope we can keep our collaboration (possibly 
related to the fabulous molecule WISP1) alive in the future. 
Dan vertrekken we nu naar de dankbetuigingen richting de (ex)leden van groepje 4. Als 
eerste Annet, als analist voor groep 4 van enorme waarde. Zonder jou was dit boekje niet 
afgekomen denk ik. Je bent een oprecht persoon en altijd recht door zee, wat ik erg 
prettig vind (en daarnaast levert het ook vaak hilarische opmerkingen/momenten op). 
Daarom ben ik ook blij dat je straks naast/achter me staat bij mijn verdediging als paranimf. 
Wouter de Munter, de slechte woordgrappen waren vaak niet van de lucht in U-tje 7. Je 
was een goeie buur en ik begin bijna je YouTube-filmpjes van trompetsoli nog te missen. 
Daarnaast hadden we ook regelmatig gezonde (wetenschappelijke) discussies. Ik vond 
het prettig om met je samen te mogen werken en ik ben er van overtuigd dat jij er wel 
komt! Rik, nadat jij al weg was heb ik het nog voor elkaar gekregen om twee manuscripten 
te publiceren over S100A8/A9 (in combi met de Wnts natuurlijk), waarvoor we samen veel 
experimenten hebben gedaan. De RNAse-vrijdag/RNA-Friday heeft niet meer echt een 
vervolg gekregen helaas. Edwin, Niels, Stephanie, Irene, Giuliana, Lilyanne, Wouter 
Hofkens, en Menno bedankt voor jullie kritische blik op mijn experimenten, de goede 
tips en natuurlijk voor de gezellige samenwerking op het lab. Succes in de toekomst en 
voor degenen van jullie voor wie het nog van toepassing is: succes met jullie eigen 
proefschrift. 
Vervolgens kan ik natuurlijk de analisten niet vergeten heel hartelijk te bedanken, 
Monique, Birgitte, Liduine, Miranda, Elly, Onno (of moet ik je nu ook bij de PhD 
students zetten Onno?). Wat verzetten jullie bergen werk om de machine draaiende te 
houden. Zonder jullie hulp, in het begin voornamelijk om technieken op het CDL te leren 
en later voornamelijk met het snijwerk, was dit boekje nog niet af geweest! Top!
Fons, Marije, als groepsleiders zijn jullie van vaste waarde voor team reuma. Beiden met, 
op een heel verschillende en eigen manier, goede inzichten en commentaren op het 
werk van anderen. Bedankt voor jullie wijze woorden tijdens lijnbesprekingen, werk-
besprekingen en daar buiten.
Marianne, een afdeling kan niet zonder een goede secretaresse, dat laat jij zien! Alles was 
tot in de puntjes geregeld, maar er was ook altijd ruimte voor een sociaal praatje. Ik zal 
proberen wat vaker vrij te nemen.
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Alle studenten die hebben bijgedragen aan de hoofdstukken in dit proefschrift: Anke, 
Sylvia, Paola, Pelle, helaas heb ik niet alles kunnen verwerken in de artikelen, maar dank 
voor jullie inzet. An extra tip o’ the hat to Teresa: thanks for writing a beautiful review, 
which was the solid base for Chapter 1. Aye aye! I wish you all the best for the future!
Esmeralda, dank je wel voor je kritische blik op en het meedenken met andermans werk. 
Ik waardeer het. Daarnaast was het ook gezellig met taartjes, ijsjes en tijdens congressen, 
waarbij onze gesprekken varieerden van heel serieus tot de grootste onzin. Ennum: 
zwiefsjoefswishhhhh….score!!
Arjan, ongeveer gelijk gestart en ongeveer gelijk klaar denk ik?! Ik wil je in het bijzonder 
nog even bedanken voor de vele, meestal wetenschappelijke, discussies die we hebben 
gehad. Ik denk dat jij van het type “onderzoeker van nature” bent en ik weet zeker dat je 
het heel ver gaat schoppen.
Daarnaast ben ik mijn mede PhD students en postdocs erkentelijk voor de wetenschap-
pelijk input, maar zeker ook de gezelligheid op het lab, op congressen of in de Aesculaaf: 
Shahla, Henk, Guus, Claire, Bartijn, Daphne, Rebecca, Debbie, Marijn, Renske, Laurie, 
Ellen, Wojciech. Mathijs, je bent in vele opzichten een waardige opvolger van Wouter als 
mijn buurman en ik hoop dat we nog lang U-genoten mogen blijven. Ik wens jullie heel 
veel succes met jullie promoties en jullie toekomst. Mede dankzij jullie ging ik zelden met 
tegenzin naar het werk.
Dit geldt natuurlijk ook voor de oud-collega’s waarmee ik gewerkt heb (de een wat langer 
dan de andere): Ben, Renoud, Kim, Lenny, Tamara, Tim, Richard, Marta, Dennis, Eva, 
Eline, Bas, Tom, Silke, Marieke. 
Thomas and Johannes, the S100-work in Chapter 2 and Chapter 3 would not have been 
possible without the fruitful collaboration between our labs. Thank you for the S100 
measurements, proteins and for critically reviewing the manuscripts.
Mijn vrienden en kennissen wil ik graag bedanken voor de interesse in mijn onderzoek of 
waar ik nu zoal mee bezig ben geweest. De één begreep er wat meer van dan de ander, 
wat soms op kritiek kwam te staan als we het met wat mensen alwéér over werk hadden 
op een verjaardag! Maike, Michiel, Jordie, Bregtje, Rick, Sanne, Eric, Anne, Mark, 
Teunke, Bart, Lieke, Ramon, Hennie, Sharon: bedankt! Martijn, ik ben blij dat je mijn 
paranimf bent vandaag. We hebben heel wat uurtjes samen gestudeerd vroeger op de 
middelbare school tijdens toetsweken en vandaag leek me een goed moment om de 
cirkel rond te maken. En al zien we elkaar nu wat minder vaak, het is altijd vreselijk gezellig!
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Jan, Anja, Paul, bedankt voor de interesse die jullie altijd toonden in mijn onderzoek en 
bezigheden op de uni. Het was altijd gezellig tijdens een etentje, whisky beurs of een 
goed potje Risken. Ik hoop dat ik nog lang bij jullie over de vloer kom. En natuurlijk flink 
wat credits voor de mooie cover van dit boekje!
Pa en ma, altijd klaarstaand, hartelijk en aanmoedigend, zo kan ik jullie wel beschrijven. 
Een goede start is iets heel bijzonders en belangrijks in het leven en die heb ik zonder 
twijfel gehad bij jullie. Altijd stonden (en staan) jullie voor mij klaar en hebben jullie me 
aangemoedigd om door te leren en nieuwe dingen te verkennen. Nou…hier sta ik dan! 
Bedankt voor jullie vertrouwen in mij en jullie onvoorwaardelijke steun. Ik weet zeker dat 
ik anders niet zo ver gekomen was. Ik wens jullie het beste!!
Anouk, last but not least!! Je geeft me de steun, vertrouwen en rust die ik nodig heb om 
recht te blijven lopen. Jij maakt thuiskomen na een werkdag fijn. Ik ben benieuwd wat de 
toekomst ons allemaal gaat brengen, maar één ding is zeker: ik kijk er echt ontzettend naar 
uit. Was de toekomst maar vast begonnen... ik hou van je!!
En nu is hij echt af: over en uit!
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Wnt erosion 
in osteoarthritis: 
where the will  
o’ the WISP leads us
Involvement of Wnt activation 
in osteoarthritis: WISP1 as 
important mediator of pathology
About the title and cover:
The term wind erosion refers to the damage done to 
the land as the result of forces exerted by wind that 
detach soil particles from the land surface, thereby 
changing the shape of the original structures. In this 
thesis, we describe that during osteoarthritis, forces 
exerted by high Wnts (winds) in like manner cause 
erosion of the articular cartilage in joints. Will o’ the 
wisp refers to the atmospheric lights seen by travelers 
over bogs, marshes and swamps, which draw the 
travelers from the safe paths and to their demise. 
The manuscripts in this book describe that the Wnt- 
induced protein WISP1 might be the protein that leads 
the joint off the safe path and causes damage to the 
articular cartilage. The cover represents the will o’ the 
wisp leading to wind erosion.
